-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 NRKhSeNRbUL9o+gz+qvEP9YlkWf6KQPcoUYyuxDQZII2XDInZz7wA/lWm7Q2ysL8
 dy0o9uL75cyPqVQJN2NSgw==

<SEC-DOCUMENT>0000950103-08-002333.txt : 20080910
<SEC-HEADER>0000950103-08-002333.hdr.sgml : 20080910
<ACCEPTANCE-DATETIME>20080910150236
ACCESSION NUMBER:		0000950103-08-002333
CONFORMED SUBMISSION TYPE:	SC TO-T/A
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20080910
DATE AS OF CHANGE:		20080910
GROUP MEMBERS:		CVS CAREMARK CORPORATION

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LONGS DRUG STORES CORP
		CENTRAL INDEX KEY:			0000764762
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				680048627
		STATE OF INCORPORATION:			MD
		FISCAL YEAR END:			0128

	FILING VALUES:
		FORM TYPE:		SC TO-T/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-37157
		FILM NUMBER:		081065017

	BUSINESS ADDRESS:	
		STREET 1:		141 NORTH CIVIC DRIVE
		CITY:			WALNUT CREEK
		STATE:			CA
		ZIP:			94596
		BUSINESS PHONE:		925-937-1170

	MAIL ADDRESS:	
		STREET 1:		141 NORTH CIVIC DRIVE
		CITY:			WALNUT CREEK
		STATE:			CA
		ZIP:			94596

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Blue MergerSub Corp.
		CENTRAL INDEX KEY:			0001442832
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC TO-T/A

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DRIVE
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		401-765-1500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DRIVE
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC TO-T/A
<SEQUENCE>1
<FILENAME>dp11297_sctota2.htm
<DESCRIPTION>AMENDMENT NO. 2 TO SCHEDULE TO
<TEXT>
<html>
  <head>
    <title> </title>
    </head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 9pt; MARGIN-LEFT: 5%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 5%; FONT-FAMILY: Arial">
    <div>&#160;</div>
    <div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
        <div>
          <hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
          <hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
        </div>
      </div>
      <div align="left">
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td valign="middle" width="79%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 16pt; FONT-FAMILY: times new roman">UNITED
      STATES</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 16pt; FONT-FAMILY: times new roman">SECURITIES
      AND EXCHANGE COMMISSION</font></div>
              </td>
            </tr>
            <tr>
              <td valign="middle" width="79%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Washington,
      D.C.&#160;&#160;20549</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
                  <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">
                    <hr style="COLOR: black" align="center" noshade size="1" width="15%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 14pt; FONT-FAMILY: times new roman">SCHEDULE
      TO</font></div>
                  </div>
                </div>
              </td>
            </tr>
            <tr>
              <td valign="middle" width="79%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Tender
      Offer Statement under Section 14(d)(1) or 13(e)(1) of</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">the
      Securities Exchange Act of 1934</font></div>
              </td>
            </tr>
            <tr>
              <td valign="middle" width="79%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">(Amendment
      No. 2)</font></div>
              </td>
            </tr>
            <tr>
              <td valign="middle" width="79%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td valign="bottom" width="79%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 16pt; FONT-FAMILY: times new roman">LONGS
      DRUG STORES CORPORATION</font></div>
              </td>
            </tr>
            <tr>
              <td valign="middle" width="79%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(Name
      of Subject Company)</font></div>
              </td>
            </tr>
            <tr>
              <td valign="middle" width="79%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td valign="middle" width="79%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">BLUE
      MERGERSUB CORP.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">CVS
      CAREMARK CORPORATION</font></div>
              </td>
            </tr>
            <tr>
              <td valign="middle" width="79%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(Names
      of Filing Persons &#8211; Offeror)</font></div>
              </td>
            </tr>
            <tr>
              <td valign="middle" width="79%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td valign="middle" width="79%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Common
      Stock, Par Value $0.50 Per Share</font></div>
              </td>
            </tr>
            <tr>
              <td valign="middle" width="79%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(Title
      of Class of Securities)</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
                  <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">
                    <hr style="COLOR: black" align="center" noshade size="1" width="15%">      </div>
                  <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">543162101</font></div>
                  </div>
                </div>
              </td>
            </tr>
            <tr>
              <td valign="middle" width="79%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(Cusip
      Number of Class of Securities)</font></div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="79%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td valign="top" width="79%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Douglas
      A. Sgarro, Esq.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Executive
      Vice President and Chief Legal Officer</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">CVS
      Caremark Corporation</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">One
      CVS Drive</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Woonsocket,
      Rhode Island 02895</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(401)
      765-1500</font></div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="79%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(Name,
      Address and Telephone Number of Person Authorized to Receive
      Notices</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">and
      Communications on Behalf of Filing Persons)</font></div>
              </td>
            </tr>
            <tr>
              <td valign="middle" width="79%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td valign="middle" width="79%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Copies
      to:</font></div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="79%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Louis
      L. Goldberg, Esq.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">John
      D. Amorosi, Esq.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Davis
      Polk&#160;&amp; Wardwell</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">450
      Lexington Avenue</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">New
      York, New York 10017</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Telephone:
      (212)&#160;450-4000</font></div>
              </td>
            </tr>
            <tr>
              <td align="left" valign="top" width="79%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
        </table>
      </div>
      <div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
        <div>
          <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
              <tr valign="top">
                <td style="WIDTH: 36pt">
                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Wingdings 2, serif">&#163;</font></font></div>
                </td>
                <td>
                  <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt">Check the box if the filing
      relates solely to preliminary communications made before the commencement
      of a tender offer.</font></font></div>
                </td>
              </tr>
          </table>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">Check the
appropriate boxes below to designate any transactions to which the statement
relates:</font><br></div>
        <div>
          <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
              <tr valign="top">
                <td style="WIDTH: 36pt">
                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Wingdings 2, serif">R</font></font></div>
                </td>
                <td>
                  <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt">third-party tender offer subject
      to Rule&#160;14d-1.</font></font></div>
                </td>
              </tr>
          </table>
        </div>
        <div>
          <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
              <tr valign="top">
                <td style="WIDTH: 36pt">
                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Wingdings 2, serif">&#163;</font></font></div>
                </td>
                <td>
                  <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt">issuer tender offer subject to
      Rule&#160;13e-4.</font></font></div>
                </td>
              </tr>
          </table>
        </div>
        <div>
          <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
              <tr valign="top">
                <td style="WIDTH: 36pt">
                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Wingdings 2, serif">&#163;</font></font></div>
                </td>
                <td>
                  <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt">going-private transaction subject
      to Rule&#160;13e-3.</font></font></div>
                </td>
              </tr>
          </table>
        </div>
        <div>
          <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
              <tr valign="top">
                <td style="WIDTH: 36pt">
                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Wingdings 2, serif">&#163;</font></font></div>
                </td>
                <td>
                  <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt">amendment to Schedule&#160;13D
      under Rule&#160;13d-2.</font></font></div>
                </td>
              </tr>
          </table>
        </div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt">Check the following box if the filing is
a final amendment reporting the results of the tender
offer.&#160;&#160;</font><font style="DISPLAY: inline;" face="Wingdings 2, serif">&#163;</font></font></div>
      </div>
      <div>&#160;</div>
      <div>
        <hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
        <hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
      </div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
          </div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div>&#160;</div>
      <div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">This
Amendment No. 2 (&#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Amendment No.
2</font>&#8221;) amends and supplements the Tender Offer Statement on Schedule TO (as
previously amended, the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Schedule TO</font>&#8221;) originally filed
on August 18, 2008 by CVS Caremark Corporation, a Delaware Corporation (&#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">CVS</font>&#8221;), and Blue MergerSub
Corp., a Maryland corporation (&#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Purchaser</font>&#8221;) and an indirect
wholly-owned subsidiary of CVS, relating to the offer by Purchaser to purchase
all outstanding shares of common stock, par value $0.50 per share (&#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Shares</font>&#8221;), of Longs Drug Stores
Corporation, a Maryland corporation (&#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Longs</font>&#8221;), for $71.50 per Share,
net to the seller in cash, without interest, upon the terms and subject to the
conditions set forth in the Offer to Purchase dated August 18, 2008 (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Offer to Purchase</font>&#8221;) and in the
related Letter of Transmittal (which, together with any amendments or
supplements thereto, collectively constitute the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Offer</font>&#8221;).</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">All
capitalized terms used in this Amendment No. 2 without definition have the
meanings ascribed to them in the Schedule TO.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">The items
of the Schedule TO set forth below are hereby amended and supplemented as
follows:</font></div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Item
11. Additional Information.</font></div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">Item 11 of
the Schedule TO is hereby amended and supplemented by adding the following text
thereto:</font></div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 38pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">&#8220;Two
purported class action lawsuits related to the Merger Agreement have been
filed.&#160; The lawsuits name as defendants Longs; its directors Warren F.
Bryant, Leroy T. Barnes, Jr., Murray H. Dashe, Evelyn S. Dilsaver, Mary S. Metz,
Donna A. Tanoue, and Anthony G. Wagner; CVS; and various other defendants, as
the case may be.&#160; The plaintiffs in the lawsuits &#8212; Steamfitters Local 449
Pension Fund v. Longs Drug Stores Corp., et al., Case No. C-08-02093 (filed Aug.
19, 2008 and amended Aug. 27, 2008, and a copy of the complaint and the amended
complaint are filed as Exhibit (a)(9) and Exhibit (a)(10), respectively, hereto)
and Louisiana Municipal Police Employees&#8217; Retirement System v. Longs Drug Stores
Corp., et al., Case No. C-08-02139 (filed Aug. 22, 2008 and a copy of the
complaint is filed as Exhibit (a)(11) hereto), each in the Superior Court for
the State of California, County of Contra Costa have agreed to consolidate the
actions.&#160; The complaints filed in connection with the lawsuits generally
allege, among other things, that Longs and its directors breached their
fiduciary duties to Longs&#8217; stockholders in connection with the transactions
contemplated by the Merger Agreement and that CVS aided and abetted Longs&#8217; and
its directors&#8217; breaches of their fiduciary duties.&#160; The complaints allege
that the defendants failed to disclose the circumstances and procedures that led
to the Merger Agreement, including the methods used by Longs and CVS to value
Longs&#8217; real estate assets.&#160; The lawsuits seek, among other relief, an
injunction preventing the defendants from completing the transaction
contemplated by the Merger Agreement, a declaration that entry into the Merger
Agreement is a breach of Longs and its directors&#8217; fiduciary duties and is
therefore unlawful and unenforceable, and attorneys&#8217; fees and expenses.&#160;
Plaintiffs have sought expedited discovery and preliminary injunction
proceedings.&#160;</font></div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 38pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">On
September 9, 2008, Longs and CVS&#160;agreed in principle with the shareholder
plaintiffs to settle the purported class action lawsuits filed in California
relating to the Offer.&#160;&#160;Under the terms of the proposed settlement,
the claims of the named plaintiffs and the proposed class of public shareholders
relating to the Offer and the Merger Agreement and the transactions contemplated
thereby will be dismissed on behalf of the settlement
class.&#160;&#160;Finalization of the proposed settlement remains subject to
several conditions, including court approval and completion of the Offer and the
other transactions contemplated by the Merger Agreement in accordance with its
terms.&#160;&#160;In connection with the proposed settlement, Longs has agreed
to provide additional disclosures in Longs&#8217; Schedule 14D-9 originally filed with
the SEC on August 18, 2008, and subsequently amended by Amendment No. 1 on
September 8, 2008 and Amendment No. 2 on September 10, 2008 (as amended from
time to time, the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Schedule
14D-9</font>&#8221;).&#160;&#160;For additional information on these matters,
investors should read the Schedule 14D-9.&#8221;</font></div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Item
12. Exhibits.</font></div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">Item 12 of
the Schedule TO is hereby amended and supplemented by adding the following
exhibits:</font></div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 38pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">&#8220;(a)(9)&#160;&#160;Complaint
filed on August 19, 2008 in the Superior Court for the State of California,
County of Contra Costa.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 38pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">(a)(10)&#160;&#160;Amended
Complaint filed on August 27, 2008 in the Superior Court for the State of
California, County of Contra Costa.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 38pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">(a)(11)&#160;&#160;Complaint
filed on August 22, 2008 in the Superior Court for the State of California,
County of Contra Costa.&#8221;</font></div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      </div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
          </div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">SIGNATURES</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">After due
inquiry and to the best knowledge and belief of the undersigned, each of the
undersigned certify that the information set forth in this statement is true,
complete and correct.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">Date:
September 10, 2008</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div align="right">
        <table cellpadding="0" cellspacing="0" width="47%">
            <tr>
              <td align="left" colspan="2" valign="top" width="42%">
                <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Blue
      MergerSub Corp.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              </td>
              <td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td align="left" valign="top" width="5%" style="PADDING-BOTTOM: 2px">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">By:</font></div>
              </td>
              <td align="left" valign="top" width="37%" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman">/s/&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Douglas
      A. Sgarro</font></font></font></div>
              </td>
              <td align="left" valign="top" width="5%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td align="left" valign="top" width="5%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="top" width="37%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Name:&#160;&#160;Douglas
      A. Sgarro</font></font></td>
              <td align="left" valign="top" width="5%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td align="left" valign="top" width="5%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="top" width="37%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Title:&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Vice
      President and Secretary</font></font></font></td>
              <td align="left" valign="top" width="5%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div align="right">
        <table cellpadding="0" cellspacing="0" width="47%">
            <tr>
              <td align="left" colspan="2" valign="top" width="42%">
                <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">CVS
      Caremark Corporation</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              </td>
              <td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td align="left" valign="top" width="5%" style="PADDING-BOTTOM: 2px">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">By:</font></div>
              </td>
              <td align="left" valign="top" width="37%" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">/s/&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Douglas
      A. Sgarro</font></font></div>
              </td>
              <td align="left" valign="top" width="5%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td align="left" valign="top" width="5%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="top" width="37%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Name:&#160;&#160;Douglas
      A. Sgarro</font></font></td>
              <td align="left" valign="top" width="5%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td align="left" valign="top" width="5%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="top" width="37%" style="PADDING-LEFT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Title:&#160;&#160;&#160;&#160;Executive
      Vice President</font> </font>

                <div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;and
      </font><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Chief&#160;Legal
      Officer</font></div>
              </td>
              <td align="left" valign="top" width="5%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
          </div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">EXHIBIT
INDEX</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div>
          <table cellpadding="0" cellspacing="0" width="100%">
              <tr>
                <td align="left" valign="top" width="11%" style="BORDER-BOTTOM: #000000 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Exhibit
      No.</font></div>
                </td>
                <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                <td align="left" valign="top" width="66%" style="BORDER-BOTTOM: #000000 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Description</font></div>
                </td>
              </tr>
              <tr>
                <td align="left" valign="top" width="11%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(a)(9)</font></div>
                </td>
                <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                <td align="left" valign="top" width="66%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Complaint
      filed on August 19, 2008 in the Superior Court for the State of
      California, County of Contra Costa.</font></div>
                </td>
              </tr>
              <tr>
                <td align="left" valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="top" width="66%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr>
                <td align="left" valign="top" width="11%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(a)(10)</font></div>
                </td>
                <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                <td align="left" valign="top" width="66%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Amended
      Complaint filed on August 27, 2008 in the Superior Court for the State of
      California, County of Contra Costa.</font></div>
                </td>
              </tr>
              <tr>
                <td align="left" valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="top" width="66%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr>
                <td align="left" valign="top" width="11%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(a)(11)</font></div>
                </td>
                <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                <td align="left" valign="top" width="66%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Complaint
      filed on August 22, 2008 in the Superior Court for the State of
      California, County of Contra
Costa.</font></div>
                </td>
              </tr>
          </table>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center">
        <div>
          <hr style="COLOR: black" align="left" noshade size="2" width="100%">
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    </div>
    <div>&#160;</div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(A)(9)
<SEQUENCE>2
<FILENAME>dp11297_ex99a9.htm
<DESCRIPTION>COMPLAINT FILED ON AUGUST 19, 2008
<TEXT>
<html>
  <head>
    <title> </title>
    </head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 9pt; MARGIN-LEFT: 5%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 5%; FONT-FAMILY: Arial">
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 241.2pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">COUGHLIN
STOIA GELLER</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 241.2pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">RUDMAN
&amp; ROBBINS LLP</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 241.2pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">DARREN J.
ROBBINS (168593)</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 241.2pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">RANDALL
J. BARON (150796)</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 241.2pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">DAVID T.
WISSBROECKER (243867)</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 241.2pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">655 West
Broadway, Suite 1900</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 241.2pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">San
Diego, CA 92101</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 241.2pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Telephone:
619/231-1058</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 241.2pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">619/231-7423
(fax)</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 241.2pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Attorneys
for Plaintiff</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><a name="calcaption">SUPERIOR COURT OF THE STATE OF CALIFORNIA</a></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">COUNTY OF
CONTRA COSTA</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman"><a name="plaintiff">STEAMFITTERS LOCAL 449 PENSION </a></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">FUND,
      Individually and On Behalf of All </font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Others
      Similarly Situated,</font></div>
            </td>
            <td align="left" rowspan="6" valign="top" width="2%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman"><a name="vertical">)</a></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
            </td>
            <td align="left" rowspan="6" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">VIA
      FAX</font></font></div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Case
      No.</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><a name="docket" />&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">CLASS
      ACTION</font></font></div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">COMPLAINT
      FOR BREACH OF FIDUCIARY DUTIES AND AIDING AND ABETTING</font></div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><a name="pleadtitle" />&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="bottom" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Plaintiff,</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="bottom" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">vs.</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman"><a name="defendant">LONGS DRUG STORES CORPORATION, WARREN F.
      BRYANT,</a></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">LEROY
      T. BARNES, JR.,</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">MURRAY
      H. DASHE,</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">EVELYN
      S. DILSAVER,</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">MARY
      S. METZ,</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">DONNA
      A. TANOUE,</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">ANTHONY
      G. WAGNER,</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">CVS
      CAREMARK CORPORATION and DOES 1-25, inclusive,</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="bottom" width="39%" style="PADDING-LEFT: 0pt">
              <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Defendants.</font></div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" width="39%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
            <div>
              <hr style="COLOR: black" align="left" noshade size="1" width="100%">
            </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">COMPLAINT FOR
BREACH OF FIDUCIARY DUTIES AND AIDING AND ABETTING</font></div>
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">SUMMARY
OF THE ACTION</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This
is a stockholder class action brought by plaintiff on behalf of the holders of
Longs Drug Stores Corporation (&#8220;Longs&#8221; or the &#8220;Company&#8221;) common stock against
the members of Longs&#8217; Board of Directors (&#8220;Board&#8221;) arising out of their breaches
of fiduciary duty in connection with their efforts to complete the sale of Longs
to CVS Caremark Corporation (&#8220;CVS&#8221;) through an unfair process and at an unfair
price (the &#8220;Proposed Buyout&#8221;).&#160;&#160;The Board was aided and abetted in its
breaches of fiduciary duty by Longs and CVS.&#160;&#160;This action seeks
equitable relief only.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Longs
was founded in 1938 in Oakland, California.&#160;&#160;Longs operates in two
business segments: retail drug stores and, through its RxAmerica subsidiary,
pharmacy benefit services.&#160;&#160;Longs is one of the most recognized retail
drug store chains on the West Coast and in Hawaii, with 510 stores as of January
31, 2008.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Proposed Buyout is an opportunistic transaction for defendants, as it allows CVS
to further consolidate the market and strengthen its position on the West Coast,
Southwest and Hawaii following its acquisition of Caremark in 2007.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Board, well aware of the material insider benefits the Caremark board secured
via its sale to CVS, was eager to cater a sale of the Company to CVS in order to
receive similar benefits, and to secure lucrative change-in-control payments
that Board members and management would not have received absent the Proposed
Buyout. Accordingly, the Board catered the sales process exclusively to CVS, and
made no attempts to adequately canvas the market to ensure that they were
securing the best price possible for the Company&#8217;s shares.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Further
exacerbating their breaches of fiduciary duty, the Board agreed to onerous deal
protection devices that make the Proposed Buyout a <font style="DISPLAY: inline; FONT-STYLE: italic">fait accompli</font>. Specifically,
the Board agreed to: (i) a no-solicitation clause that prevents the Company from
providing confidential Company information to or negotiating with potential
competing bidders for the Company except under limited circumstances; (ii) a
&#8220;matching rights,&#8221; or &#8220;last look&#8221; provision that provides CVS with five business
days to match any competing proposal for the Company; and (iii) pay CVS a
termination fee of $115 million in the event the Proposed Buyout is terminated
in favor of a superior proposal.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">- 1 -
</font>

          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
            <div>
              <hr style="COLOR: black" align="left" noshade size="1" width="100%">
            </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">COMPLAINT FOR
BREACH OF FIDUCIARY DUTIES AND AIDING AND ABETTING</font></div>
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In
addition, the Board agreed to an egregious &#8220;top-up&#8221; provision that ensures CVS
will be able to consummate the Proposed Buyout even if it meets with substantial
resistance from the Company&#8217;s shareholders. The &#8220;top-up&#8221; provides that (i) once
CVS secures tender of at least 66.67% of the Company&#8217;s shares, (ii) CVS will
have the right to purchase any and all additional shares from the Company
treasury that it requires in order to control 90% of the Company&#8217;s shares and
(iii) squeeze out the rest of the Company&#8217;s remaining public shareholders via a
&#8220;short-form&#8221; merger. The combined effect of the deal protection devices and top
up provision precludes any and all competing bidders for the
Company.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In
pursuing the unlawful plan to sell Longs, each of the defendants violated
applicable law by directly breaching and/or aiding the other defendants&#8217;
breaches of their fiduciary duties of loyalty, due care, independence, candor,
good faith and fair dealing.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Immediate
judicial intervention is warranted here to rectify existing and future
irreparable harm to the Company&#8217;s shareholders. Plaintiff, on behalf of the
Class, seeks only to level the playing field and to ensure that if shareholders
are to be ultimately stripped of their respective equity interests through the
Proposed Buyout, that the Proposed Buyout is conducted in a manner that is not
overtly improper, unfair and illegal.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">JURISDICTION
AND VENUE</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This
Court has jurisdiction over defendants because they conduct business in
California and/or are citizens of California. This action is not
removable.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#160;(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Venue
is proper in this Court because the conduct at issue took place and had an
effect in this County. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>&#160;
(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Longs&#8217;
principal place of business is located at 141 North Civic Drive, Walnut Creek,
California.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">PARTIES</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plaintiff
Steamfitters Local 449 Pension Fund, is, and at all times relevant hereto was, a
shareholder of Longs.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">12.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defendant
Longs is a Maryland corporation headquartered in Walnut Creek, California. Longs
operates in two business segments: retail drug stores and, through its RxAmerica
subsidiary, </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">- 2 -
</font>

          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
            <div>
              <hr style="COLOR: black" align="left" noshade size="1" width="100%">
            </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">COMPLAINT FOR
BREACH OF FIDUCIARY DUTIES AND AIDING AND ABETTING</font></div>
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">pharmacy
benefit services. Longs is one of the most recognized retail drug store chains
on the West Coast and in Hawaii, with 510 stores as of January 31,
2008.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defendant
Warren F. Bryant (&#8220;Bryant&#8221;) has been the Company&#8217;s President and Chief Executive
Officer since 2002, and has served as the Chairman of the Board since
2003.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defendant
Leroy T. Barnes, Jr. (&#8220;Barnes&#8221;) has been a director of the Company since
2002.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">15.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defendant
Murray H. Dashe (&#8220;Dashe&#8221;) has been a director of the Company since
2002.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">16.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defendant
Evelyn S. Dilsaver (&#8220;Dilsaver&#8221;) has been a director of the Company since
2007.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">17.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defendant
Mary S. Metz (&#8220;Metz&#8221;) has been a director of the Company since
1991.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">18.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defendant
Donna A. Tanoue (&#8220;Tanoue&#8221;) has been a director of the Company since
2005.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">19.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defendant
Anthony G. Wagner (&#8220;Wagner&#8221;) has been a director of the Company since
1999.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">20.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defendant
CVS is a Delaware corporation headquartered in Woonsocket, Rhode Island. CVS is
the largest provider of prescriptions and related healthcare services in the
United States, and fills or manages more than one billion prescriptions
annually. CVS operates two business segments: Retail Pharmacy and Pharmacy
Services.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">21.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
true names and capacities of defendants sued herein under California Code of
Civil Procedure &#167;474 as Does 1 through 25, inclusive, are presently not known to
plaintiff, who therefore sues these defendants by such fictitious names.
Plaintiff will seek to amend this Complaint and include these Doe defendants&#8217;
true names and capacities when they are ascertained. Each of the fictitiously
named defendants is responsible in some manner for the conduct alleged herein
and for the injuries suffered by the Class.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">22.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
defendants named above in &#182;&#182;13-19 are sometimes collectively referred to herein
as the &#8220;Individual Defendants.&#8221;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">DEFENDANTS&#8217;
FIDUCIARY DUTIES</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">23.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In
accordance with their duties of loyalty, care and good faith, the Individual
Defendants, as directors and/or officers of Longs, are obligated to refrain
from:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">- 3 -
</font>

          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
            <div>
              <hr style="COLOR: black" align="left" noshade size="1" width="100%">
            </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">COMPLAINT FOR
BREACH OF FIDUCIARY DUTIES AND AIDING AND ABETTING</font></div>
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;participating
in any transaction where the directors&#8217; or officers&#8217; loyalties are
divided;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;participating
in any transaction where the directors or officers receive or are entitled to
receive a personal financial benefit not equally shared by the public
shareholders of the corporation; and/or</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;unjustly
enriching themselves at the expense or to the detriment of the public
shareholder.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">24.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plaintiff
alleges herein that the Individual Defendants, separately and together, in
connection with the proposed sale of Longs, are violating the fiduciary duties
owed to plaintiff and the other public shareholders of Longs, including their
duties of loyalty, good faith and independence, insofar as they stand on both
sides of the transaction and are engaging in self-dealing and obtaining for
themselves personal benefits, including personal financial benefits, not shared
equally by plaintiff or the Class.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">25.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Because
the Individual Defendants are breaching and have breached their duties of
loyalty, good faith and independence in connection with the proposed sale of
Longs, the burden of proving the inherent or entire fairness of the Proposed
Buyout, including all aspects of its negotiation and structure, is placed upon
the Individual Defendants as a matter of law.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">CLASS
ACTION ALLEGATIONS</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">26.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plaintiff
brings this action individually and as a class action pursuant to &#167;382 of the
California Code of Civil Procedure on behalf of all holders of Longs stock who
are being and will be harmed by defendants&#8217; actions described below (the
&#8220;Class&#8221;). Excluded from the Class are defendants herein and any person, firm,
trust, corporation or other entity related to or affiliated with any
defendant.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">27.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This
action is properly maintainable as a class action.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">28.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Class is so numerous that joinder of all members is impracticable. According to
Longs&#8217; SEC filings, there are more than 35 million shares of Longs common stock
outstanding.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">29.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;There
are questions of law and fact which are common to the Class and which
predominate over questions affecting any individual Class member. The common
questions include, <font style="DISPLAY: inline; FONT-STYLE: italic">inter
alia</font>, the following:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">- 4 -
</font>

          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
            <div>
              <hr style="COLOR: black" align="left" noshade size="1" width="100%">
            </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">COMPLAINT FOR
BREACH OF FIDUCIARY DUTIES AND AIDING AND ABETTING</font></div>
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;whether
the Individual Defendants, aided and abetted by Longs and CVS, have breached
their fiduciary duties of undivided loyalty, independence or due care with
respect to plaintiff and the other members of the Class in connection with the
Proposed Buyout;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;whether
the Individual Defendants, aided and abetted by Longs and CVS, are engaging in
self-dealing in connection with the Proposed Buyout;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;whether
the Individual Defendants, aided and abetted by Longs and CVS, are unjustly
enriching themselves and other insiders or affiliates of Longs;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;whether
Individual Defendants, aided and abetted by Longs and CVS, have breached any of
their other fiduciary duties to plaintiff and the other members of the Class
in&#160;&#160;connection with the Proposed Buyout, including the duties of good
faith, diligence, candor and fair dealing;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;whether
Individual Defendants, aided and abetted by Longs and CVS, in bad faith and for
improper motives, have impeded or erected barriers to discourage other offers
for the Company or its assets; and</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;whether
plaintiff and the other members of the Class would suffer irreparable injury
were the transactions complained of herein consummated.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">30.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plaintiff&#8217;s
claims are typical of the claims of the other members of the Class and plaintiff
does not have any interests adverse to the Class.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">31.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plaintiff
is an adequate representative of the Class, has retained competent counsel
experienced in litigation of this nature and will fairly and adequately protect
the interests of the Class.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">32.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
prosecution of separate actions by individual members of the Class would create
a risk of inconsistent or varying adjudications with respect to individual
members of the Class which would establish incompatible standards of conduct for
the party opposing the Class.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">33.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plaintiff
anticipates that there will be no difficulty in the management of this
litigation. A class action is superior to other available methods for the fair
and efficient adjudication of this controversy.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">- 5 -
</font>

          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
            <div>
              <hr style="COLOR: black" align="left" noshade size="1" width="100%">
            </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">COMPLAINT FOR
BREACH OF FIDUCIARY DUTIES AND AIDING AND ABETTING</font></div>
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">34.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defendants
have acted on grounds generally applicable to the Class with respect to the
matters complained of herein, thereby making appropriate the relief sought
herein with respect to the Class as a whole.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">BACKGROUND
TO THE PROPOSED BUYOUT</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">35.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Longs
was founded in 1938 in Oakland, California. Longs operates in two business
segments: retail drug stores and, through its RxAmerica subsidiary, pharmacy
benefit services. Longs is one of the most recognized retail drug store chains
on the West Coast and in Hawaii, with 510 stores as of January 31,
2008.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">36.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On
August 5, 2008, activist hedge fund Pershing Square Capital (&#8220;Pershing&#8221;)
announced that it had built up an 8.8% stake in the Company, and that it may
engage the Company in discussions. Pershing further stated that it had purchased
total return swaps to bring its total economic interest in Longs to 15.4%. After
the Proposed Buyout was announced, Pershing executed these swaps and now holds a
voting and tender interest in 15.4% of Longs&#8217; shares.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">37.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Pershing&#8217;s
announcement effectively put the Company &#8220;in play,&#8221; and susceptible to offers
from potentially interested bidders. The Board did not take the opportunity to
conduct a full and fair auction for the Company presented by Pershing&#8217;s
announcement, however. Instead, the Board entered into the Proposed Buyout just
one week later, catering the entire process to the interests of CVS and
eschewing any attempt to maximize shareholder value.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">THE
PROPOSED BUYOUT</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">38.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On
August 12, 2008, the Company announced that it had entered into a merger
agreement with CVS. As the joint press release stated:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">CVS
Caremark Corporation and Longs Drug Stores Corporation today announced that they
have entered into a definitive agreement under which CVS Caremark will acquire
Longs for $71.50 per share in cash for a total purchase price of $2.9 billion
including the assumption of net debt. Through this acquisition, CVS Caremark
will acquire Longs&#8217; 521 retail drugstores in California, Hawaii, Nevada and
Arizona as well as its Rx America subsidiary, which offers prescription benefits
management (&#8220;PBM&#8221;) services to over 8 million members and prescription drug plan
benefits to approximately 450,000 Medicare beneficiaries.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>The addition of Longs&#8217; valuable store
locations in Central and Northern California, Hawaii, and Nevada will provide
CVS Caremark with substantial market positions in these highly attractive, fast
growing markets. Further, the acquisition complements CVS Caremark&#8217;s substantial
presence in Southern California and provides</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">- 6 -
</font>

          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
            <div>
              <hr style="COLOR: black" align="left" noshade size="1" width="100%">
            </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">COMPLAINT FOR
BREACH OF FIDUCIARY DUTIES AND AIDING AND ABETTING</font></div>
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">a
foundation for significant future growth throughout the nation&#8217;s largest state.
The transaction also offers CVS Caremark immediate market leadership in the
highly attractive Hawaiian market, where it currently does not have a presence,
as well as high-quality locations in Nevada and Arizona.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Significantly, Longs owns the real
estate associated with approximately 200 store locations, three distribution
centers and three office facilities. CVS Caremark has conservatively valued the
store locations alone at more than $1 billion. These stores are located in
markets where commercial real estate values are among the highest in the country
and prime locations are especially difficult to acquire. CVS Caremark intends to
unlock the intrinsic value of these locations, as well as the distribution
centers and office facilities, by monetizing a substantial portion of these
assets over time.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>With an enhanced national reach, CVS
Caremark will be in a stronger position as it rolls out its new suite of
offerings under the Proactive Pharmacy Care model, taking advantage of its
retail and PBM services.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Tom Ryan, Chairman, President and CEO
of CVS Caremark, commented, &#8220;This transaction provides tremendous benefits to
CVS Caremark by accelerating our expansion in very attractive drugstore markets
and strengthening our geographic reach. In fact, Longs has a significant
presence in ten non-CVS markets that are among the top 100 drugstore markets in
the country. More than 490 of the stores we are acquiring are located in the
Central and Northern California and Hawaiian markets, where Longs is a leading
player. Longs&#8217; store network in these regions is excellent and is one that would
take a decade or more for us to replicate through organic growth.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>&#8220;With this acquisition, we will
increase accessibility to our pharmacies for consumers and put us in an even
better position to grow our new Proactive Pharmacy Care offerings with our PBM
clients. We are very excited about the potential offered by this combination and
the opportunity to build on our strong track record of acquiring and
successfully integrating PBMs and retail drugstore chains, and we expect this
integration to be seamless.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>&#8220;Over the years, I have been very
impressed with the strong customer loyalty Longs&#8217; employees have earned
throughout the West Coast and Hawaii, as well as the high quality of Longs&#8217;
stores in these markets. We look forward to completing the transaction and
welcoming the talented Longs associates to our company,&#8221; Mr. Ryan
concluded.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Warren F. Bryant, Chairman, President
and Chief Executive Officer of Longs, stated, &#8220;The transaction represents an
excellent opportunity for Longs to deliver significant and certain value to its
shareholders while positioning its stores to thrive in the future for the
benefit of its employees and customers.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>&#8220;Over the course of the last five
years, we have transformed Longs into a stronger, more productive, more
profitable company. Given the changing industry landscape, we believe this
combination is the logical next step for Longs. CVS Caremark has a strong record
of successfully integrating drug store chains and pharmacy benefit services into
its portfolio and working with employees to strengthen the performance, format
and offerings of stores. We believe this will present excellent opportunities
for our employees and ensure that our customers continue to receive excellent
pharmacy care and high quality products.&#8221;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Longs generates annual revenues in
excess of $5 billion, consistently strong operating cash flow, and reported
EBITDA in the last 12 months of approximately $276</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">- 7 -
</font>

          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
            <div>
              <hr style="COLOR: black" align="left" noshade size="1" width="100%">
            </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">COMPLAINT FOR
BREACH OF FIDUCIARY DUTIES AND AIDING AND ABETTING</font></div>
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">million.
Assuming completion of the transaction in the fourth quarter of 2008, the
acquisition is expected to be dilutive to earnings per share in the first year,
and accretive to EPS beginning in 2010. CVS Caremark expects to achieve
significant cost synergies of approximately $100 million in 2009 and
approximately $140-$150 million in 2010, resulting from purchasing efficiencies
and a reduction of SG&amp;A expense.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>The combination will expand CVS
Caremark&#8217;s position as the #1 provider of prescriptions in the U.S. Following
the acquisition, CVS Caremark will fill or manage more than 1.2 billion
prescriptions per year and will operate approximately 6,800 drugstores in 41
states and the District of Columbia.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>The acquisition will be effected
through a tender offer to be launched shortly by a subsidiary of CVS Caremark
for all outstanding Longs shares. The tender offer will be subject to, among
other things, the condition that at least two-thirds of the outstanding Longs
shares are tendered.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>CVS Caremark plans to finance the
acquisition with a $1.5 billion bridge loan facility, together with existing
cash and liquidity, which will provide CVS Caremark with funding sufficient to
satisfy its obligations for the acquisition. The transaction is subject to
review under the Hart-Scott-Rodino Act and has other customary closing
conditions. It is expected to be completed in the fourth quarter of
2008.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Lehman Brothers and Deutsche Bank
served as financial advisors to CVS Caremark on this transaction and provided
the bridge loan commitment. Davis Polk &amp; Wardwell and Mintz Levin Cohn
Ferris Glovsky and Popeo P.C. served as legal advisors to CVS Caremark. J.P.
Morgan Securities Inc. served as financial advisor to Longs and Wachtell,
Lipton, Rosen &amp; Katz served as its legal advisor.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">39.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As
a result of the Proposed Buyout, shareholders will be unable to share in the
long-term gains the Company is likely to achieve. Moreover, the consideration
offered in the Proposed Buyout does not provide shareholders with fair value for
the cost and revenue synergies that will flow to CVS via the Proposed
Buyout.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">40.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defendants
concede that the Proposed Buyout will generate tremendous synergies for CVS. On
Conference Call on August 12, 2008, CVS&#8217;s Chairman and CEO stated the following
regarding the Proposed Buyout:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>With today&#8217;s announcement, we will now
become a leading player in Central and Northern California and Hawaii. As you
know, California is the most populous state with 36 million plus people adding
300,000 alone. So, from when we entered California in just four years, after
this transaction, we will have over 830 stores in the state. More than anybody
else.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Our experience, as well as others in
the real estate business, have proven that site selection and development in
Northern and Central California markets as well as Hawaii is pretty costly and
very time consuming. And this is as evidenced by the limited amount of
development. Many of these markets are mature with a minimum supply of
appropriate drug store sites. We estimate that the timeframe needed to assemble
a quality portfolio like the one we are acquiring would be at least 10 years.
Development of sites, even if they become available, are time consuming, because
of complex zoning</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">- 8 -
</font>

          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
            <div>
              <hr style="COLOR: black" align="left" noshade size="1" width="100%">
            </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">COMPLAINT FOR
BREACH OF FIDUCIARY DUTIES AND AIDING AND ABETTING</font></div>
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">and
entitlement issues and significant capital investment. Consequently, an
opportunity like this to acquire hundreds of quality locations in these markets
is rare.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>More than 490 of the stores we are
acquiring in Central and Northern California and Hawaii stores are good with
valuable well located sites. In fact, these sites &#8211; these stores will give us a
leading positions in 10 new markets that are in the top 100 markets in the
country. We&#8217;ll have strong positions in Oakland, Sacramento, San Jose, San
Francisco and Honolulu, just for an example.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>In addition to California and Hawaii,
we&#8217;ll also add 24 stores in Nevada and a couple of stores in Arizona. We will
gain leadership in the Reno, Nevada market, where we currently only have three
stores. And this market&#8217;s projected to grow twice the annual average growth rate
of the rest of the country.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>So, in total, following this
acquisition, we will operate 6,800 drug stores in 41 states and the District of
Columbia.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>About 470 of those stores we are
acquiring, average about 22,000 to 23,000 square feet. That&#8217;s a little bit
bigger than the Sav-On stores, but not much. Sav-On stores have - we have some
stores that size. And the rest of the stores - the rest of the Longs&#8217; stores are
smaller stores in the 4,000 to 7,000 square foot range. And these are located
mainly in or near medical centers. And, we think, there&#8217;s an opportunity for us
to put our specialty pharmacy in these stores.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>It&#8217;s important also to note that Longs
owns the real estate associated with approximately 200 plus store locations,
three distribution centers and three office facilities. We have valued these
store locations alone at more than $1 billion.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>As noted earlier, these stores are
located in markets, where commercial real estate and values are among the
highest in the country and prime locations are difficult to acquire. We intend
to unlock the intrinsic value of these locations as well as distribution centers
and office facilities by monetizing a substantial portion of these assets over
time. In addition, Longs&#8217; distribution centers will be valuable additions to our
distribution network.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Now, as I said, many of you know Longs
also operates a PBM, RX America, which serves about 8.5 million commercial lives
and it has a Med. D standalone PDP that insures about 450,000 lives. The PBM
generates about $380 million in annual revenue including the PDP lives. CVS
Caremark will insure over 1.5 million lives through the PDP plans. We will
integrate RxAmerica&#8217;s PBM and PDP business over time. And it will be a nice
complement to our PBM.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Let me talk a little bit about the
financials. Longs generates approximately $5 billion in annual revenues and a
reported EBITDA in the last 12 months of $276 million. So, this transaction is
priced at approximately 10 times EBITDA which is roughly what we paid for the
Osco Sav-On stores in 2006. The company has a consistent cash flow generator,
reporting operating cash flow of about $200 million annually.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>In terms of synergies, we are currently
anticipating cost synergies of $100 million in &#8216;09 an approximately $140 million
to $150 million in 2010. These are obviously resulting from purchasing
efficiencies as well as reduction SG&amp;A.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">- 9 -
</font>

          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
            <div>
              <hr style="COLOR: black" align="left" noshade size="1" width="100%">
            </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">COMPLAINT FOR
BREACH OF FIDUCIARY DUTIES AND AIDING AND ABETTING</font></div>
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>To me, the acquisition of Longs
provides important strategic and financial benefits for us both in the near and
the long term. One, we&#8217;re accelerating our growth into key new markets that are
difficult to enter. Two, we&#8217;re broadening our geographic reach that will help us
facilitate the rollout of our new Proactive Pharmacy Care offerings. Three,
together with the management team of Longs and the CVS management team, we
believe, we can improve the performance of the stores with our technology, our
process and our merchandising. Four, over time, we will be able to monetize $1
billion in real estate.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">41.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In
response to questions from analysts on the accuracy of CVS&#8217;s synergies
estimates, Ryan stated:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Well, I&#8217;ll just say that I don&#8217;t think
we&#8217;ve ever missed our projections on acquisition, either on the revenue side or
the synergy side. So, we take a fairly conservative approach.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>We run the synergies the way we always
have . . . this is a $5 billion on top of our $80 plus billion. So, we&#8217;re
looking at the purchasing synergies around the obvious areas in generics and
private label and some other front-end items and then also the
overhead.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br>&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">42.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Board, well aware of the material insider benefits the Caremark board secured
via its sale to CVS, was eager to cater a sale of the Company to CVS in order to
receive similar benefits, and to secure lucrative change-in-control payments
that they would not have received absent the Proposed Buyout. Accordingly, the
Board catered the sales process exclusively to CVS, and made no attempts to
adequately canvas the market to ensure that they were securing the best price
possible for the Company&#8217;s shares.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">43.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;For
example, defendant Bryant has nearly $10 million in unvested equity awards that
will immediately vest and become monetized once the Proposed Buyout is
consummated. Additionally, Bryant will secure $23.6 million in &#8220;golden
parachute&#8221; change-in-control payments.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">44.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Further
exacerbating their breaches of fiduciary duty, the Board agreed to onerous deal
protection devices that make the Proposed Buyout a <font style="DISPLAY: inline; FONT-STYLE: italic">fait accompli</font>. Specifically,
the Board agreed to: (i) a no-solicitation clause that prevents the Company from
providing confidential Company information to or negotiating with potential
competing bidders for the Company except under limited circumstances; (ii) a
&#8220;matching rights,&#8221; or &#8220;last look&#8221; provision that provides CVS with five business
days to match&#160;&#160;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">- 10 -
</font>

          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
            <div>
              <hr style="COLOR: black" align="left" noshade size="1" width="100%">
            </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">COMPLAINT FOR
BREACH OF FIDUCIARY DUTIES AND AIDING AND ABETTING</font></div>
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">any
competing proposal for the Company; and (iii) pay CVS a termination fee of $115
million in the event the Proposed Buyout is terminated in favor of a superior
proposal.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">45.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In
addition, the Board agreed to an egregious &#8220;top-up&#8221; provision that ensures CVS
will be able to consummate the Proposed Buyout even if it meets with substantial
resistance from the Company&#8217;s shareholders. The &#8220;top-up&#8221; provides that (i) once
CVS secures tender of at least 66.67% of the Company&#8217;s shares, (ii) CVS will
have the right to purchase any and all additional shares from the Company
treasury that it requires in order to control 90% of the Company&#8217;s shares and
(iii) squeeze out the rest of the Company&#8217;s remaining public shareholders via a
&#8220;short-form&#8221; merger. The combined effect of the deal protection devices and
top-up provision precludes any and all competing bidders for the
Company.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">46.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Importantly,
CVS is already assured of tender of at least 20% of the Company&#8217;s shares, which
includes the nearly 5% held by Company insiders, and the more than 15% held by
Pershing, whose speculation in the Company put it in play, and who purchased the
Company&#8217;s shares only to turn a quick profit in the Proposed Buyout. Thus,
because of the top-up, CVS will need only about 46% of rest of the Company&#8217;s
publicly held shares in order the squeeze out the remaining minority
shareholders in a short-form merger.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">SELF-DEALING</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">47.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By
reason of their positions with Longs, the Individual Defendants are in
possession of non-public information concerning the financial condition and
prospects of Longs, and especially the true value and expected increased future
value of Longs and its assets, which they have not disclosed to Longs&#8217; public
shareholders. Moreover, despite their duty to maximize shareholder value, the
defendants have clear and material conflicts of interest and are acting to
better their own interests at the expense of Longs&#8217; public
shareholders.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">48.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
proposed sale is wrongful, unfair and harmful to Longs&#8217; public shareholders, and
represents an effort by defendants to aggrandize their own financial position
and interests at the expense of and to the detriment of Class members. The
Proposed Buyout is an attempt to deny plaintiff and the other members of the
Class their rights while usurping the same for the benefit of defendants and CVS
on unfair terms.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">- 11 -
</font>

          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
            <div>
              <hr style="COLOR: black" align="left" noshade size="1" width="100%">
            </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">COMPLAINT FOR
BREACH OF FIDUCIARY DUTIES AND AIDING AND ABETTING</font></div>
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">49.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In
light of the foregoing, the Individual Defendants must, as their fiduciary
obligations require:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td style="WIDTH: 45pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">&#160;
      </font></div>
            </td>
            <td style="WIDTH: 36pt">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
            </td>
            <td>
              <div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Withdraw
      their consent to the sale of Longs and allow the shares to trade freely,
      without impediments, and undertake a fair and open sales process directed
      towards maximizing shareholder
value.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td style="WIDTH: 45pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">&#160;
      </font></div>
            </td>
            <td style="WIDTH: 36pt">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
            </td>
            <td>
              <div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Act
      independently so that the interests of Longs&#8217; public shareholders will be
      protected, including, but not limited to, the retention of truly
      independent advisors and/or the appointment of a truly independent Special
      Committee and require that any buyout proposal be approved by a majority
      of the minority shareholders.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td style="WIDTH: 45pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">&#160;
      </font></div>
            </td>
            <td style="WIDTH: 36pt">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
            </td>
            <td>
              <div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Adequately
      ensure that no conflicts of interest exist between defendants&#8217; own
      interests and their fiduciary obligation to maximize stockholder value or,
      if such conflicts exist, to ensure that all conflicts be resolved in the
      best interests of Longs&#8217; public
shareholders.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">CAUSE
OF ACTION</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Claim
for Breach of Fiduciary Duties and Aiding and Abetting</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">50.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plaintiff
repeats and realleges each allegation set forth herein.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">51.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Individual Defendants, aided and abetted by Longs and CVS, have violated
fiduciary duties of care, loyalty, candor and independence owed under applicable
law to the public shareholders of Longs and have acted to put their personal
interests ahead of the interests of Longs&#8217; shareholders.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">52.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Longs
and CVS have knowledge of, and actively participated in, the Individual
Defendants&#8217; breaches of fiduciary duty complained of herein.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">53.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By
the acts, transactions and courses of conduct alleged herein, defendants,
individually and acting as a part of a common plan, are attempting to advance
their interests at the expense of plaintiff and other members of the
Class.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">54.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Individual Defendants, aided and abetted by Longs and CVS, have violated their
fiduciary duties by negotiating a transaction with CVS without regard to the
fairness of the transaction to Longs&#8217; shareholders.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">55.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As
demonstrated by the allegations above, the Individual Defendants, aided and
abetted by Longs and CVS, failed to exercise the care required, and breached
their duties of loyalty, good faith, candor and independence owed to the
shareholders of Longs because, among other reasons:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">- 12 -
</font>

          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
            <div>
              <hr style="COLOR: black" align="left" noshade size="1" width="100%">
            </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">COMPLAINT FOR
BREACH OF FIDUCIARY DUTIES AND AIDING AND ABETTING</font></div>
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;they
ignored or did not protect against the numerous conflicts of interest resulting
from their own interrelationships or connection with the Proposed Buyout;
and</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;they
are using the proposed sale of the Company to aggrandize their own interests
upon completion of the sale.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">56.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Because
the Individual Defendants dominate and control the business and corporate
affairs of Longs, and are in possession of private corporate information
concerning Longs&#8217; assets, business and future prospects, there exists an
imbalance and disparity of knowledge and economic power between them and the
public shareholders of Longs which makes it inherently unfair for them to pursue
any proposed transaction wherein they will reap disproportionate
benefits.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">57.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By
reason of the foregoing acts, practices and course of conduct, the Individual
Defendants, aided and abetted by Longs and CVS, have failed to exercise ordinary
care and diligence in the exercise of their fiduciary obligations toward
plaintiff and the other members of the Class.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">58.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As
a result of the actions of defendants, plaintiff and the Class will suffer
irreparable injury as a result of defendants&#8217; self-dealing.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">59.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unless
enjoined by this Court, the Individual Defendants, aided and abetted by Longs
and CVS, will continue to breach their fiduciary duties owed to plaintiff and
the Class, and may consummate the Proposed Buyout which will exclude the Class
from its fair share of Longs&#8217; valuable assets and businesses, and/or benefit
them in the unfair manner complained of herein, all to the irreparable harm of
the Class, as aforesaid.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">60.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Individual Defendants, aided and abetted by Longs and CVS, are engaging in
self-dealing, are not acting in good faith toward plaintiff and the other
members of the Class and have breached and are breaching their fiduciary duties
to the members of the Class.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">61.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unless
the Proposed Buyout is enjoined by the Court, the Individual Defendants, aided
and abetted by Longs and CVS, will continue to breach their fiduciary duties
owed to plaintiff and the members of the Class, will not engage in arm&#8217;s-length
negotiations on the Proposed Buyout terms, and may consummate the Proposed
Buyout, all to the irreparable harm of the members of the Class.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">- 13 -
</font>

          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
            <div>
              <hr style="COLOR: black" align="left" noshade size="1" width="100%">
            </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">COMPLAINT FOR
BREACH OF FIDUCIARY DUTIES AND AIDING AND ABETTING</font></div>
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">62.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plaintiff
and the members of the Class have no adequate remedy at law. Only through the
exercise of this Court&#8217;s equitable powers can plaintiff and the Class be fully
protected from the immediate and irreparable injury which defendants&#8217; actions
threaten to inflict.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">PRAYER
FOR RELIEF</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">WHEREFORE,
plaintiff demands preliminary and permanent injunctive relief in his favor and
in favor of the Class and against defendants as follows:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Declaring
that this action is properly maintainable as a class action;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Declaring
and decreeing that the Proposed Buyout is in breach of the fiduciary duties of
the defendants and is therefore unlawful and unenforceable;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Enjoining
defendants, their agents, counsel, employees and all persons acting in concert
with them from consummating the Proposed Buyout, unless and until the Company
adopts and implements a procedure or process to obtain the highest possible
price for shareholders;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Directing
the Individual Defendants to exercise their fiduciary duties to obtain a
transaction which is in the best interests or Longs&#8217; shareholders;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Rescinding,
to the extent already implemented, the Proposed Buyout and proposals, voting
agreements and termination fees associated therewith;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">F.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Awarding
plaintiff the costs and disbursements of this action, including reasonable
attorneys&#8217; and experts&#8217; fees; and</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">G.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Granting
such other and further equitable relief as this Court may deem just and
proper.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td align="left" valign="top" width="43%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">DATED:
      August 19, 2008</font></div>
            </td>
            <td valign="top" width="43%" style="BORDER-BOTTOM: black 2px solid">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">COUGHLIN
      STOIA GELLER</font></div>
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">RUDMAN
      &amp; ROBBINS LLP</font></div>
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">DARREN
      J. ROBBINS</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">RANDALL
      J. BARON</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">DAVID
      T. WISSBROECKER</font></div>
                <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
                <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">/s/&#160;David
      T. Wissbroecker</font></div>
                </div>
              </div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="43%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="43%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">DAVID
      T. WISSBROECKER</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">- 14 -
</font>

          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
            <div>
              <hr style="COLOR: black" align="left" noshade size="1" width="100%">
            </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">COMPLAINT FOR
BREACH OF FIDUCIARY DUTIES AND AIDING AND ABETTING</font></div>
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td valign="top" width="43%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" valign="top" width="43%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">655
      West Broadway, Suite 1900</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">San
      Diego, CA 92101</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Telephone:&#160;&#160;619/231-1058</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">619/231-7423
      (fax)</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="43%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td align="left" valign="top" width="43%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td valign="top" width="43%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" valign="top" width="43%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Attorneys
      for Plaintiff</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br>&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">
      <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">- 15 -
</font>

        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
          <div>
            <hr style="COLOR: black" align="left" noshade size="1" width="100%">
          </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">COMPLAINT FOR
BREACH OF FIDUCIARY DUTIES AND AIDING AND ABETTING</font></div>
      </div>
      <div>
        <hr style="COLOR: black" align="left" noshade size="1" width="100%">
      </div>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(A)(10)
<SEQUENCE>3
<FILENAME>dp11297_ex99a10.htm
<DESCRIPTION>AMENDED COMPLAINT FILED ON AUGUST 27, 2008
<TEXT>
<html>
  <head>
    <title> </title>
    </head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 9pt; MARGIN-LEFT: 5%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 5%; FONT-FAMILY: Arial">
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 241.2pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">COUGHLIN
STOIA GELLER</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 241.2pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">RUDMAN
&amp; ROBBINS LLP</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 241.2pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">DARREN J.
ROBBINS (168593)</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 241.2pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">RANDALL
J. BARON (150796)</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 241.2pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">DAVID T.
WISSBROECKER (243867)</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 241.2pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">655 West
Broadway, Suite 1900</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 241.2pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">San
Diego, CA 92101</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 241.2pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Telephone:
619/231-1058</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 241.2pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">619/231-7423
(fax)</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 241.2pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Attorneys
for Plaintiffs</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><a name="calcaption">SUPERIOR COURT OF THE STATE OF CALIFORNIA</a></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">COUNTY OF
CONTRA COSTA</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman"><a name="plaintiff">STEAMFITTERS LOCAL 449 PENSION </a></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">FUND
      and PIPEFITTERS LOCAL NO. 636<br>DEFINED BENEFIT PLAN, On Behalf
      of<br>Themselves and All </font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Others
      Similarly Situated,</font></div>
            </td>
            <td align="left" rowspan="6" valign="top" width="2%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman"><a name="vertical">)</a></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
            </td>
            <td align="left" rowspan="6" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">VIA
      FAX</font></font></div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Case
      No. C-08-02093</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><a name="docket" />&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">CLASS
      ACTION</font></font></div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">AMENDED
      COMPLAINT FOR BREACH OF FIDUCIARY DUTIES AND AIDING AND
      ABETTING<br><br>DEPT: 6<br>DATE ACTION FILED: 08/19/08</font></div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><a name="pleadtitle" />&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="bottom" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Plaintiffs,</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="bottom" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">vs.</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman"><a name="defendant">LONGS DRUG STORES CORPORATION,<br>WARREN F.
      BRYANT,</a></font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;LEROY
      T. <br>BARNES, JR., </font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">MURRAY
      H. DASHE,</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">EVELYN
      S. DILSAVER, </font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">MARY
      S. METZ,</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">DONNA
      A. TANOUE, </font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">ANTHONY
      G. <br>WAGNER, </font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">CVS
      CAREMARK <br>CORPORATION and DOES 1-25, inclusive,</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="bottom" width="39%" style="PADDING-LEFT: 0pt">
              <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Defendants.</font></div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" width="39%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
            <div>
              <hr style="COLOR: black" align="left" noshade size="1" width="100%">
            </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">AMENDED
COMPLAINT FOR BREACH OF FIDUCIARY DUTIES AND AIDING AND
ABETTING</font></div>
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="center"><a name="calcaption" />&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="center">
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">SUMMARY
OF THE ACTION</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This
is a stockholder class action brought by plaintiffs on behalf of the holders of
Longs Drug Stores Corporation (&#8220;Longs&#8221; or the &#8220;Company&#8221;) common stock against
the members of Longs&#8217; Board of Directors (&#8220;Board&#8221;) arising out of their breaches
of fiduciary duty in connection with their efforts to complete the sale of Longs
to CVS Caremark Corporation (&#8220;CVS&#8221;) through an unfair process and at an unfair
price (the &#8220;Proposed Buyout&#8221;), via a tender offer that is set to expire on
September 15, 2008. The Board was aided and abetted in its breaches of fiduciary
duty by Longs and CVS. This action seeks equitable relief only.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Longs
was founded in 1938 in Oakland, California. Longs operates in two business
segments: retail drug stores and, through its RxAmerica subsidiary, pharmacy
benefit services. Longs is one of the most recognized retail drug store chains
on the West Coast and in Hawaii, with 510 stores as of January 31,
2008.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Proposed Buyout is an opportunistic transaction for defendants, as it allows
industry competitor CVS to further consolidate the market and strengthen its
position on the West Coast, Southwest and Hawaii following its acquisition of
Caremark in 2007.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Board, well aware of the material insider benefits the Caremark board secured
via its sale to CVS, was eager to cater a sale of the Company to CVS in order to
receive similar benefits, and to secure lucrative change-in-control payments
that Board members and management would not have received absent the Proposed
Buyout. Accordingly, the Board catered the sales process exclusively to CVS, and
made no attempts to adequately canvas the market to ensure that they were
securing the best price possible for the Company&#8217;s shares.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By
way of specific example, the Board had the opportunity to engage in a full and
fair sales process when it was approached by strategic partner and industry
competitor Walgreens Co. (&#8220;Walgreens&#8221;) in mid-2008, and offered as much as $70
per share without being provided significant confidential Company information.
Rather than negotiation in good faith with Walgreens, or immediately embark on a
sales process designed to maximize shareholder value, the Board raised obstacles
to Walgreens&#8217; bid by exaggerating the risk of regulatory scrutiny, demanding
that Walgreens shoulder the entire burden that regulatory approval would not be
received, and refusing to provide</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">-&#160;1 -
</font>

              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">AMENDED
COMPLAINT FOR BREACH OF FIDUCIARY DUTIES AND AIDING AND
ABETTING</font></div>
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Walgreens
with the confidential Company information it needed to determine whether its was
willing to take on the risk of non-approval by regulatory authorities. As a
result, Walgreens withdrew its offer for the Company, and, when CVS came forward
with its bid, the Board was not in a position to stimulate a competitive bidding
process for the Company or maximize shareholder value.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Further
exacerbating their breaches of fiduciary duty, the Board agreed to onerous deal
protection devices that make the Proposed Buyout a <font style="DISPLAY: inline; FONT-STYLE: italic">fait accompli</font>. Specifically,
the Board agreed to: (i) a no-solicitation clause that prevents the Company from
providing confidential Company information to or negotiating with potential
competing bidders for the Company except under limited circumstances; (ii) a
&#8220;matching rights,&#8221; or &#8220;last look&#8221; provision that provides CVS with five business
days to match any competing proposal for the Company; and (iii) pay CVS a
termination fee of $115 million in the event the Proposed Buyout is terminated
in favor of a superior proposal.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In
addition, the Board agreed to an egregious &#8220;top-up&#8221; provision that ensures CVS
will be able to consummate the Proposed Buyout even if it meets with substantial
resistance from the Company&#8217;s shareholders. The &#8220;top-up&#8221; provides that (i) once
CVS secures tender of at least 66.67% of the Company&#8217;s shares, (ii) CVS will
have the right to purchase any and all additional shares from the Company
treasury that it requires in order to control 90% of the Company&#8217;s shares and
(iii) squeeze out the rest of the Company&#8217;s remaining public shareholders via a
&#8220;short-form&#8221; merger. The combined effect of the deal protection devices and top
up provision precludes any and all competing bidders for the
Company.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Moreover,
based on the public information about the Company, certain large shareholders
are convinced that the Proposed Buyout does not adequately value the Company&#8217;s
significant real estate assets, which CVS is utilizing to leverage its purchase
of Longs &#8211; essentially buying the Company with debt secured on Longs&#8217; own
assets. Indeed, many other shareholders agree, as demonstrated by the fact that
the Company&#8217;s stock price has consistently traded over the $71.50 offered in the
Proposed Buyout since it was announced.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;With
the unfair Top-Up provision the Board agreed to, however, those shareholders who
oppose the Proposed Buyout will not be in a position to prevent its
consummation. Moreover, because the Proposed Buyout does not provide for an
alternate remedy of appraisal for shareholders, these </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">- 2 -
</font>

              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">AMENDED
COMPLAINT FOR BREACH OF FIDUCIARY DUTIES AND AIDING AND
ABETTING</font></div>
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">shareholders
will have no choice but to tender their shares or get squeezed out on the
back-end in a short-form merger even though they do not believe that the
Proposed Buyout adequately values the Company&#8217;s shares.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On
August 18, 2008, defendants filed a Form 14D-9 Recommendation Statement (the
&#8220;14D-9&#8221;), recommending that shareholders tender their shares into the Proposed
Buyout. The 14D-9 is materially misleading, in that it fails to fairly and fully
disclose, or does so in misleading fashion, material information about, among
other things: (i) the sales process for the Company; (ii) conflicts of interest
that burden the Board and its financial advisors; (iii) the true value of the
Company&#8217;s assets, including its real estate holdings; and (iv) the financial
analyses under the so-called &#8220;fairness opinion&#8221; of the Board&#8217;s financial
advisor, J.P. Morgan Securities, Inc. (&#8220;JPM&#8221;).</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In
pursuing the unlawful plan to sell Longs, each of the defendants violated
applicable law by directly breaching and/or aiding the other defendants&#8217;
breaches of their fiduciary duties of loyalty, due care, independence, candor,
good faith and fair dealing.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">12.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Immediate
judicial intervention is warranted here to rectify existing and future
irreparable harm to the Company&#8217;s shareholders. Plaintiffs, on behalf of the
Class, seek only to level the playing field and to ensure that if shareholders
are to be ultimately stripped of their respective equity interests through the
Proposed Buyout, that the Proposed Buyout is conducted in a manner that is not
overtly improper, unfair and illegal.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">JURISDICTION
AND VENUE</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This
Court has jurisdiction over defendants because they conduct business in
California and/or are citizens of California. This action is not
removable.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Venue
is proper in this Court because the conduct at issue took place and had an
effect in this County.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>&#160;(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Longs&#8217;
principal place of business is located at 141 North Civic Drive, Walnut Creek,
California.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">PARTIES</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">15.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plaintiff
Steamfitters Local 449 Pension Fund is, and at all times relevant hereto was, a
shareholder of Longs.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">-&#160;3 -
</font>

              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">AMENDED
COMPLAINT FOR BREACH OF FIDUCIARY DUTIES AND AIDING AND
ABETTING</font></div>
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">16.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plaintiff
Pipefitters Local No. 636 Defined Benefit Plan is, and at all times relevant
hereto was, a shareholder of Longs.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">17.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defendant
Longs is a Maryland corporation headquartered in Walnut Creek, California. Longs
operates in two business segments: retail drug stores and, through its RxAmerica
subsidiary, pharmacy benefit services. Longs is one of the most recognized
retail drug store chains on the West Coast and in Hawaii, with 510 stores as of
January 31, 2008.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">18.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defendant
Warren F. Bryant (&#8220;Bryant&#8221;) has been the Company&#8217;s President and Chief Executive
Officer since 2002, and has served as the Chairman of the Board since
2003.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">19.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defendant
Leroy T. Barnes, Jr. (&#8220;Barnes&#8221;) has been a director of the Company since
2002.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">20.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defendant
Murray H. Dashe (&#8220;Dashe&#8221;) has been a director of the Company since
2002.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">21.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defendant
Evelyn S. Dilsaver (&#8220;Dilsaver&#8221;) has been a director of the Company since
2007.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">22.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defendant
Mary S. Metz (&#8220;Metz&#8221;) has been a director of the Company since
1991.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">23.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defendant
Donna A. Tanoue (&#8220;Tanoue&#8221;) has been a director of the Company since
2005.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">24.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defendant
Anthony G. Wagner (&#8220;Wagner&#8221;) has been a director of the Company since
1999.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">25.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defendant
CVS is a Delaware corporation headquartered in Woonsocket, Rhode Island. CVS is
the largest provider of prescriptions and related healthcare services in the
United States, and fills or manages more than one billion prescriptions
annually. CVS operates two business segments: Retail Pharmacy and Pharmacy
Services.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">26.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
true names and capacities of defendants sued herein under California Code of
Civil Procedure &#167;474 as Does 1 through 25, inclusive, are presently not known to
plaintiffs, who therefore sue these defendants by such fictitious names.
Plaintiffs will seek to amend this Complaint and include these Doe defendants&#8217;
true names and capacities when they are ascertained. Each of the fictitiously
named defendants is responsible in some manner for the conduct alleged herein
and for the injuries suffered by the Class.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">-&#160;4 -
</font>

              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">AMENDED
COMPLAINT FOR BREACH OF FIDUCIARY DUTIES AND AIDING AND
ABETTING</font></div>
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">27.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
defendants named above in &#182;&#182;18-24 are sometimes collectively referred to herein
as the &#8220;Individual Defendants.&#8221;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">DEFENDANTS&#8217;
FIDUCIARY DUTIES</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">28.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In
accordance with their duties of loyalty, care and good faith, the Individual
Defendants, as directors and/or officers of Longs, are obligated to refrain
from:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 81pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">&#160;(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;participating
in any transaction where the directors&#8217; or officers&#8217; loyalties are
divided;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 81pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">&#160;(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;participating
in any transaction where the directors or officers receive or are entitled to
receive a personal financial benefit not equally shared by the public
shareholders of the corporation; and/or</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 81pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">&#160;(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;unjustly
enriching themselves at the expense or to the detriment of the public
shareholders.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">29.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plaintiffs
allege herein that the Individual Defendants, separately and together, in
connection with the proposed sale of Longs, are violating the fiduciary duties
owed to plaintiffs and the other public shareholders of Longs, including their
duties of loyalty, good faith and independence, insofar as they stand on both
sides of the transaction and are engaging in self-dealing and obtaining for
themselves personal benefits, including personal financial benefits, not shared
equally by plaintiffs or the Class.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">30.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Because
the Individual Defendants are breaching and have breached their duties of
loyalty, good faith and independence in connection with the proposed sale of
Longs, the burden of proving the inherent or entire fairness of the Proposed
Buyout, including all aspects of its negotiation and structure, is placed upon
the Individual Defendants as a matter of law.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">CLASS
ACTION ALLEGATIONS</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">31.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plaintiffs
bring this action individually and as a class action pursuant to &#167;382 of the
California Code of Civil Procedure on behalf of all holders of Longs stock who
are being and will be harmed by defendants&#8217; actions described below (the
&#8220;Class&#8221;). Excluded from the Class are defendants herein and any person, firm,
trust, corporation or other entity related to or affiliated with any
defendant.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">32.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This
action is properly maintainable as a class action.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">-&#160;5 -
</font>

              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">AMENDED
COMPLAINT FOR BREACH OF FIDUCIARY DUTIES AND AIDING AND
ABETTING</font></div>
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">33.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Class is so numerous that joinder of all members is impracticable. According to
Longs&#8217; SEC filings, there are more than 35 million shares of Longs common stock
outstanding.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">34.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;There
are questions of law and fact which are common to the Class and which
predominate over questions affecting any individual Class member. The common
questions include, <font style="DISPLAY: inline; FONT-STYLE: italic">inter
alia</font>, the following:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>&#160;(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;whether
the Individual Defendants, aided and abetted by Longs and CVS have breached
their fiduciary duties of undivided loyalty, independence or due care with
respect to plaintiffs and the other members of the Class in connection with the
Proposed Buyout;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>&#160;(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;whether
the Individual Defendants, aided and abetted by Longs and CVS, are engaging in
self-dealing in connection with the Proposed Buyout;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>&#160;(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;whether
the Individual Defendants, aided and abetted by Longs and CVS, are unjustly
enriching themselves and other insiders or affiliates of Longs;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>&#160;(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;whether
Individual Defendants, aided and abetted by Longs and CVS, have breached any of
their other fiduciary duties to plaintiffs and the other members of the Class in
connection with the Proposed Buyout, including the duties of good faith,
diligence, candor and fair dealing;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>&#160;(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;whether
Individual Defendants, aided and abetted by Longs and CVS, in bad faith and for
improper motives, have impeded or erected barriers to discourage other offers
for the Company or its assets; and</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>&#160;(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;whether
plaintiffs and the other members of the Class would suffer irreparable injury
were the transactions complained of herein consummated.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">35.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plaintiffs&#8217;
claims are typical of the claims of the other members of the Class and
plaintiffs do not have any interests adverse to the Class.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">36.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plaintiffs
are adequate representatives of the Class, have retained competent counsel
experienced in litigation of this nature and will fairly and adequately protect
the interests of the Class.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">37.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
prosecution of separate actions by individual members of the Class would create
a risk of inconsistent or varying adjudications with respect to individual
members of the Class which would establish incompatible standards of conduct for
the party opposing the Class.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">-&#160;6 -
</font>

              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">AMENDED
COMPLAINT FOR BREACH OF FIDUCIARY DUTIES AND AIDING AND
ABETTING</font></div>
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">38.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plaintiffs
anticipate that there will be no difficulty in the management of this
litigation. A class action is superior to other available methods for the fair
and efficient adjudication of this controversy.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">39.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defendants
have acted on grounds generally applicable to the Class with respect to the
matters complained of herein, thereby making appropriate the relief sought
herein with respect to the Class as a whole.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">BACKGROUND
TO THE PROPOSED BUYOUT</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">40.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Longs
was founded in 1938 in Oakland, California. Longs operates in two business
segments: retail drug stores and, through its RxAmerica subsidiary, pharmacy
benefit services. Longs is one of the most recognized retail drug store chains
on the West Coast and in Hawaii, with 510 stores as of January 31,
2008.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">41.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In
April 2008, Walgreens&#8217; CEO contacted defendant Bryant to discuss a potential
all-cash transaction with the Company in the range of $62-$65 per share. Bryant
informed Walgreens&#8217; CEO that they only way the Board would even consider a
transaction with Walgreens was if Walgreens shouldered all regulatory risk.
Walgreens&#8217; CEO told Bryant that Walgreens&#8217; could only agree to such an
arrangement if it was provided with the necessary due diligence to investigate
the level of regulatory risk presented by a proposed merger between Longs and
Walgreens.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">42.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On
April 24, 2008, Walgreens&#8217; CEO again contacted defendant Bryant and raised its
indication of interest to $67-$70 per share, but reiterated its position that it
needed to conduct due diligence before agreeing to shoulder the regulatory risk
in a merger with Longs.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">43.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In
subsequent conversations between April 26, 2008 and May 17, 2008, Walgreens&#8217; CEO
reiterated its request for due diligence so it could assess potential regulatory
risk, and requested that Longs enter into a joint defense agreement that would
allow Walgreens access to confidential Company information. The Board eventually
agreed to do so, and provided Walgreens with some due diligence information over
the ensuing weeks.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">44.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Beginning
around June 11, 2008, Bryant had preliminary discussions with CVS about a
potential merger. Two days later, Walgreens&#8217; CEO contacted Bryant to discuss
merger provisions that would shift some of the risk of regulatory approval to
Longs. These discussions never moved forward, </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">-&#160;7 -
</font>

              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">AMENDED
COMPLAINT FOR BREACH OF FIDUCIARY DUTIES AND AIDING AND
ABETTING</font></div>
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">and on
July 11, 2008, Walgreens informed Bryant that it was no longer interested in a
transaction with Longs because of, among other things, the failure of Longs to
engage in good faith negotiations around the issue of regulatory
risk.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">45.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Thereafter,
the Board negotiated exclusively with CVS, and, even though the Board had failed
to engage Walgreens in a competitive process despite numerous opportunities to
do so and maximize shareholder value, did not subsequently reach out to any
other interested bidders to solicit bids to compete with CVS.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">46.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On
August 5, 2008, activist hedge fund Pershing Square Capital (&#8220;Pershing&#8221;)
announced that it had built up an 8.8% stake in the Company, and that it may
engage the Company in discussions. Pershing further stated that it had purchased
total return swaps to bring its total economic interest in Longs to 15.4%. After
the Proposed Buyout was announced, Pershing executed these swaps and now holds a
voting and tender interest in 15.4% of Longs&#8217; shares.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">47.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Pershing&#8217;s
announcement effectively put the Company &#8220;in play,&#8221; and susceptible to offers
from potentially interested bidders. The Board did not take the opportunity to
conduct a full and fair auction for the Company presented by Pershing&#8217;s
announcement, however. Instead, the Board entered into the Proposed Buyout just
one week later, catering the entire process to the interests of CVS and
eschewing any attempt to maximize shareholder value.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">48.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On
August 11, 2008, the Board agreed to the Proposed Buyout based in large part on
a so-called &#8220;fairness opinion&#8221; offered by JPM.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">THE
PROPOSED BUYOUT</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">49.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On
August 12, 2008, the Company announced that it had entered into a merger
agreement with CVS. As the joint press release stated:<br></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">CVS
Caremark Corporation and Longs Drug Stores Corporation today announced that they
have entered into a definitive agreement under which CVS Caremark will acquire
Longs for $71.50 per share in cash for a total purchase price of $2.9 billion
including the assumption of net debt. Through this acquisition, CVS Caremark
will acquire Longs&#8217; 521 retail drugstores in California, Hawaii, Nevada and
Arizona as well as its Rx America subsidiary, which offers prescription benefits
management (&#8220;PBM&#8221;) services to over 8 million members and prescription drug plan
benefits to approximately 450,000 Medicare beneficiaries.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>The addition of Longs&#8217; valuable store
locations in Central and Northern California, Hawaii, and Nevada will provide
CVS Caremark with substantial market</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">-&#160;8 -
</font>

              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">AMENDED
COMPLAINT FOR BREACH OF FIDUCIARY DUTIES AND AIDING AND
ABETTING</font></div>
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">positions
in these highly attractive, fast growing markets. Further, the acquisition
complements CVS Caremark&#8217;s substantial presence in Southern California and
provides a foundation for significant future growth throughout the nation&#8217;s
largest state. The transaction also offers CVS Caremark immediate market
leadership in the highly attractive Hawaiian market, where it currently does not
have a presence, as well as high-quality locations in Nevada and
Arizona.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Significantly, Longs owns the real
estate associated with approximately 200 store locations, three distribution
centers and three office facilities. CVS Caremark has conservatively valued the
store locations alone at more than $1 billion. These stores are located in
markets where commercial real estate values are among the highest in the country
and prime locations are especially difficult to acquire. CVS Caremark intends to
unlock the intrinsic value of these locations, as well as the distribution
centers and office facilities, by monetizing a substantial portion of these
assets over time.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>With an enhanced national reach, CVS
Caremark will be in a stronger position as it rolls out its new suite of
offerings under the Proactive Pharmacy Care model, taking advantage of its
retail and PBM services.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Tom Ryan, Chairman, President and CEO
of CVS Caremark, commented, &#8220;This transaction provides tremendous benefits to
CVS Caremark by accelerating our expansion in very attractive drugstore markets
and strengthening our geographic reach. In fact, Longs has a significant
presence in ten non-CVS markets that are among the top 100 drugstore markets in
the country. More than 490 of the stores we are acquiring are located in the
Central and Northern California and Hawaiian markets, where Longs is a leading
player. Longs&#8217; store network in these regions is excellent and is one that would
take a decade or more for us to replicate through organic growth.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>&#8220;With this acquisition, we will
increase accessibility to our pharmacies for consumers and put us in an even
better position to grow our new Proactive Pharmacy Care offerings with our PBM
clients. We are very excited about the potential offered by this combination and
the opportunity to build on our strong track record of acquiring and
successfully integrating PBMs and retail drugstore chains, and we expect this
integration to be seamless.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>&#8220;Over the years, I have been very
impressed with the strong customer loyalty Longs&#8217; employees have earned
throughout the West Coast and Hawaii, as well as the high quality of Longs&#8217;
stores in these markets. We look forward to completing the transaction and
welcoming the talented Longs associates to our company,&#8221; Mr. Ryan
concluded.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Warren F. Bryant, Chairman, President
and Chief Executive Officer of Longs, stated, &#8220;The transaction represents an
excellent opportunity for Longs to deliver significant and certain value to its
shareholders while positioning its stores to thrive in the future for the
benefit of its employees and customers.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>&#8220;Over the course of the last five
years, we have transformed Longs into a stronger, more productive, more
profitable company. Given the changing industry landscape, we believe this
combination is the logical next step for Longs. CVS Caremark has a strong record
of successfully integrating drug store chains and pharmacy benefit services into
its portfolio and working with employees to strengthen the performance, format
and offerings of stores. We believe this will present excellent opportunities
for our employees and ensure that our customers continue to receive excellent
pharmacy care and high quality products.&#8221;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">-&#160;9 -
</font>

              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">AMENDED
COMPLAINT FOR BREACH OF FIDUCIARY DUTIES AND AIDING AND
ABETTING</font></div>
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Longs generates annual revenues in
excess of $5 billion, consistently strong operating cash flow, and reported
EBITDA in the last 12 months of approximately $276 million. Assuming completion
of the transaction in the fourth quarter of 2008, the acquisition is expected to
be dilutive to earnings per share in the first year, and accretive to EPS
beginning in 2010. CVS Caremark expects to achieve significant cost synergies of
approximately $100 million in 2009 and approximately $140-$150 million in 2010,
resulting from purchasing efficiencies and a reduction of SG&amp;A
expense.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>The combination will expand CVS
Caremark&#8217;s position as the #1 provider of prescriptions in the U.S. Following
the acquisition, CVS Caremark will fill or manage more than 1.2 billion
prescriptions per year and will operate approximately 6,800 drugstores in 41
states and the District of Columbia.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>The acquisition will be effected
through a tender offer to be launched shortly by a subsidiary of CVS Caremark
for all outstanding Longs shares. The tender offer will be subject to, among
other things, the condition that at least two-thirds of the outstanding Longs
shares are tendered.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>CVS Caremark plans to finance the
acquisition with a $1.5 billion bridge loan facility, together with existing
cash and liquidity, which will provide CVS Caremark with funding sufficient to
satisfy its obligations for the acquisition. The transaction is subject to
review under the Hart-Scott-Rodino Act and has other customary closing
conditions. It is expected to be completed in the fourth quarter of
2008.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Lehman Brothers and Deutsche Bank
served as financial advisors to CVS Caremark on this transaction and provided
the bridge loan commitment. Davis Polk &amp; Wardwell and Mintz Levin Cohn
Ferris Glovsky and Popeo P.C. served as legal advisors to CVS Caremark. J.P.
Morgan Securities Inc. served as financial advisor to Longs and Wachtell,
Lipton, Rosen &amp; Katz served as its legal advisor.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">50.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As
a result of the Proposed Buyout, shareholders will be unable to share in the
long-term gains the Company is likely to achieve. Moreover, the consideration
offered in the Proposed Buyout does not provide shareholders with fair value for
the cost and revenue synergies that will flow to CVS via the Proposed
Buyout.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">51.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defendants
concede that the Proposed Buyout will generate tremendous synergies for CVS. On
Conference Call on August 12, 2008, CVS&#8217;s Chairman and CEO stated the following
regarding the Proposed Buyout:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>With today&#8217;s announcement, we will now
become a leading player in Central and Northern California and Hawaii. As you
know, California is the most populous state with 36 million plus people adding
300,000 alone. So, from when we entered California in just four years, after
this transaction, we will have over 830 stores in the state. More than anybody
else.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Our experience, as well as others in
the real estate business, have proven that site selection and development in
Northern and Central California markets as well as Hawaii is pretty costly and
very time consuming. And this is as evidenced by the limited amount of
development. Many of these markets are mature with a minimum supply of
appropriate drug store sites. We estimate that the timeframe needed to assemble
a</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">-&#160;10
- - </font>

              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">AMENDED
COMPLAINT FOR BREACH OF FIDUCIARY DUTIES AND AIDING AND
ABETTING</font></div>
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">quality
portfolio like the one we are acquiring would be at least 10 years. Development
of sites, even if they become available, are time consuming, because of complex
zoning and entitlement issues and significant capital investment. Consequently,
an opportunity like this to acquire hundreds of quality locations in these
markets is rare.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>More than 490 of the stores we are
acquiring in Central and Northern California and Hawaii stores are good with
valuable well located sites. In fact, these sites &#8211; these stores will give us a
leading positions in 10 new markets that are in the top 100 markets in the
country. We&#8217;ll have strong positions in Oakland, Sacramento, San Jose, San
Francisco and Honolulu, just for an example.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>In addition to California and Hawaii,
we&#8217;ll also add 24 stores in Nevada and a couple of stores in Arizona. We will
gain leadership in the Reno, Nevada market, where we currently only have three
stores. And this market&#8217;s projected to grow twice the annual average growth rate
of the rest of the country.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>So, in total, following this
acquisition, we will operate 6,800 drug stores in 41 states and the District of
Columbia.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>About 470 of those stores we are
acquiring, average about 22,000 to 23,000 square feet. That&#8217;s a little bit
bigger than the Sav-On stores, but not much. Sav-On stores have &#8211; we have some
stores that size. And the rest of the stores &#8211; the rest of the Longs&#8217; stores are
smaller stores in the 4,000 to 7,000 square foot range. And these are located
mainly in or near medical centers. And, we think, there&#8217;s an opportunity for us
to put our specialty pharmacy in these stores.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>It&#8217;s important also to note that Longs
owns the real estate associated with approximately 200 plus store locations,
three distribution centers and three office facilities. We have valued these
store locations alone at more than $1 billion.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>As noted earlier, these stores are
located in markets, where commercial real estate and values are among the
highest in the country and prime locations are difficult to acquire. We intend
to unlock the intrinsic value of these locations as well as distribution centers
and office facilities by monetizing a substantial portion of these assets over
time. In addition, Longs&#8217; distribution centers will be valuable additions to our
distribution network.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Now, as I said, many of you know Longs
also operates a PBM, RxAmerica, which serves about 8.5 million commercial lives
and it has a Med. D standalone PDP that insures about 450,000 lives. The PBM
generates about $380 million in annual revenue, including the PDP lives. CVS
Caremark will insure over 1.5 million lives through the PDP plans. We will
integrate RxAmerica&#8217;s PBM and PDP business over time. And it will be a nice
complement to our PBM.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Let me talk a little bit about the
financials. Longs generates approximately $5 billion in annual revenues and a
reported EBITDA in the last 12 months of $276 million. So, this transaction is
priced at approximately 10 times EBITDA, which is roughly what we paid for the
Osco Sav-On stores in 2006. The company has a consistent cash flow generator,
reporting operating cash flow of about $200 million annually.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">-&#160;11
- - </font>

              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">AMENDED
COMPLAINT FOR BREACH OF FIDUCIARY DUTIES AND AIDING AND
ABETTING</font></div>
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>In terms of synergies, we are currently
anticipating cost synergies of $100 million in &#8216;09 an approximately $140 million
to $150 million in 2010. These are obviously resulting from purchasing
efficiencies as well as reduction SG&amp;A.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>To me, the acquisition of Longs
provides important strategic and financial benefits for us both in the near and
the long term. One, we&#8217;re accelerating our growth into key new markets that are
difficult to enter. Two, we&#8217;re broadening our geographic reach that will help us
facilitate the rollout of our new Proactive Pharmacy Care offerings. Three,
together with the management team of Longs and the CVS management team, we
believe, we can improve the performance of the stores with our technology, our
process and our merchandising. Four, over time, we will be able to monetize $1
billion in real estate.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">52.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In
response to questions from analysts on the accuracy of CVS&#8217;s synergies
estimates, Ryan stated:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Well, I&#8217;ll just say that I don&#8217;t think
we&#8217;ve ever missed our projections on acquisition, either on the revenue side or
the synergy side. So, we take a fairly conservative approach.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>We run the synergies the way we always
have ... this is a $5 billion on top of our $80 plus billion. So, we&#8217;re looking
at the purchasing synergies around the obvious areas in generics and private
label and some other front-end items and then also the overhead.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">53.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Certain
of the Company&#8217;s large shareholders, including Pershing, have publicly taken the
position since the Proposed Buyout was announced that the consideration offered
does not adequately value the Company, especially its expansive real estate
interests. In fact, as reported in a news article entitled &#8220;Pershing Hires
Blackstone to Boost Longs Price,&#8221; Pershing has hired its own financial advisor
to evaluate the Proposed Buyout:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Pershing
Square Capital Management on Friday hired Blackstone Group to help it drive up
the purchase price for Longs Drug Stores Corp., the Wall Street Journal said in
its online edition, citing a person familiar with the situation.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Officials at neither U.S. private
equity firm Blackstone Group, nor activist hedge fund Pershing Square Capital,
could immediately be reached for comment.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Longs agreed on Tuesday to be acquired
by CVS Caremark Corp. for about $2.5 billion, or $71.50 a share, a significant
premium to Longs&#8217; closing price that day.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Pershing Square, through common stock
and private contracts called swaps, has an economic interest in Longs equivalent
to almost 26 percent of the drug store chain&#8217;s outstanding shares, the report
said.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">- 12 -
</font>

              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">AMENDED
COMPLAINT FOR BREACH OF FIDUCIARY DUTIES AND AIDING AND
ABETTING</font></div>
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Pershing Square has been approached by
a real-estate investor that claims it could earn more money selling unwanted
Longs sites than CVS could on its own, according to the person familiar with the
matter, the Journal said.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>The potential extra income from such
sales could make the assets of Longs more valuable than the current purchase
price would indicate, the Journal said, citing the source.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">54.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Pershing&#8217;s
dissent has been joined by Advisory Research, Inc., which has also criticized
the Proposed Buyout for undervaluing the Company&#8217;s real estate assets, as
reported in an article entitled &#8220;Longs Drug Shareholders Question CVS
Bid&#8221;:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Two of
the largest shareholders at Longs Drug Stores Corp. aren&#8217;t convinced CVS
Caremark Corp.&#8217;s takeover offer reflects the full value of the
company.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Despite the 32% premium CVS is willing
to pay Longs shareholders, Advisory Research Inc. and activist hedge fund
Pershing Square Capital Management are questioning whether CVS and Longs&#8217; own
management team are lowballing the value of Longs&#8217; real estate
assets.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>The rest of the market is skeptical,
too. Shares of Longs have traded above the deal&#8217;s $71.50 a share offer price for
the past six trading sessions. This suggests other investors are betting CVS
will increase its initial Aug. 12 bid.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Advisory Research, which owns 9.2% of
Longs common stock, said in a Securities and Exchange Commission filing
Wednesday it has asked Longs for more information about the value put on
drug-store chain&#8217;s real estate assets before it decides on whether the offer is
in the &#8220;best interests of its clients.&#8221;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>In an interview, David Heller, chairman
of Advisory Research, said Longs Chief Executive Warren Bryant told him in a
phone conversation that Longs signed&#160;&#160;an agreement with CVS stating it
would not reveal the value of its real estate.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Longs owns 521 drug stores in
California, parts of Nevada, Arizona and Hawaii.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>&#8220;This is outrageous,&#8221; Heller said.
&#8220;We&#8217;re certainly entitled to this information. This is an issue of fairness to
shareholders. Management needs to get off its lofty perch.&#8221;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Longs couldn&#8217;t be immediately reached
for comment Wednesday. A CVS spokeswoman said in an emailed statement that the
company&#8217;s offer is fair.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Pershing, run by Bill Ackman, who is
known to be a vocal critic of companies, is working with Blackstone Group LP to
weigh its options. As of Aug. 14, Pershing owned an 8.8% stake in Longs common
stock, or 3 million shares. But through private contracts called equity swaps,
its overall economic stake in Longs is 25.8%.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>One arbitrage trader who looks to
profit on price spreads in mergers said Pershing&#8217;s track record could convince
other Longs shareholders to hold out for a higher price.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">-&#160;13
- - </font>

              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">AMENDED
COMPLAINT FOR BREACH OF FIDUCIARY DUTIES AND AIDING AND
ABETTING</font></div>
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>&#8220;There&#8217;s a pretty good chance Pershing
can be successful,&#8221; said Thomas Kirchner, who runs the Pennsylvania Avenue
Event-Driven Fund. &#8220;They can potentially block the deal.&#8221;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Kirchner
bought Longs shares after the deal was announced and said he doesn&#8217;t plan to
tender them to CVS, betting instead that CVS will eventually sweeten its offer.
He said buying Longs Drug is a cheap way for CVS to grow its store base in
California and Hawaii, which have some of the priciest real estate in the
country.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>What&#8217;s missing in the merger equation
is how CVS and Longs came up with their real estate assessment. The companies
haven&#8217;t provided such data in regulatory documents.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>When the deal was announced Aug. 12,
CVS said it planned to either sell off or restructure Long&#8217;s real estate through
sale-leaseback transactions. It put a conservative value of $1 billion on 200
Longs retail stores, three distribution centers, and three office
building.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>In an SEC filing Monday, Longs said it
doesn&#8217;t think CVS can readily sell off its real estate assets in a manner that
would warrant a higher offer price, especially due to hefty tax
implications.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Longs shares are now trading at almost
four times their value five years ago. This may have prompted long term
shareholders to cash out rather than hand their stock over to CVS in the tender
offer. Buyers of those shares are likely arbitragers, said
Kirchner.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 50.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>For the deal to go through, CVS needs
to obtain two-thirds of Longs diluted common shares outstanding in the tender
offer. On that basis, the transaction could be derailed if Pershing and another
25% of Longs&#8217; shares on the market are withheld.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">55.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On
August 26, 2008, the Company&#8217;s stock price closed at $72.70 per share, $1.20
over the consideration offered in the Proposed Buyout.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">56.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Further
exacerbating their breaches of fiduciary duty, the Board agreed to onerous deal
protection devices that make the Proposed Buyout a <font style="DISPLAY: inline; FONT-STYLE: italic">fait accompli</font>. Specifically,
the Board agreed to: (i) a no-solicitation clause that prevents the Company from
providing confidential Company information to or negotiating with potential
competing bidders for the Company except under limited circumstances; (ii) a
&#8220;matching rights,&#8221; or &#8220;last look&#8221; provision that provides CVS with five business
days to match any competing proposal for the Company; and (iii) pay CVS a
termination fee of $115 million in the event the Proposed Buyout is terminated
in favor of a superior proposal.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">57.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In
addition, the Board agreed to an egregious &#8220;top-up&#8221; provision that ensures CVS
will be able to consummate the Proposed Buyout even if it meets with substantial
resistance from the </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">-&#160;14
- - </font>

              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">AMENDED
COMPLAINT FOR BREACH OF FIDUCIARY DUTIES AND AIDING AND
ABETTING</font></div>
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Company&#8217;s
shareholders. The &#8220;top-up&#8221; provides that (i) once CVS secures tender of at least
66.67% of the Company&#8217;s shares, (ii) CVS will have the right to purchase any and
all additional shares from the Company treasury that it requires in order to
control 90% of the Company&#8217;s shares and (iii) squeeze out the rest of the
Company&#8217;s remaining public shareholders via a &#8220;short-form&#8221; merger. The combined
effect of the deal protection devices and top-up provision precludes any and all
competing bidders for the Company.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">58.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;With
the unfair Top-Up provision the Board agreed to, those shareholders who oppose
the Proposed Buyout will not be in a position to prevent its consummation.
Moreover, because the Proposed Buyout does not provide for an alternate remedy
of appraisal for shareholders, these shareholders will have no choice to tender
their shares or get squeezed out on the back-end in a short-form merger even
though they do not believe that the Proposed Buyout adequately values the
Company&#8217;s shares.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">59.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On
August 18, 2008, defendants filed the materially misleading 14D-9, recommending
that shareholders tender their shares into the Proposed Buyout. The 14D-9 is
materially misleading, in that it fails to fairly and fully disclose, or does so
in a misleading fashion, material information about, among other things: (i) the
sales process for the Company; (ii) conflicts of interest that burdened the
Board and its financial advisors; (iii) the true value of the Company&#8217;s assets,
including its real estate holdings; and (iv) the financial analyses under JPM&#8217;s
so-called &#8220;fairness opinion.&#8221;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">SELF-DEALING</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">60.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Board, well aware of the material insider benefits the Caremark board secured
via its sale to CVS, was eager to cater a sale of the Company to CVS in order to
receive similar benefits, and to secure lucrative change-in-control payments
that they would not have received absent the Proposed Buyout. Accordingly, the
Board catered the sales process exclusively to CVS, and made no attempts to
adequately canvas the market to ensure that they were securing the best price
possible for the Company&#8217;s shares.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">61.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;For
example, defendant Bryant has nearly $10 million in unvested equity awards that
will immediately vest and become monetized once the Proposed Buyout is
consummated. Additionally, Bryant will secure $23.6 million in &#8220;golden
parachute&#8221; change-in-control payments.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">-&#160;15
- - </font>

              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">AMENDED
COMPLAINT FOR BREACH OF FIDUCIARY DUTIES AND AIDING AND
ABETTING</font></div>
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">62.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By
reason of their positions with Longs, the Individual Defendants are in
possession of non-public information concerning the financial condition and
prospects of Longs, and especially the true value and expected increased future
value of Longs and its assets, which they have not disclosed to Longs&#8217; public
shareholders. Moreover, despite their duty to maximize shareholder value, the
defendants have clear and material conflicts of interest and are acting to
better their own interests at the expense of Longs&#8217; public
shareholders.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">63.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
proposed sale is wrongful, unfair and harmful to Longs&#8217; public shareholders, and
represents an effort by defendants to aggrandize their own financial position
and interests at the expense of and to the detriment of Class members. The
Proposed Buyout is an attempt to deny plaintiffs and the other members of the
Class their rights while usurping the same for the benefit of defendants and CVS
on unfair terms.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">64.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In
light of the foregoing, the Individual Defendants must, as their fiduciary
obligations require:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
            <tr valign="top" style="LINE-HEIGHT: 1.25;">
              <td style="WIDTH: 36pt">
                <div><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">&#160;
      </font></div>
              </td>
              <td style="WIDTH: 36pt">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
              </td>
              <td>
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Withdraw
      their consent to the sale of Longs and allow the shares to trade freely,
      without impediments, and undertake a fair and open sales process directed
      towards maximizing shareholder
value.</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
            <tr valign="top" style="LINE-HEIGHT: 1.25;">
              <td style="WIDTH: 36pt">
                <div><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">&#160;
      </font></div>
              </td>
              <td style="WIDTH: 36pt">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
              </td>
              <td>
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Act
      independently so that the interests of Longs&#8217; public shareholders will be
      protected, including, but not limited to, the retention of truly
      independent advisors and/or the appointment of a truly independent Special
      Committee and require that any buyout proposal be approved by a majority
      of the minority shareholders.</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
            <tr valign="top" style="LINE-HEIGHT: 1.25;">
              <td style="WIDTH: 36pt">
                <div><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">&#160;
      </font></div>
              </td>
              <td style="WIDTH: 36pt">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
              </td>
              <td>
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Adequately
      ensure that no conflicts of interest exist between defendants&#8217; own
      interests and their fiduciary obligation to maximize stockholder value or,
      if such conflicts exist, to ensure that all conflicts be resolved in the
      best interests of Longs&#8217; public
shareholders.</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
            <tr valign="top" style="LINE-HEIGHT: 1.25;">
              <td style="WIDTH: 36pt">
                <div><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">&#160;
      </font></div>
              </td>
              <td style="WIDTH: 36pt">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
              </td>
              <td>
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Fully
      and fully disclose all material information about the Company, including
      the true value of its real estate assets, the sales process, conflicts of
      interests that burdened the Board and its advisors, and the financial
      analyses underlying JPM&#8217;s &#8220;fairness
opinion.&#8221;</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">FIRST
CAUSE OF ACTION</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Claim
for Breach of Fiduciary Duties and Aiding and Abetting</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">65.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plaintiffs
repeat and reallege each allegation set forth herein.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">66.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Individual Defendants, aided and abetted by Longs and CVS, have violated
fiduciary duties of care, loyalty, candor and independence owed under applicable
law to the public </font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">-&#160;16
- - </font>

              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">AMENDED
COMPLAINT FOR BREACH OF FIDUCIARY DUTIES AND AIDING AND
ABETTING</font></div>
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">shareholders
of Longs and have acted to put their personal interests ahead of the interests
of Longs&#8217; shareholders.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">67.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Longs
and CVS have knowledge of, and actively participated in, the Individual
Defendants&#8217; breaches of fiduciary duty complained of herein.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">68.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By
the acts, transactions and courses of conduct alleged herein, defendants,
individually and acting as a part of a common plan, are attempting to advance
their interests at the expense of plaintiffs and other members of the
Class.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">69.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Individual Defendants, aided and abetted by Longs and CVS, have violated their
fiduciary duties by negotiating a transaction with CVS without regard to the
fairness of the transaction to Longs&#8217; shareholders.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">70.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As
demonstrated by the allegations above, the Individual Defendants, aided and
abetted by Longs and CVS, failed to exercise the care required, and breached
their duties of loyalty, good faith, candor and independence owed to the
shareholders of Longs because, among other reasons:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 81pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">&#160;(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;they
ignored or did not protect against the numerous conflicts of interest resulting
from their own interrelationships or connection with the Proposed Buyout;
and</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 81pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">&#160;(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;they
are using the proposed sale of the Company to aggrandize their own interests
upon completion of the sale.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">71.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Because
the Individual Defendants dominate and control the business and corporate
affairs of Longs, and are in possession of private corporate information
concerning Longs&#8217; assets, business and future prospects, there exists an
imbalance and disparity of knowledge and economic power between them and the
public shareholders of Longs which makes it inherently unfair for them to pursue
any proposed transaction wherein they will reap disproportionate
benefits.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">72.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By
reason of the foregoing acts, practices and course of conduct, the Individual
Defendants, aided and abetted by Longs and CVS, have failed to exercise ordinary
care and diligence in the exercise of their fiduciary obligations toward
plaintiffs and the other members of the Class.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">73.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As
a result of the actions of defendants, plaintiffs and the Class will suffer
irreparable injury as a result of defendants&#8217; self-dealing.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">-&#160;17
- - </font>

              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">AMENDED
COMPLAINT FOR BREACH OF FIDUCIARY DUTIES AND AIDING AND
ABETTING</font></div>
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">74.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unless
enjoined by this Court, the Individual Defendants, aided and abetted by Longs
and CVS, will continue to breach their fiduciary duties owed to plaintiffs and
the Class, and may consummate the Proposed Buyout which will exclude the Class
from its fair share of Longs&#8217; valuable assets and businesses, and/or benefit
them in the unfair manner complained of herein, all to the irreparable harm of
the Class, as aforesaid.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">75.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Individual Defendants, aided and abetted by Longs and CVS, are engaging in
self-dealing, are not acting in good faith toward plaintiffs and the other
members of the Class and have breached and are breaching their fiduciary duties
to the members of the Class.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">76.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unless
the Proposed Buyout is enjoined by the Court, the Individual Defendants, aided
and abetted by Longs and CVS, will continue to breach their fiduciary duties
owed to plaintiffs and the members of the Class, will not engage in arm&#8217;s-length
negotiations on the Proposed Buyout terms, and may consummate the Proposed
Buyout, all to the irreparable harm of the members of the Class.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">77.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plaintiffs
and the members of the Class have no adequate remedy at law. Only through the
exercise of this Court&#8217;s equitable powers can plaintiffs and the Class be fully
protected from the immediate and irreparable injury which defendants&#8217; actions
threaten to inflict.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">PRAYER
FOR RELIEF</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">WHEREFORE,
plaintiffs demand preliminary and permanent injunctive relief in his favor and
in favor of the Class and against defendants as follows:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Declaring
that this action is properly maintainable as a class action;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Declaring
and decreeing that the Proposed Buyout is in breach of the fiduciary duties of
the defendants and is therefore unlawful and unenforceable;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Enjoining
defendants, their agents, counsel, employees and all persons acting in concert
with them from consummating the Proposed Buyout, unless and until the Company
adopts and implements a procedure or process to obtain the highest possible
price for shareholders;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Directing
the Individual Defendants to exercise their fiduciary duties to obtain a
transaction which is in the best interests of Longs&#8217; shareholders;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Rescinding,
to the extent already implemented, the Proposed Buyout and proposals, voting
agreements and termination fees associated therewith;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">-&#160;18
- - </font>

              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">AMENDED
COMPLAINT FOR BREACH OF FIDUCIARY DUTIES AND AIDING AND
ABETTING</font></div>
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">F.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Awarding
plaintiffs the costs and disbursements of this action, including reasonable
attorneys&#8217; and experts&#8217; fees; and</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">G.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Granting such other and further equitable relief as this Court may deem just and
proper.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td align="left" valign="top" width="41%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">DATED:
      August 27, 2008</font></div>
              </td>
              <td align="left" valign="top" width="41%" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">COUGHLIN
      STOIA GELLER</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;&#160;RUDMAN
      &amp; ROBBINS LLP</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">DARREN
      J. ROBBINS</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">RANDALL
      J. BARON</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">DAVID
      T. WISSBROECKER</font></div>
                <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">/s/
      Randall J. Baron</font></div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="41%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="41%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">RANDALL
      J. BARON</font></div>
                <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="41%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="41%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">655
      West Broadway, Suite 1900</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">San
      Diego, CA 92101</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Telephone:
      619/231-1058</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">619/231-7423
      (fax)</font></div>
                <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Attorneys
      for Plaintiffs</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">-&#160;19
- - </font>

              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">AMENDED
COMPLAINT FOR BREACH OF FIDUCIARY DUTIES AND AIDING AND
ABETTING</font></div>
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">DECLARATION OF SERVICE BY
UPS DELIVERY</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">I, the
undersigned, declare:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;That
declarant is and was, at all times herein mentioned, a citizen of the United
States and a resident of the County of San Diego, over the age of 18 years, and
not a party to or interested party in the within action; that declarant&#8217;s
business address is 655 West Broadway, Suite 1900, San Diego, California
92101.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;That
on August 27, 2008, declarant served by UPS, next day delivery, the <font style="DISPLAY: inline; FONT-WEIGHT: bold">AMENDED COMPLAINT FOR BREACH OF
FIDUCIARY DUTIES AND AIDING AND ABETTING</font> to the parties listed on the
attached Service List. Declarant also served the parties by
facsimile.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">I declare
under penalty of perjury that the foregoing is true and correct. Executed this
27th day of August, 2008, at San Diego, California.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div align="right">
        <table cellpadding="0" cellspacing="0" width="36%">
            <tr>
              <td align="left" valign="top" width="36%" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">/s/
      Alison K. Sloan</font></div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="36%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">ALISON
      K. SLOAN</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">- 20 -
</font>

              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">AMENDED
COMPLAINT FOR BREACH OF FIDUCIARY DUTIES AND AIDING AND
ABETTING</font></div>
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br>&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">LONGS
DRUG</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Service
List - 8/27/2008&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-SIZE: 9pt">
(08-0165)</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Page 1 of
1</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">&#160;&#160;Counsel
For Defendant(s)</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">William
D. Savitt</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Wachtell,
Lipton, Rosen &amp; Katz</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">51 West
52nd Street</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">New York,
NY 10019</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">212/403-1000</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">212/403-2000
(Fax)</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">&#160;&#160;Counsel
For Plaintiff(s)</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Darren J.
Robbins</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Randall
J. Baron</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">David T.
Wissbroecker</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Coughlin
Stoia Geller Rudman &amp; Robbins LLP</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">655 West
Broadway, Suite 1900</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">San
Diego, CA 92101</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">619/231-1058</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">619/231-7423
(Fax)</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br>&#160;</div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center"><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">- 21 -</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(A)(11)
<SEQUENCE>4
<FILENAME>dp11297_ex99a11.htm
<DESCRIPTION>COMPLAINT FILED ON AUGUST 22, 2008
<TEXT>
<html>
  <head>
    <title> </title>
    </head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 5%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 5%; FONT-FAMILY: Times New Roman">
    <div>
      <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>
      <div>
        <div align="left">
          <table cellpadding="2" cellspacing="0" width="100%">
              <tr>
                <td valign="top" width="80%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 13pt; FONT-FAMILY: arial, sans-serif">SUMMONS</font></div>
                </td>
                <td align="right" valign="bottom" width="20%" style="BORDER-RIGHT: medium none; BORDER-LEFT: medium none; BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: arial">SUM-100</font></div>
                </td>
              </tr>
              <tr>
                <td valign="top" width="80%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-STYLE: italic; FONT-FAMILY: arial">(CITACION
      JUDICIAL)</font></div>
                </td>
                <td valign="top" width="20%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid">&#160;</td>
              </tr>
              <tr>
                <td align="left" valign="top" width="80%" style="PADDING-BOTTOM: 2px">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: arial">NOTICE
      TO DEFENDANT:</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-STYLE: italic; FONT-FAMILY: arial">(AVISO
      AL DEMANDADO):</font></div>
                </td>
                <td rowspan="7" valign="top" width="20%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
                  <div align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;
      </font><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;
      </font><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;
      </font><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;
      </font><img src="sum_p1.jpg" alt=""></div>
                </td>
              </tr>
              <tr>
                <td align="left" valign="top" width="80%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: arial">&#160;</font></td>
              </tr>
              <tr>
                <td align="left" valign="top" width="80%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: arial">LONGS DRUG
      STORES CORPORATION, WARREN F. BRYANT,</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">MURRAY
      H. DASHE, MARY S. METZ, DONNA A. TANOUE, LEROY T. BARNES, JR., EVELYN S.
      DILSAVER, ANTHONY G. WAGNER, CVS CAREMARK CORPORATION, and BLUE MERGERSUB
      CORP.</font></div>
                </td>
              </tr>
              <tr>
                <td align="left" valign="top" width="80%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: arial">&#160;</font></td>
              </tr>
              <tr>
                <td align="left" valign="top" width="80%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: arial">YOU
      ARE BEING SUED BY PLAINTIFF:</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-STYLE: italic; FONT-FAMILY: arial">(LO
      EST&#193; DEMANDANDO EL DEMANDANTE):</font></div>
                </td>
              </tr>
              <tr>
                <td align="left" valign="top" width="80%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: arial">&#160;</font></td>
              </tr>
              <tr>
                <td align="left" valign="top" width="80%" style="BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">LOUISIANA
      MUNICIPAL POLICE EMPLOYEES<font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#8217;</font> RETIREMENT
      SYSTEM, on behalf of itself and all other similarly situated shareholders
      of Longs Drug Stores Corporation,</font></div>
                </td>
              </tr>
          </table>
        </div>
        <div align="left">
          <table cellpadding="2" cellspacing="0" width="100%">
              <tr>
                <td align="left" colspan="2" valign="top" width="100%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">You have 30
      CALENDAR DAYS after this summons and legal papers are served on you to
      file a written response at this court and have a copy served on the
      plaintiff. A letter or phone call will not protect you. Your written
      response must be in proper legal form if you want the court to hear your
      case. There may be a court form that you can use for your response. You
      can find these court forms and more information at the California Courts
      Online Self-Help Center (www.courtinfo.ca.gov/selfhelp), your county law
      library, or the courthouse nearest you. If you cannot pay the filing fee,
      ask the court clerk for a fee waiver form. If you do not file your
      response on time, you may lose the case by default, and your wages, money,
      and property may be taken without further warning from the
      court.</font></div>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="2" valign="top" width="100%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">There are
      other legal requirements. You may want to call an attorney right away. If
      you do not know an attorney, you may want to call an attorney referral
      service. If you cannot afford an attorney, you may be eligible for free
      legal services from a nonprofit legal services program. You can locate
      these nonprofit groups at the California Legal Services Web site
      (www.lawhelpcalifornia.org ), the California Courts Online Self-Help
      Center (www.courtinfo.ca.gov/selfhelp), or by contacting your local court
      or county bar association.</font></div>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="2" valign="top" width="100%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-STYLE: italic; FONT-FAMILY: arial">Tiene
      30 D&#205;AS DE CALENDARIO despu&#233;s de que le entreguen esta citaci&#243;n y papeles
      legales para presentar una respuesta por escrito en esta corte y hacer que
      se entregue una copia al demandante. Una carta o una llamada telef&#243;nica no
      lo protegen. Su respuesta por escrito tiene que estar en formato legal
      correcto si desea que procesen su caso en Ia corte. Es posible que haya un
      formulario que usted pueda usar para su respuesta. Puede encontrar estos
      formularios de Ia corte y m&#225;s informaci&#243;n en el Centro de Ayuda de las
      Cortes de California (www.courtinfo.ca.gov/selfhelp/espanol/), en la
      biblioteca de leyes de su condado o en Ia corte que le quede m&#225;s cerca. Si
      no puede pagar Ia cuota de presentaci&#243;n, pida al secretario de Ia corte
      que le d&#233; un formulario de exenci&#243;n de pago do cuotas. Si no presenta su
      respuesta a tiempo, puede perder el caso por incumplimiento y la corte le
      podr&#225; quitar su sueldo, dinero y bienes sin m&#225;s
    advertencia.</font></div>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="2" valign="top" width="100%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-STYLE: italic; FONT-FAMILY: arial">Hay
      otros requisitos legales. Es recomendable que llame a un abogado
      inmediatamente. Si no conoce a un abogado, puede llamar a un servicio de
      remisi&#243;n a abogados. Si no puede pagar a un abogado, es posible que cumpla
      con los requisitos para obtener servicios legales gratuitos de un programa
      de servicios legales sin fines de lucro. Puede encontrar estos grupos sin
      fines de lucro en el sitio web de California Legal Services,
      (www.lawhelpcaIifornia.org), en el Centro de Ayuda de las Cortes de
      California, (www.courtinfo.ca.gov/selfhelp/espanol/) o poni&#233;ndose en
      contacto con la corte o el colegio de abogados locales.</font></div>
                </td>
              </tr>
              <tr>
                <td align="left" valign="top" width="70%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">The name and
      address of the court is:</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-STYLE: italic; FONT-FAMILY: arial">(El
      nombre y direcci&#243;n de la corte es):</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">SUPERIOR
      COURT FOR THE STATE OF CALIFORNIA</font></div>
                </td>
                <td align="left" valign="top" width="30%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">CASE
      NUMBER</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="FONT-STYLE: italic">(<font style="DISPLAY: inline; FONT-STYLE: italic">N&#250;mero del
      Caso):&#160;&#160;&#160;&#160;&#160;&#160;&#160;
      </font></font></font><font style="DISPLAY: inline; FONT-STYLE: italic"><font style="FONT-SIZE: 12pt; FONT-STYLE: normal; FONT-FAMILY: times new roman">C
      08-02139</font></font></div>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="2" valign="top" width="100%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">COUNTY
      OF CONTRA COSTA</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Martinez
      Superior Court - Wakefield Taylor Courthouse</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">725
      Court Street</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Martinez,
      CA 94553</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">The name,
      address, and telephone number of plaintiff&#8217;s attorney, or plaintiff
      without an attorney, is:</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-STYLE: italic; FONT-FAMILY: arial">(El
      nombre, la direcci&#243;n y el n&#250;mero de tel&#233;fono del abogado del demandante, o
      del demandante que no tiene abogado, es):</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Blair
      A.
      Nicholas&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;858-793-0700&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
      858-793-0323</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Bernstein
      Litowitz Berger &amp; Grossmann LLP</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">12481
      High Bluff Drive</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">San
      Diego, CA 92130</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial; TEXT-DECORATION: none">DATE:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Clerk,
      by&#160;<font style="TEXT-DECORATION: underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
      S.
      KRICKEN&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
      </font>, Deputy</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-STYLE: italic; FONT-FAMILY: arial">(Fecha)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 8pt; FONT-STYLE: normal; FONT-FAMILY: arial">8/22/08</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(Secretario)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
      (Adjunto)</font></div>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="2" valign="top" width="100%" style="BORDER-RIGHT: medium none">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">(<font style="DISPLAY: inline; FONT-STYLE: italic">For proof of service of this
      summons, use</font> Proof of Service of Summons (<font style="DISPLAY: inline; FONT-STYLE: italic">form
      POS-010</font>).)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">(<font style="DISPLAY: inline; FONT-STYLE: italic">Para prueba de entrega de esta
      citati&#243;n use el formulario</font> Proof of Service of Summons, (<font style="DISPLAY: inline; FONT-STYLE: italic">POS-010</font>)).</font></div>
                </td>
              </tr>
          </table>
        </div>
        <div align="left">
          <table cellpadding="2" cellspacing="0" width="100%">
              <tr>
                <td valign="top" width="15%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                <td align="left" valign="bottom" width="45%" style="BORDER-RIGHT: medium none">
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-WEIGHT: bold">NOTICE TO THE PERSON
      SERVED:</font> You are served</font></div>
                </td>
                <td align="left" valign="bottom" width="40%" style="BORDER-RIGHT: medium none"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">&#160;</font></td>
              </tr>
              <tr>
                <td align="left" valign="top" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">(SEAL)</font></div>
                </td>
                <td align="left" valign="top" width="45%" style="BORDER-RIGHT: medium none">
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">1.&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;&#160;<a name="check1">&#160;&#160;&#160;&#160;&#160;&#160;as an individual
      defendant</a>.</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">2.&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;&#160;<a name="check2">&#160;&#160;&#160;&#160;&#160;&#160;as the person sued under
      the fictitious name of <font style="DISPLAY: inline; FONT-STYLE: italic">(specify)</font>:</a></font></div>
                  <div style="DISPLAY: block; TEXT-INDENT: 0pt" align="left">&#160;</div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">3.&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;&#160;<a name="check3">&#160;&#160;&#160;&#160;&#160;&#160;on behalf of <font style="DISPLAY: inline; FONT-STYLE: italic">(specify)</font>:</a></font></div>
                </td>
                <td align="left" valign="top" width="40%" style="BORDER-RIGHT: medium none"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">&#160;</font></td>
              </tr>
              <tr>
                <td align="left" valign="top" width="15%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                <td align="left" valign="top" width="45%" style="BORDER-RIGHT: medium none">
                  <div style="DISPLAY: block; MARGIN-LEFT: 63pt; TEXT-INDENT: -36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">under:&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;&#160;&#160;
      CCP 416.10 (corporation)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 63pt; TEXT-INDENT: -36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font id="TAB1" style="MARGIN-LEFT: 27.45pt"></font>&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;&#160;&#160;
      CCP 416.20 (defunct corporation)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 63pt; TEXT-INDENT: -36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font id="TAB1" style="MARGIN-LEFT: 27.45pt"></font>&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;&#160;&#160;
      CCP 416.40 (association or partnership)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 63pt; TEXT-INDENT: -36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font id="TAB1" style="MARGIN-LEFT: 27.45pt"></font>&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;&#160;&#160;
      other <font style="DISPLAY: inline; FONT-STYLE: italic">(specify):</font></font></div>
                </td>
                <td align="left" valign="top" width="40%" style="BORDER-RIGHT: medium none">
                  <div><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;&#160;&#160;&#160;&#160;
      CCP 416.60 (minor)</font></div>
                  <div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;&#160;&#160;&#160;&#160;
      CCP 416.70 (conservatee)</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;&#160;&#160;&#160;&#160;
      CCP 416.90 (authorized person)</font></div>
                  </div>
                </td>
              </tr>
              <tr>
                <td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                <td align="left" nowrap valign="top" width="45%" style="BORDER-RIGHT: medium none; PADDING-BOTTOM: 2px">
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">4.&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;by
      personal delivery on <font style="DISPLAY: inline; FONT-STYLE: italic">(date)</font>:</font></div>
                </td>
                <td align="left" nowrap valign="top" width="40%" style="BORDER-RIGHT: medium none; PADDING-BOTTOM: 2px">
                  <div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">&#160;<font style="FONT-SIZE: 8pt; FONT-FAMILY: arial">Page 1 of
    1</font></font></div>
                </td>
              </tr>
          </table>
        </div>
        <div align="left">
          <table cellpadding="2" cellspacing="0" width="100%">
              <tr>
                <td align="left" valign="top" width="20%" style="BORDER-TOP: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">Form Adopted
      for Mandatory Use</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">Judicial
      Council of California</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">SUM-100 [Rev.
      January 1, 2004]</font></div>
                </td>
                <td valign="middle" width="22%" style="BORDER-TOP: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: arial">SUMMONS</font></div>
                </td>
                <td colspan="3" valign="top" width="22%" style="BORDER-TOP: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">Legal</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">Solutions</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">Plus<br>Logo</font></div>
                </td>
                <td align="right" valign="top" width="22%" style="BORDER-RIGHT: medium none; BORDER-TOP: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">Code of Civil
      Procedure &#167;&#167; 412.20, 465</font></div>
                </td>
              </tr>
          </table>
        </div>
      </div>
      <div>&#160;</div>
      <div>&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
          </div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div>&#160;</div>
      <div>
        <div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: arial">CM-010</font></div>
      </div>
      <div>
        <div align="left">
          <table cellpadding="2" cellspacing="0" width="100%">
              <tr>
                <td align="left" colspan="2" valign="top" width="80%" style="BORDER-TOP: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">ATTORNEY OR
      PARTY WITHOUT ATTORNEY <font style="DISPLAY: inline; FONT-STYLE: italic">(Name, State Bar number, and
      address)</font>:</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Blair
      A. Nicholas (Bar No. 178428)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Bernstein
      Litowitz Berger &amp; Grossmann LLP</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">12481
      High Bluff Drive, Suite 300</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">San
      Diego, CA 92130</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">TELEPHONE
      NO.:</font>&#160;&#160;<font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">858-793-0070</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">FAX
      NO.:</font>&#160;&#160;<font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">858-793-0323</font></font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">ATTORNEY FOR
      </font><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-STYLE: italic; FONT-FAMILY: arial">(Name)</font><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">:</font> <font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Plaintiff Louisiana
      Muni. Police Emp. Ret. Sys.</font></font></div>
                </td>
                <td rowspan="2" valign="top" width="20%" style="BORDER-RIGHT: black 2px solid; BORDER-TOP: black 2px solid; BORDER-LEFT: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 5pt; FONT-STYLE: italic; FONT-FAMILY: arial, sans-serif">FOR
      COURT USE ONLY</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
                  <div align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;
      </font><img src="sum_p1.jpg" alt=""></div>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="2" valign="top" width="80%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">SUPERIOR COURT
      OF CALIFORNIA, COUNTY OF&#160;<font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">CONTRA
      COSTA</font></font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">&#160; STREET
      ADDRESS:</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">725
      Court Street</font></font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt">&#160;MAILING
      ADDRESS:</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-FAMILY: arial">CITY AND ZIP
      CODE:</font>&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Martinez,
      CA 94553</font></font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: arial">BRANCH NAME:&#160;&#160;
      </font><font id="TAB1" style="MARGIN-LEFT: 5.55pt"></font><font style="DISPLAY: inline; FONT-SIZE: 8pt">Wakefield Taylor
      Courthouse</font></font></div>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="2" valign="top" width="80%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">CASE
      NAME:</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Louisiana
      Muni. Police Emp. Ret. Sys. v. Longs Drugs Stores Corp. et
    al</font></div>
                </td>
                <td align="left" valign="top" width="20%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              </tr>
              <tr>
                <td rowspan="2" valign="top" width="40%" style="PADDING-LEFT: 0pt; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: arial">CIVIL
      CASE COVER SHEET</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: -27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">&#254;</font>&#160;&#160;&#160;Unlimited</font><font style="DISPLAY: inline; FONT-SIZE: 8pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
      &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">Limited</font></font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 45pt; TEXT-INDENT: -27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">(Amount&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
      (Amount</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 45pt; TEXT-INDENT: -27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">demanded&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
      demanded is</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 45pt; TEXT-INDENT: -27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">exceeds
      $25,000)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;$25,000
      or less)</font></div>
                </td>
                <td rowspan="2" valign="top" width="40%" style="BORDER-RIGHT: medium none; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: arial">Complex
      Case Designation</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt">&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Counter</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-SIZE: 8pt">&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font>&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Joinder</font></font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">Filed with
      first appearance by defendant</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font id="TAB1" style="MARGIN-LEFT: 6.3pt"></font>(Cal. Rules of Court, rule
      3.402)</font></div>
                </td>
                <td align="left" nowrap valign="top" width="20%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">CASE NUMBER:
      <font style="FONT-SIZE: 12pt; FONT-FAMILY: times new roman">C
      08-02139</font></font></div>
                </td>
              </tr>
              <tr>
                <td align="left" valign="top" width="40%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">JUDGE:</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">&#160;&#160;&#160;DEPT:</font></div>
                </td>
              </tr>
          </table>
        </div>
        <div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-STYLE: italic; FONT-FAMILY: arial">Items
1-6 below must be completed (see instructions on page 2).</font></div>
        </div>
        <div align="left">
          <table cellpadding="2" cellspacing="0" width="100%">
              <tr>
                <td align="left" colspan="8" valign="top" width="100%" style="BORDER-RIGHT: black 2px solid; BORDER-TOP: black 2px solid; BORDER-LEFT: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">1.&#160;&#160;&#160;&#160;&#160;Check
      <font style="FONT-WEIGHT: bold">one</font> box below for the case type
      that best describes this case:</font></div>
                </td>
              </tr>
              <tr>
                <td align="left" nowrap valign="top" width="33%" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: arial">Auto
      Tort</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Auto
      (22)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Uninsured
      motorist (46)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: arial">Other
      PI/PD/WD (Personal Injury/</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: arial">Property
      Damage/Wrongful Death) Tort</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Asbestos
      (04)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Product
      liability (24)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Medical
      malpractice (45)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Other
      PI/PD/WD (23)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: arial">Non-PI/PD/WD
      (Other) Tort</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Business
      tort/unfair</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">&#160;business
      practice (07)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Civil
      rights (08)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Defamation
      (13)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Fraud
      (16)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Intellectual
      property (19)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Professional
      negligence (25)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Other
      non-PI/PD/WD tort (35)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: arial">Employment</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Wrongful
      termination (36)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Other
      employment (15)</font></div>
                </td>
                <td align="left" colspan="4" nowrap valign="top" width="67%" style="BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: arial">Contract</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Breach
      of contract/warranty (06)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Rule
      3.740 collections (09)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Other
      collections (09)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Insurance
      coverage (18)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Other
      contract (37)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: arial">Real
      Property</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Eminent
      domain/Inverse</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">&#160;condemnation
      (14)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Wrongful
      eviction (33)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Other
      real property (26)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: arial">Unlawful
      Detainer</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Commercial
      (31)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Residential
      (32)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Drugs
      (38)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: arial">Judicial
      Review</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Asset
      forfeiture (05)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Petition
      re: arbitration award (11)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Writ
      of mandate (02)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Other
      judicial review (39)</font></div>
                </td>
                <td align="left" colspan="3" nowrap valign="top" width="29%" style="BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: arial">Provisionally
      Complex Civil Litigation</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: arial">(Cal.
      Rules of Court, rules 3.400-3.403)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;</font>&#160;Antitrust/Trade
      regulation (03)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;</font>&#160;Construction
      defect (10)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;</font>&#160;Mass
      tort (40)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">&#254;</font>&#160;</font>&#160;Securities
      litigation (28)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;</font>&#160;Environmental/Toxic
      tort (30)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;</font>&#160;Insurance
      coverage claims arising</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">&#160;from
      the&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">above listed
      provisionally</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">&#160;complex
      case&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">types
      (41)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: arial">Enforcement
      of Judgment</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Enforcement
      of judgment (20)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: arial">Miscellaneous
      Civil Complaint</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>RICO(27)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Other
      complaint <font style="DISPLAY: inline; FONT-STYLE: italic">(not specified
      </font><font style="DISPLAY: inline; FONT-STYLE: italic">above)</font>
      (42)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: arial">Miscellaneous
      Civil Petition</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Partnership
      and corporate governance (21)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;</font>Other
      petition <font style="DISPLAY: inline; FONT-STYLE: italic">(not specified
      above)</font>(43)</font></div>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="8" valign="top" width="100%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">2.&#160;&#160;&#160;&#160;&#160;This
      case&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">&#254;</font><font style="DISPLAY: inline; FONT-SIZE: 8pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 8pt">&#160;</font>is&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160; is not
      &#160;&#160;&#160;&#160;&#160;complex under rule 3.400 of the California
      Rules of Court. If the case is complex, mark the factors requiring
      exceptional judicial management:</font></div>
                </td>
              </tr>
          </table>
        </div>
        <div align="left">
          <table cellpadding="2" cellspacing="0" width="100%">
              <tr>
                <td align="left" valign="top" width="50%" style="PADDING-LEFT: 0pt">
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">a.&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">&#254;</font>&#160;&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">Large number
      of separately represented parties</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">b.&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">&#254;</font>&#160;&#160;Extensive
      motion practice raising difficult or novel issues</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">&#160;&#160;that
      will be time-consuming to resolve</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">c.&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;Substantial
      amount of documentary evidence</font></div>
                </td>
                <td align="left" valign="top" width="50%" style="PADDING-LEFT: 0pt">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">d.&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;Large
      number of witnesses</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">e.&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;Coordination
      with related actions pending in one or more courts in other</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">&#160;&#160;counties,
      states, or countries, or in a federal court</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">f.&#160;
      &#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;&#160;Substantial
      postjudgment judicial supervision</font></div>
                </td>
              </tr>
          </table>
        </div>
        <div align="left">
          <table cellpadding="2" cellspacing="0" width="100%">
              <tr>
                <td align="left" colspan="8" valign="top" width="100%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">3.&#160;&#160;&#160;&#160;&#160;Remedies
      sought <font style="DISPLAY: inline; FONT-STYLE: italic">(check all that
      apply)</font>: a.<font style="DISPLAY: inline; FONT-SIZE: 8pt">&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font><font style="DISPLAY: inline; FONT-SIZE: 8pt">&#160;&#160;</font>monetary
      &#160;&#160;&#160;b.&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">&#254;</font><font style="DISPLAY: inline; FONT-SIZE: 8pt">&#160;&#160;</font>nonmonetary;
      declaratory or injunctive relief &#160;&#160;&#160;c.&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;<font style="DISPLAY: inline; FONT-SIZE: 8pt">&#160;</font>punitive</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">4.&#160;&#160;&#160;&#160;&#160;Number
      of causes of action <font style="DISPLAY: inline; FONT-STYLE: italic">(specify)</font>: <font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Three</font></font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">5.&#160;&#160;&#160;&#160;&#160;This
      case&#160;<font style="DISPLAY: inline; FONT-SIZE: 8pt">&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">&#254;</font></font><font style="DISPLAY: inline; FONT-SIZE: 8pt">&#160;&#160;</font>
      is&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;is not
      &#160;&#160;&#160;&#160;&#160;a class action suit.</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">6.&#160;&#160;&#160;&#160;&#160;If
      there are any known related cases, file and serve a notice of related
      case. <font style="DISPLAY: inline; FONT-STYLE: italic">(You may use form
      CM-015.)</font></font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial"><font style="DISPLAY: inline; FONT-FAMILY: arial">Date: </font><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">August
      22, 2008</font></font></div>
                </td>
              </tr>
              <tr>
                <td colspan="2" valign="top" width="66%" style="BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Blair
      A. Nicholas</font></div>
                </td>
                <td colspan="2" valign="top" width="34%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                <td colspan="4" valign="top" width="40%" style="BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">/s/
      Blair A. Nicholas</font></div>
                </td>
              </tr>
              <tr>
                <td colspan="2" valign="top" width="66%" style="BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">(TYPE OR PRINT
      NAME)</font></div>
                </td>
                <td colspan="2" valign="top" width="34%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                <td colspan="4" valign="top" width="40%" style="BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">(SIGNATURE OF
      PARTY OR ATTORNEY FOR PARTY)</font></div>
                </td>
              </tr>
              <tr>
                <td colspan="8" valign="top" width="100%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: arial">NOTICE</font></div>
                  <div style="MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">&#9679;</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">Plaintiff must
      file this cover sheet with the first paper filed In the action or
      proceeding (except small claims cases or cases filed under the Probate
      Code, Family Code, or Welfare and Institutions Code). (Cal. Rules of
      Court, rule 3.220.) Failure to file may result in sanctions.</font></div>
                  <div style="MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">&#9679;</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">File this
      cover sheet in addition to any cover sheet required by local court
      rule.</font></div>
                  <div style="MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">&#9679;</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">If this case
      Is complex under rule 3.400 et seq. of the California Rules of Court, you
      must serve a copy of this cover sheet on all other parties to the action
      or proceeding.</font></div>
                  <div style="MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">&#9679;</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">Unless this is
      a collections case under rule 3.740 or a complex case, this cover sheet
      will be used for statistical purposes only.</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">Page 1 of
      2</font></div>
                </td>
              </tr>
          </table>
        </div>
        <div align="left">
          <table cellpadding="2" cellspacing="0" width="100%">
              <tr>
                <td align="left" valign="top" width="33%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">Form Adopted
      for Mandatory Use</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">Judicial
      Council of California</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">CM-010 [Rev.
      July 1, 2007]</font></div>
                </td>
                <td valign="top" width="33%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: arial">CIVIL
      CASE COVER SHEET</font></div>
                </td>
                <td align="right" colspan="2" valign="top" width="34%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">Cal. Rules of
      Court, rules 2.30, 3.220, 3.400-3.403, 3.740;</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">Cal. Standards
      of Judicial Administration, std. 3.10</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-STYLE: italic; FONT-FAMILY: arial">www.courtinfo.ca.gov</font></div>
                </td>
              </tr>
          </table>
        </div>
        <div align="left">
          <table cellpadding="2" cellspacing="0" width="100%">
              <tr>
                <td valign="top" width="90%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                <td align="left" nowrap valign="top" width="10%" style="BORDER-RIGHT: black 2px solid; BORDER-TOP: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: arial">American
      LegalNet, Inc.</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-STYLE: italic; FONT-FAMILY: arial"><font style="FONT-STYLE: normal"><font style="FONT-STYLE: normal">www.Forms</font><font style="FONT-STYLE: italic">Workflow.<font style="FONT-STYLE: normal">com</font></font></font></font></div>
                </td>
              </tr>
          </table>
        </div>
      </div>
      <div>&#160;</div>
      <div>&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
          </div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 241.2pt" align="left">
          <div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font size="+0"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">BERNSTEIN
LITOWITZ BERGER</font></font></div>
          </div>
          <div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font size="+0"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">&#160;
</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">&amp;
GROSSMANN LLP</font></font></div>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">BLAIR A.
NICHOLAS (Bar No. 178428)</font></div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">12481
High Bluff Drive, Suite 300</font></div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">San
Diego, CA 92130</font></div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Tel:&#160;&#160;&#160;&#160;&#160;&#160;(858)
793-0070</font></div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Fax:&#160;&#160;&#160;&#160;&#160;(858)
793-0323</font></div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">blairn@blbglaw.com</font></div>
          <div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Attorneys
for Plaintiff Louisiana Municipal</font></div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Police
Employees&#8217; Retirement System and</font></div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Proposed
Lead Counsel for the Class</font></div>
          <div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">&#160;</div><br></div>
        <div>&#160;</div>
        <div align="center">
          <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
              <tr>
                <td width="50%">
                  <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font size="3">SUPERIOR COURT OF THE STATE OF CALIFORNIA<br><br>COUNTRY OF CONTRA
      COSTA</font></font></div>
                </td>
              </tr>
          </table>
        </div>
        <div>&#160;</div>
        <div>
          <table cellpadding="0" cellspacing="0" width="100%">
              <tr>
                <td align="left" valign="top" width="45%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">LOUISIANA
      MUNICIPAL POLICE</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">EMPLOYEES&#8217;
      RETIREMENT SYSTEM, on</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">behalf
      of itself and all other similarly situated</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">shareholders
      of Longs Drug Stores</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Corporation,</font></div>
                  </div>
                </td>
                <td align="left" rowspan="6" valign="top" width="9%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">)</font></div>
                </td>
                <td align="left" rowspan="6" valign="top" width="46%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
                  <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Case
      No. C_08-02139</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; TEXT-DECORATION: none">Judge:</font></font></div>
                  <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">CLASS
      ACTION COMPLAINT</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">DEMAND
      FOR JURY TRIAL</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><br><br><font style="FONT-SIZE: 12pt; FONT-FAMILY: arial">PER
      LOCAL RULE 5 THIS </font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="FONT-SIZE: 12pt; FONT-FAMILY: arial">CASE IS
      ASSIGNED TO</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="FONT-SIZE: 12pt; FONT-FAMILY: arial">DEPT
      ______</font></div>
                  <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
                </td>
              </tr>
              <tr>
                <td align="left" valign="bottom" width="45%" style="PADDING-LEFT: 0pt">
                  <div style="DISPLAY: block; MARGIN-LEFT: 180pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Plaintiff,</font></div>
                </td>
              </tr>
              <tr>
                <td align="left" valign="bottom" width="45%" style="PADDING-LEFT: 0pt">
                  <div style="DISPLAY: block; MARGIN-LEFT: 54pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">v.</font></div>
                </td>
              </tr>
              <tr>
                <td align="left" valign="top" width="45%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr>
                <td align="left" valign="top" width="45%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">LONGS
      DRUG STORES CORPORATION,</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">WARREN
      F. BRYANT, MURRAY H.</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">DASHE,
      MARY S. METZ, DONNA A.</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">TANOUE,
      LEROY T. BARNES, JR.,</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">EVELYN
      S. DILSAVER, ANTHONY G.</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">WAGNER,
      CVS CAREMARK</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">CORPORATION,
      and BLUE MERGERSUB</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">CORP.</font></div>
                  </div>
                </td>
              </tr>
              <tr>
                <td align="left" valign="bottom" width="45%" style="PADDING-LEFT: 0pt">
                  <div style="DISPLAY: block; MARGIN-LEFT: 63pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Defendants.</font></div>
                </td>
              </tr>
              <tr>
                <td valign="bottom" width="45%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              </tr>
          </table>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left">
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">CLASS
ACTION COMPLAINT</font></div>
                  </div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">Case
No</font>.</font></font></div>
                </div>
              </div>
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="2">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="center">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="center">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Plaintiff
Louisiana Municipal Police Employees&#8217; Retirement System (&#8220;LAMPERS&#8221; or
&#8220;Plaintiff&#8221;) on behalf of itself and all other similarly situated public
shareholders (the &#8220;Class&#8221;) of Longs Drug Stores Corporation (hereafter, &#8220;Longs&#8221;
or &#8220;the Company&#8221;), by its attorneys, makes the following allegations against
Longs, the members of Longs&#8217; Board of Directors, CVS Caremark Corporation (&#8220;CVS
Caremark&#8221; or &#8220;CVS&#8221;) and Blue MergerSub Corp. (&#8220;Blue MergerSub&#8221;) in support of
Plaintiff&#8217;s claims.</font></div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">SUMMARY OF THE
ACTION</font></font></div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">1.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160; </font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">This
class action, filed on behalf of the public shareholders of Longs, is brought
against the Company, Longs Directors (as defined below) and CVS Caremark to
enjoin an unlawful plan through which CVS Caremark would acquire all shares of
Longs (the &#8220;Proposed Transaction&#8221; or &#8220;Acquisition Proposal&#8221;) without providing
material disclosures, for inadequate consideration and under circumstances
unfair to the Class.</font></div>
          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">2.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160; </font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">On August
12, 2008, Longs entered into an agreement to be acquired by CVS Caremark for
approximately $2.9 billion via tender offer. As CVS Caremark Chief Executive
Officer (&#8220;CEO&#8221;) Tom Ryan made clear in numerous public statements in support of
the Proposed Transaction, Longs&#8217; real estate assets are a key component of the
transaction and a substantial expected benefit to CVS Caremark.&#160;&#160;Ryan
stated publicly that Longs&#8217; real estate assets are worth a conservative estimate
of $1 billion, which CVS Caremark would be able to monetize to its
benefit.</font></div>
          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">3.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160; </font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">After the
Proposed Transaction was announced and CVS Caremark CEO Ryan made his remarks,
several major shareholders of Longs started to question whether the true value
of Longs&#8217; real estate assets was actually far higher.&#160;&#160;Indeed, one
major Longs investor, Pershing Square Capital Management (&#8220;Pershing Square&#8221;),
reported that it had conducted its own market research and that Longs&#8217; real
estate assets were worth significantly more than $1 billion.</font></div>
          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">4.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160; </font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Soon
after Pershing Square questioned CVS Caremark&#8217;s publicly-stated estimate of
Longs&#8217; real estate assets, another major Longs shareholder, Advisory Research,
Inc. (&#8220;Advisory Research&#8221;), formally requested through a filing with the United
States Securities and Exchange Commission (&#8220;SEC&#8221;) more information regarding the
Company&#8217;s real estate holdings </font></div>
          <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
            <div id="FTR">
              <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                <div id="FTR">
                  <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                    <div id="FTR">&#160;</div>
                    <div id="PN" style="PAGE-BREAK-AFTER: always">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">
                        <div align="center">
                          <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
                              <tr>
                                <td colspan="3" width="33%" style="BORDER-TOP: medium none; BORDER-BOTTOM: #000000 1px solid">&#160;</td>
                              </tr>
                              <tr>
                                <td width="33%"><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">CLASS ACTION
      COMPLAINT </font>

                                  <div><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Case
      No.</font></div>
                                </td>
                                <td width="34%">
                                  <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font size="3">-1-</font></font></div>
                                </td>
                                <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                              </tr>
                          </table>
                          <div style="WIDTH: 100%; TEXT-ALIGN: center">
                            <hr style="COLOR: black" noshade size="2">
                          </div>
                          <div id="HDR">
                            <div id="GLHDR" style="WIDTH: 100%" align="right">
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">prior to
voting its shares.&#160;&#160;However, the Chairman of Advisory Research was
told directly by Longs&#8217; CEO Warren Bryant that <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Longs signed an
agreement with CVS Caremark that it would not reveal the value of its real
estate assets.</font>&#160;&#160;In other words, Longs shareholders are being
asked to make the most important, fundamental decision <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#8211;</font> whether to
relinquish their shares in exchange for cash <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#8211;</font> without the
benefit of necessary material information to which they are
entitled.</font></div>
          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">5.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160; </font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">In
addition, the agreement entered into between Longs, CVS Caremark and Blue
MergerSub erects several barriers meant to deter competing bids and to prevent
Longs shareholders from receiving full value for their shares.&#160;&#160;For
example, even if Longs were to receive a superior bid for the Company, <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Longs would be
required to pay CVS Caremark a break-up fee of $115 million, or an astounding
4.5% of the equity value of the Proposed Transaction.</font></font></div>
          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">6.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160; </font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Moreover,
the Longs Directors structured the Proposed Transaction so that CVS Caremark
need not comply with the usual corporate formalities that go along with the
usual third-party merger.&#160;&#160;Instead, in addition to granting
significant &#8220;deal protections&#8221; in the Proposed Transaction, the Longs Directors
have granted a &#8220;top-up&#8221; option to CVS Caremark that allows CVS Caremark to
complete a &#8220;short form&#8221; merger even it never pays a price sufficient to obtain
90% of the Company&#8217;s outstanding shares.&#160;&#160;The &#8220;top up&#8221; option allows
CVS Caremark to pay the lowest possible price necessary to get the required
66-2/3% of the Company&#8217;s shares, but enjoy the benefits of a short form
merger.&#160;&#160;Inclusion of this provision makes clear the parties&#8217; intent
to avoid applicable shareholder voting protections at the expense of Longs
shareholders.</font></div>
          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">7.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160; </font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Consequently,
Plaintiff and the other Class members face certain and irreparable harm if the
Proposed Transaction is allowed to proceed, or if Plaintiff and the other Class
members are forced to evaluate the Proposed Transaction without necessary
material information to assess the value of the Acquisition
Proposal.&#160;&#160;As such, Plaintiff, on behalf of itself and the other Class
members, respectfully requests the Court to enjoin the Proposed Transaction, as
Plaintiff and the other Class members have no adequate remedy at
law.</font></div>
          <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
            <div id="FTR">
              <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                <div id="FTR">
                  <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                    <div id="FTR">&#160;</div>
                    <div id="PN" style="PAGE-BREAK-AFTER: always">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">
                        <div align="center">
                          <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
                              <tr>
                                <td colspan="3" width="33%" style="BORDER-TOP: medium none; BORDER-BOTTOM: #000000 1px solid">&#160;</td>
                              </tr>
                              <tr>
                                <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">CLASS ACTION
      COMPLAINT </font></font>

                                  <div><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Case
      No.</font></div>
                                </td>
                                <td width="34%">
                                  <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font size="3">-2-</font></font></div>
                                </td>
                                <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                              </tr>
                          </table>
                        </div>
                        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">
                          <div id="PN" style="PAGE-BREAK-AFTER: always">
                            <div style="WIDTH: 100%; TEXT-ALIGN: center">
                            </div>
                            <div style="WIDTH: 100%; TEXT-ALIGN: center">
                              <hr style="COLOR: black" noshade size="2">
                            </div>
                          </div>
                          <div id="HDR">
                            <div id="GLHDR" style="WIDTH: 100%" align="right">
                            </div>
                          </div>
                        </div>
                        <div align="center"><font style="FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: times new roman; TEXT-DECORATION: underline">JURISDICTION
AND VENUE</font></div>
                        <div style="TEXT-INDENT: 36pt; TEXT-ALIGN: justify" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">8.&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">This
Court has jurisdiction over all causes of action asserted herein pursuant to
&#167;&#160;410.10 of the California Code of Civil Procedure and &#167; 2116 of the
California Corporations Code. </font></div>
                        <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">9.&#160;&#160;&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">This
Court has jurisdiction over each defendant named herein because each defendant
is either a corporation that does sufficient business in California, or an
individual who has sufficient minimum contacts with California, to render the
exercise of jurisdiction by the California courts permissible under traditional
notions of fair play and substantial justice.&#160;&#160;All of the defendants
conduct business and/or maintain offices in California, and Longs&#8217; headquarters
and its principal place of business is located in Walnut Creek, Contra Costa
County, California.&#160;&#160;Also, many of the Individual Defendants reside in
California.</font></div>
                        <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">10.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160; </font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Venue is
proper in this Court because a substantial portion of the wrongs complained of
herein, including the defendants&#8217; primary participation in the wrongful acts
detailed herein in violation of their fiduciary duties, occurred in Contra Costa
County, and the defendants have received substantial compensation in Contra
Costa County by doing business here and engaging in numerous activities which
had an effect in this County.&#160;&#160;Venue is also proper in this Court
because many of those affected by defendants&#8217; conduct reside in this County, and
many of the potential witnesses reside or work in this County.</font></div>
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline"><br>THE
PARTIES</font></font></div>
                        <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">11.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160; </font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Plaintiff
Louisiana Municipal Police Employees&#8217; Retirement System is a retirement system
created in 1973 by State of Louisiana enabling legislation for the purpose of
investing and providing retirement allowances and other benefits for the
full-time municipal police officers and employees in the State of Louisiana,
secretaries to chiefs of police, and employees of LAMPERS.&#160;&#160;LAMPERS is
a shareholder of Longs, has been a shareholder of Longs at all material times
alleged in this Complaint, and will continue to be a shareholder through the
pendency of this action.</font></div>
                        <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">12.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160; </font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Defendant
Longs Drug Stores Corporation (&#8220;Longs&#8221;) is incorporated under the laws of the
State of Maryland, with its principal executive offices located at 141 North
Civic </font>

                          <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                            <div id="FTR">
                              <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                <div id="FTR">&#160;</div>
                                <div id="PN" style="PAGE-BREAK-AFTER: always">
                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">
                                    <div align="center">
                                      <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
                                          <tr>
                                            <td colspan="3" width="33%" style="BORDER-TOP: medium none; BORDER-BOTTOM: #000000 1px solid">&#160;</td>
                                          </tr>
                                          <tr>
                                            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">CLASS ACTION
      COMPLAINT </font></font>

                                              <div><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Case
      No.</font></div>
                                            </td>
                                            <td width="34%">
                                              <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font size="3">-3-</font></font></div>
                                            </td>
                                            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                          </tr>
                                      </table>
                                    </div>
                                    <div id="PN" style="PAGE-BREAK-AFTER: always">
                                      <div style="WIDTH: 100%; TEXT-ALIGN: center">
                                        <hr style="COLOR: black" noshade size="2">
                                      </div>
                                    </div>
                                    <div id="HDR">
                                      <div id="GLHDR" style="WIDTH: 100%" align="right">
                                      </div>
                                    </div>
                                    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Drive,
Walnut Creek, California 94596.&#160;&#160;Founded in Oakland, California in
1938, Longs operates retail drug stores and provides pharmacy benefit management
services in the United States.&#160;&#160;Through its retail drug segment, Longs
is one of the most recognized retail drug store chains on the West Coast of the
United States and in Hawaii, with 510 stores as of January 31,
2008.&#160;&#160;Longs&#8217; retail drug segment also operates a mail order pharmacy
business.&#160;&#160;In addition, Longs operates a pharmacy benefit services
segment, which offers prescription drug plans under Medicare Part D as
established by the Medicare Prescription Drug, Improvement and Modernization Act
of 2003.&#160;&#160;These plans will provide prescription drug benefits to an
estimated 440,000 to 450,000 Medicare beneficiaries in all 50 states and the
District of Columbia in the calendar 2008 plan year.</font></div>
                                    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">13.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160; </font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Defendant
CVS Caremark Corporation is incorporated under the laws of the State of
Delaware, with its principal executive offices located at One CVS Drive,
Woonsocket, Rhode Island 02895.&#160;&#160;CVS Caremark is the largest provider
of prescriptions and related healthcare services in the United
States.&#160;&#160;CVS Caremark fills or manages more than one billion
prescriptions annually.&#160;&#160;As of December 29, 2007, CVS Caremark
operated 6,245 retail drug stores, which are located in 40 states, including
California, and the District of Columbia.&#160;&#160;CVS Caremark also operates
a Pharmacy Services segment, which provides pharmacy benefit management, mail
order and specialty pharmacy services.</font></div>
                                    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">14.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160; </font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Defendant
Blue MergerSub Corp. is an indirect wholly owned subsidiary of CVS Caremark
created in order to effectuate the Proposed Transaction, believed to be
incorporated under the laws of the State of Maryland, with its Resident Agent
and Principal Office located at 300 E. Lombard Street, Baltimore, Maryland
21202.</font></div>
                                    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">15.&#160;&#160;&#160;&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Defendant
Warren F. Bryant (&#8220;Bryant&#8221;) has served as the President and Chief Executive
Officer of Longs since joining the Company in 2002.&#160;&#160;In 2003,
Defendant Bryant was elected Chairman of the Board of Directors of Longs, which
is a position he still maintains.</font></div>
                                    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">16.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160; </font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Defendant
Murray H. Dashe (&#8220;Dashe&#8221;) is the Lead Director of the Board of Directors of
Longs, which he joined in 2002.&#160;&#160;Defendant Dashe formerly served as
the Chief Executive Officer and President of Cost Plus, Inc., a specialty
retailer of casual home living </font></div>
                                    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify">
                                      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                        <div id="FTR">
                                          <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                            <div id="FTR">
                                              <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                <div id="FTR">&#160;</div>
                                                <div id="PN" style="PAGE-BREAK-AFTER: always">
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">
                                                    <div align="center">
                                                      <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
                                                          <tr>
                                                            <td colspan="3" width="33%" style="BORDER-TOP: medium none; BORDER-BOTTOM: #000000 1px solid">&#160;</td>
                                                          </tr>
                                                          <tr>
                                                            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">CLASS ACTION
      COMPLAINT </font></font>

                                                              <div><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Case
      No.</font></div>
                                                            </td>
                                                            <td width="34%">
                                                              <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font size="3">-4-</font></font></div>
                                                            </td>
                                                            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                          </tr>
                                                      </table>
                                                      <div style="WIDTH: 100%; TEXT-ALIGN: center">
                                                        <hr style="COLOR: black" noshade size="2">
                                                      </div>
                                                      <div id="HDR">
                                                        <div id="GLHDR" style="WIDTH: 100%" align="right">
                                                        </div>
                                                      </div>
                                                    </div>
                                                  </div>
                                                </div>
                                              </div>
                                            </div>
                                          </div>
                                        </div>
                                      </div>
                                    </div>
                                    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify">
                                      <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">entertainment
products until March 2005.&#160;&#160;Defendant Dashe currently serves as a
member of the Board&#8217;s Audit and Finance Committee, Compensation Committee, and
Governance and Nominating Committee.</font></div>
                                      <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">17.&#160;
&#160; </font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Defendant
Leroy T. Barnes, Jr. (&#8220;Barnes&#8221;) has been a member of the Board of Directors of
Longs since 2002.&#160;&#160;Defendant Barnes formerly served as Vice President
and Treasurer of PG&amp;E Corporation, an energy-based holding company, from
2001 to 2005.&#160;&#160;Defendant Barnes currently chairs the Board&#8217;s Audit and
Finance Committee.</font></div>
                                      <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">18.&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Defendant
Mary S. Metz, Ph.D. (&#8220;Metz&#8221;) has been a member of the Board of Directors of
Longs since 1991.&#160;&#160;Defendant Metz formerly served as President of S.H.
Cowell Foundation, a California non-profit public benefit corporation, from 1999
until 2005.&#160;&#160;Defendant Metz currently chairs the Board&#8217;s Governance
and Nominating Committee and is a member of the Board&#8217;s Audit and Finance
Committee.</font></div>
                                      <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">19.&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Defendant
Donna A. Tanoue (&#8220;Tanoue&#8221;) has been a member of the Board of Directors of Longs
since 2005 and is currently a member of the Board&#8217;s Audit and Finance Committee
and Compensation Committee.&#160;&#160;Defendant Tanoue is also the Vice
Chairman of Bank of Hawaii, the primary subsidiary of Bank of Hawaii
Corporation, a financial services&#160;&#160;holding company.</font></div>
                                      <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">20.&#160;&#160;&#160;&#160;</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Defendant
Evelyn S. Dilsaver (&#8220;Dilsaver&#8221;) has been a member of the Board of Directors of
Longs since 2007, and is currently a member of the Board&#8217;s Audit and Finance
Committee and Governance and Nominating Committee.&#160;&#160;Defendant Dilsaver
formerly served as President and Chief Executive Officer of Charles Schwab
Investment Management, Inc., a wholly-owned subsidiary of The Charles Schwab
Corporation, until August 2007.&#160;&#160;Defendant Dilsaver is a designated
financial expert of the Audit and Finance Committee.</font></div>
                                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
                                        <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">21.&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Defendant
Anthony G. Wagner (&#8220;Wagner&#8221;) has been a member of the Board of Directors of
Longs since 1999.&#160;&#160;Defendant Wagner formerly served as the Vice
President of the Office of Labor Management Partnership for Kaiser Foundation
Health Plan, Inc. until December 2006.&#160;&#160;Defendant Wagner currently
chairs the Board&#8217;s Compensation Committee and is a member of the Board&#8217;s
Governance and Nominating Committee.</font></div>
                                      </div>
                                    </div>
                                    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                      <div id="FTR">
                                        <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify">
                                            <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                              <div id="FTR">
                                                <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                  <div id="FTR">
                                                    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                      <div id="PN" style="PAGE-BREAK-AFTER: always">
                                                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">
                                                          <div align="center">
                                                            <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
                                                                <tr>
                                                                  <td colspan="3" width="33%" style="BORDER-TOP: medium none; BORDER-BOTTOM: #000000 1px solid">&#160;</td>
                                                                </tr>
                                                                <tr>
                                                                  <td width="33%"><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">CLASS ACTION
      COMPLAINT </font>

                                                                    <div><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Case
      No.</font></div>
                                                                  </td>
                                                                  <td width="34%">
                                                                    <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font size="3">-5-</font></font></div>
                                                                  </td>
                                                                  <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                </tr>
                                                            </table>
                                                            <div style="WIDTH: 100%; TEXT-ALIGN: center">
                                                              <hr style="COLOR: black" noshade size="2">
                                                            </div>
                                                            <div id="HDR">
                                                              <div id="GLHDR" style="WIDTH: 100%" align="right">
                                                              </div>
                                                            </div>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </div>
                                                  </div>
                                                </div>
                                              </div>
                                            </div>
                                          </div>
                                          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">22.&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Defendants
Bryant, Dashe, Barnes, Metz, Tanoue, Dilsaver and Wagner are referred to herein
as the &#8220;Board&#8221; or &#8220;Longs Directors&#8221; or the &#8220;Individual Defendants.&#8221; Each of the
Longs Directors was a member of Longs&#8217; Board of Directors at all pertinent
times.&#160;&#160;By reason of their positions, the Longs Directors owe
fiduciary duties to Longs and its shareholders, including the obligations of
loyalty, good faith, fair dealing, disclosure, and due care.</font></div>
                                          <div>&#160;</div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline"><br>FACTUAL
BACKGROUND</font></font></div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">The Company Suddenly
Announces A Merger With CVS Caremark<br></font></font></div>
                                          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">23.&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">On August
12, 2008, Longs announced, along with CVS Caremark, that CVS Caremark had
agreed, through an indirect wholly owned subsidiary, Blue MergerSub, to acquire
Longs through a tender offer of $71.50 per share.&#160;&#160;This offer amounts
to a total purchase price of $2.9 billion.&#160;&#160;The announcement
highlights the benefits flowing to CVS (the &#8220;Proposed Transaction&#8221; or the
&#8220;Acquisition Proposal&#8221;):</font></div>
                                          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25">&#160;</div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">The
addition of Longs&#8217; valuable store locations in Central and Northern California,
Hawaii, and Nevada will provide CVS Caremark with substantial market positions
in these highly attractive, fast growing markets.&#160;&#160;Further, the
acquisition complements CVS Caremark&#8217;s substantial presence in Southern
California and provides a foundation for significant future growth throughout
the nation&#8217;s largest state.&#160;&#160;The transaction also offers CVS Caremark
immediate market leadership in the highly attractive Hawaiian market, where it
currently does not have a presence, as well as high-quality locations in Nevada
and Arizona.</font></div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Significantly,
Longs owns the real estate associated with approximately 200 store locations,
three distribution centers and three office facilities.&#160;&#160;CVS Caremark
has conservatively valued the store locations alone at more than $1
billion</font>. These stores are located in markets where commercial real estate
values are among the highest in the country and prime locations are especially
difficult to acquire. <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">CVS Caremark
intends to unlock the intrinsic value of these locations, as well as the
distribution centers and office facilities, by monetizing a substantial portion
of these assets over time.</font></font></div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</font></div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><br>Tom
Ryan, Chairman, President and CEO of CVS Caremark, commented, &#8220;This transaction
provides tremendous benefits to CVS Caremark by accelerating our expansion in
very attractive drugstore markets and strengthening our geographic
reach.&#160;&#160;In fact, Longs has a significant presence in ten non-CVS
markets that are among the top 100 drugstore markets in the country. More than
490 of the stores we are acquiring are located in the Central and Northern
California and Hawaiian markets, where Longs is a leading
player.&#160;&#160;Longs&#8217; store network in these regions is excellent and is one
that would take a decade or more for us to replicate through organic
growth.</font></div>
                                          <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                            <div id="FTR">
                                              <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                <div id="FTR">
                                                  <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                    <div id="FTR">&#160;</div>
                                                    <div id="PN" style="PAGE-BREAK-AFTER: always">
                                                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">
                                                        <div align="center">
                                                          <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
                                                              <tr>
                                                                <td colspan="3" width="33%" style="BORDER-TOP: medium none; BORDER-BOTTOM: #000000 1px solid">&#160;</td>
                                                              </tr>
                                                              <tr>
                                                                <td width="33%"><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">CLASS ACTION
      COMPLAINT </font>

                                                                  <div><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Case
      No.</font></div>
                                                                </td>
                                                                <td width="34%">
                                                                  <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font size="3">-6-</font></font></div>
                                                                </td>
                                                                <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                              </tr>
                                                          </table>
                                                          <div style="WIDTH: 100%; TEXT-ALIGN: center">
                                                            <hr style="COLOR: black" noshade size="2">
                                                          </div>
                                                          <div>&#160;</div>
                                                        </div>
                                                      </div>
                                                    </div>
                                                  </div>
                                                </div>
                                              </div>
                                            </div>
                                          </div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">With this
acquisition, we will increase accessibility to our pharmacies for consumers and
put us in an even better position to grow our new Proactive Pharmacy Care
offerings with our PBM clients.&#160;&#160;We are very excited about the
potential offered by this combination and the opportunity to build on our strong
track record of acquiring and successfully integrating PBMs and retail drugstore
chains, and we expect this integration to be seamless.&#8221;</font></div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">(Emphasis
added.)</font></div>
                                          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">24.&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">As made
clear in the announcement, the valuation of Longs&#8217; real estate properties is a
key driver of value in the transaction.</font></div>
                                          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">25.&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Also on
August 12, 2008, the Company filed with the SEC on Form 8-K a copy of the
Agreement and Plan of Merger dated August 12, 2008, between Longs, CVS Caremark
and Blue MergerSub (the &#8220;Agreement and Plan of Merger&#8221;).&#160;&#160;Further, on
August 20, 2008, the Company filed with the SEC on Schedule 14D-9 a
&#8220;Solicitation/Recommendation Statement under Section 14(d)(4) of the Securities
Exchanges Act of 1934&#8221; (the &#8220;Solicitation&#8221;).&#160;&#160;As discussed below, the
Solicitation failed to make adequate disclosures regarding, among other things,
Longs&#8217; real estate assets.</font></div>
                                          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify">&#160;</div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Specific Concerns From Major
Investors Have Been Ignored</font></font></div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">26.&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Both the
process behind the Proposed Transaction and the disclosed facts regarding the
Company&#8217;s real-estate holdings elicited concerns from large investors in Longs
that the Acquisition Proposal undervalued the Company.</font></div>
                                          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">27.&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">The
announcement of the Proposed Transaction came mere days after an announcement on
August 5, 2008, that Pershing Square, a well-known shareholder activist hedge
fund run by manager William Ackman (&#8220;Ackman&#8221;), owned 8.8% of the common stock in
Longs.&#160;&#160;According to a <font style="DISPLAY: inline; FONT-STYLE: italic">Financial Times</font> article
titled &#8220;Longs faces pressure from activist,&#8221; dated August 14, 2008, Pershing
Square also owns derivative &#8220;swaps&#8221; that &#8220;puts its actual economic exposure at
23.6 percent.&#8221; According to the <font style="DISPLAY: inline; FONT-STYLE: italic">Financial Times</font> article,
Ackman believed that Longs should receive a higher acquisition price than that
offered by CVS Caremark.&#160;&#160;Indeed, Pershing Square had already
conducted market research to evaluate the regulatory implications of a takeover
of Longs by either CVS Caremark or Walgreen.&#160;&#160;According to the
article, &#8220;Pershing [Square] was surprised by how quickly Longs announced a deal
with CVS Caremark in the wake of its </font>

                                            <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                              <div id="FTR">
                                                <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                  <div id="FTR">&#160;</div>
                                                  <div id="PN" style="PAGE-BREAK-AFTER: always">
                                                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">
                                                      <div align="center">
                                                        <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
                                                            <tr>
                                                              <td colspan="3" width="33%" style="BORDER-TOP: medium none; BORDER-BOTTOM: #000000 1px solid"><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                            </tr>
                                                            <tr>
                                                              <td width="33%"><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">CLASS ACTION
      COMPLAINT </font>

                                                                <div><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Case
      No.</font></div>
                                                              </td>
                                                              <td width="34%">
                                                                <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font size="3">-7-</font></font></div>
                                                              </td>
                                                              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                            </tr>
                                                        </table>
                                                        <div style="WIDTH: 100%; TEXT-ALIGN: center">
                                                          <hr style="COLOR: black" noshade size="2">
                                                        </div>
                                                        <div id="HDR">
                                                          <div id="GLHDR" style="WIDTH: 100%" align="right">
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </div>
                                                  </div>
                                                </div>
                                              </div>
                                            </div>
                                          </div>
                                          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">regulatory
filing, and feels Longs may have accelerated its sale in order to maintain
controls of its sale process[.]&#8221;</font></div>
                                          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">28.&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">According
to a <font style="DISPLAY: inline; FONT-STYLE: italic">Wall Street
Journal</font> article titled &#8220;Pershing Square Taps Blackstone On Longs,&#8221; Longs&#8217;
real estate was worth potentially far more than the $1 billion at which CVS
Caremark valued the real-estate holdings.&#160;&#160;The article disclosed that
on August 15, Pershing Square had hired Blackstone Group LP to assist Pershing
Square in raising the Acquisition Proposal price per share.&#160;&#160;According
to the article:</font></div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify">&#160;</div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Pershing
Square ha[d] been approached by a real estate investor that claim[ed] it could
earn more money selling unwanted Longs sites that CVS could on its own,
according to the person familiar with the matter.&#160;&#160;The potential extra
income from such sales could make the assets of Longs more valuable than the
current purchase price would indicate, this person said.</font></div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">29.&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">As noted
in a <font style="DISPLAY: inline; FONT-STYLE: italic">New York Post</font>
article titled &#8220;Pershing Craves Higher Bid,&#8221; dated August 19, 2008, &#8220;&#8216;It&#8217;s not
clear it was a fully shopped process,&#8217; said a person close to the hedge
fund.&#160;&#160;Two bidders &#8216;is not a robust process.&#8217;&#8221;</font></div>
                                          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">30.&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Other
large investors soon publicly joined in Pershing Square&#8217;s
concerns.&#160;&#160;On August 20, 2008, in an SEC filing on Schedule 13-D,
Advisory Research, which owned 9.2% of the Company&#8217;s shares, requested
additional information regarding the value of the Company&#8217;s real-estate holdings
prior to voting its shares.&#160;&#160;The Schedule 13-D stated in
part:</font></div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify">&#160;</div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt; TEXT-ALIGN: justify" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">The
Reporting Persons [Advisory Research] reviewed the proposed tender offer by Blue
MergerSub Corp., an indirect wholly owned subsidiary of CVS Caremark Corporation
(&#8220;CVS Caremark&#8221;), to purchase all outstanding shares of Common Stock of the
Company (the &#8220;Offer&#8221;).</font></div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">To
evaluate the Offering, the Reporting Persons asked the Company for additional
information regarding the assets of the Company, <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">specifically with
respect to the valuation of the real estate owned and leased by the
Company.</font></font></div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">As set
forth in the third paragraph of the Joint Press Release issued by the Company
and CVS Caremark, dated August 12, 2008:</font></div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 63pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 72pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">&#8220;Significantly,
Longs owns the real estate associated with approximately 200 store locations,
three distribution centers and three office facilities.&#160;&#160;CVS Caremark
has conservatively valued the store locations alone at more than $1
billion.&#160;&#160;These stores are located in markets where commercial real
estate values are among the highest in the country and prime locations are
especially difficult to acquire.&#160;&#160;CVS Caremark intends to unlock the
intrinsic value of these locations, as well as the distribution centers and
</font></div>
                                          <div>
                                            <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                              <div id="FTR">
                                                <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                  <div id="FTR">
                                                    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                      <div id="FTR">&#160;</div>
                                                      <div id="PN" style="PAGE-BREAK-AFTER: always">
                                                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">
                                                          <div align="center">
                                                            <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
                                                                <tr>
                                                                  <td colspan="3" width="33%" style="BORDER-TOP: medium none; BORDER-BOTTOM: #000000 1px solid">&#160;</td>
                                                                </tr>
                                                                <tr>
                                                                  <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">CLASS ACTION
      COMPLAINT </font></font>

                                                                    <div><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Case
      No.</font></div>
                                                                  </td>
                                                                  <td width="34%">
                                                                    <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font size="3">-8-</font></font></div>
                                                                  </td>
                                                                  <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                </tr>
                                                            </table>
                                                            <div style="WIDTH: 100%; TEXT-ALIGN: center">
                                                              <hr style="COLOR: black" noshade size="2">
                                                            </div>
                                                            <div id="HDR">
                                                              <div id="GLHDR" style="WIDTH: 100%" align="right">
                                                              </div>
                                                            </div>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </div>
                                                  </div>
                                                </div>
                                              </div>
                                            </div>
                                          </div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 63pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 72pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">office
facilities, by monetizing a substantial portion of these assets over
time.&#8221;</font></div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt; TEXT-ALIGN: justify" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">As stated
in the Schedule 14D9 filed by the Company on August 18, 2008, in the sixth
bullet point contained under &#8220;Reasons for the Recommendation,&#8221; the Company, in
evaluating the Offer, considered that:</font></div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 72pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">&#8220;The
Board&#8217;s belief that the Company would not be able to readily liquidate or
monetize its real estate in a manner that would be certain to yield value to the
Company and its shareholders in excess of the Offer consideration and that there
were significant tax implications to doing so.&#8221;</font></div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">In light
of these potentially conflicting assertions, and the absence of any substantive
disclosure or analysis regarding the value of the Company&#8217;s owned and leased
real estate, the Reporting Persons believe that additional information is needed
with respect to the valuation of such real estate of the Company.</font></div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Prior to
making any decision to tender in the Offer shares of Common Stock held under
investment management by the Reporting Persons, the Reporting Persons believe
that they should perform additional due diligence regarding the Company and the
Offer to determine whether the Offer is in the best interests of its
clients.</font></div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">31.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">However,
as reported in a <font style="DISPLAY: inline; FONT-STYLE: italic">Dow
Jones</font> article entitled, &#8220;Longs Drug Shareholders Question Value of CVS
Bid,&#8221; dated August 20, 2008, &#8220;[i]n an interview, David Heller, Chairman of
Advisory Research, said Longs Chief Executive Warren Bryant told him in a phone
conversation that <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Longs signed an
agreement with CVS stating it would not reveal the value of its real
estate.&#8221;</font> Indeed, neither Longs nor CVS Caremark disclosed how they
devised their real estate assessment in either regulatory filings or through the
press.</font></div>
                                          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">32.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">During
the interview with <font style="DISPLAY: inline; FONT-STYLE: italic">Dow
Jones</font>, Heller stated, &#8220;This is outrageous . . . .&#160;&#160;We&#8217;re
certainly entitled to this information.&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">This is an issue
of fairness to shareholders</font>. Management needs to get off its lofty
perch.&#8221;&#160;&#160;The same article reported that Thomas Kirchner, who runs the
Pennsylvania Avenue Event-Driven Fund, believed that the purchase of Longs was a
&#8220;cheap way for CVS to grow its store base in California and Hawaii, which have
some of the priciest real estate in the country.&#8221;</font></div>
                                          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">33.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">As noted
above, neither the Company nor CVS Caremark disclosed the method for evaluating
Longs&#8217; real-estate holdings at $1 billion.&#160;&#160;To the contrary, Longs
specifically agreed to withhold this vital information from shareholders,
evidently at CVS Caremark&#8217;s request. Without this information, it is impossible
for shareholders to make an informed decision</font></div>
                                          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify">
                                            <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                              <div id="FTR">&#160;</div>
                                              <div id="PN" style="PAGE-BREAK-AFTER: always">
                                                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">
                                                  <div align="center">
                                                    <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
                                                        <tr>
                                                          <td colspan="3" width="33%" style="BORDER-TOP: medium none; BORDER-BOTTOM: #000000 1px solid">&#160;</td>
                                                        </tr>
                                                        <tr>
                                                          <td width="33%"><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">CLASS ACTION
      COMPLAINT </font>

                                                            <div><font style="FONT-SIZE: 8pt">Case No.</font></div>
                                                          </td>
                                                          <td width="34%">
                                                            <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font size="3">-9-</font></font></div>
                                                          </td>
                                                          <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                        </tr>
                                                    </table>
                                                    <div style="WIDTH: 100%; TEXT-ALIGN: center">
                                                      <hr style="COLOR: black" noshade size="2">
                                                    </div>
                                                    <div id="HDR">
                                                      <div id="GLHDR" style="WIDTH: 100%" align="right">
                                                      </div>
                                                    </div>
                                                  </div>
                                                </div>
                                              </div>
                                            </div>
                                          </div>
                                          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">regarding
the value of the Company and the value of their shares.&#160;&#160;The agreement
by Longs to deliberately withhold such basic information from shareholders is a
blatant violation of their fiduciary duty of disclosure to their
shareholders.</font></div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">The Solicitation is Vague
and Misleading in Numerous Other Respects</font></font></div>
                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">34.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Besides
omitting material information related to the worth of the Company&#8217;s most basic
asset, its real estate holdings &#8211; the value of which Longs Directors agreed to
withhold from shareholders &#8211; the Solicitation is materially misleading regarding
other information of necessary disclosure to Longs
shareholders.&#160;&#160;Furthermore, the Solicitation is too vague to afford
Longs shareholders the opportunity to evaluate adequately the fairness of the
Acquisition Proposal and the process that led to the Agreement and Plan of
Merger.</font></div>
                                          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">35.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">For
example, the Solicitation expounds at great length on prior negotiations with a
party identified as &#8220;Party A.&#8221; (Indeed, Plaintiff believes &#8220;Party A&#8221; maybe
Walgreens Co., based on information provided in certain news reports regarding
the Proposed Transaction.) Disclosures regarding the depth and breadth of any
bidding process are important to shareholders when assessing whether to trust
the recommendation of the Longs Directors.</font></div>
                                          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">36.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">The
seemingly extensive and detailed discussions in the Solicitation regarding
numerous conversations between &#8220;Party A&#8221; and Longs included the disclosure that
in May 2008, &#8220;Party A&#8221; and Longs entered into a &#8220;joint defense agreement&#8221; and
agreed to engage in due diligence.&#160;&#160;Similarly, the Solicitation
related that in June 2008, CVS Caremark and Longs entered into a confidentiality
agreement before embarking on the due diligence that resulted in the Agreement
and Plan of Merger.</font></div>
                                          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">37.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">The
disclosures in the Solicitation imply that both &#8220;Party A&#8221; and CVS Caremark were
treated equally in terms of performing due diligence and preparing bids for
Longs.&#160;&#160;However, the Solicitation remains vague as to whether, in
fact, &#8220;Party A&#8221; actually engaged in due diligence related to the Company&#8217;s
business, financial prospects, and real estate holdings &#8211; as CVS Caremark
eventually did&#160;<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#8211;</font> or if the due
diligence performed by &#8220;Party A&#8221; related only to the regulatory concerns that
caused negotiations to terminate.</font></div>
                                          <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify">
                                            <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                              <div id="FTR">&#160;</div>
                                              <div id="PN" style="PAGE-BREAK-AFTER: always">
                                                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">
                                                  <div style="TEXT-INDENT: 36pt; TEXT-ALIGN: justify" align="center">
                                                    <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
                                                        <tr>
                                                          <td colspan="3" width="33%" style="BORDER-TOP: medium none; BORDER-BOTTOM: #000000 1px solid"><font style="FONT-SIZE: 8pt">&#160;</font></td>
                                                        </tr>
                                                        <tr>
                                                          <td width="33%"><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">CLASS ACTION
      COMPLAINT </font>

                                                            <div><font style="FONT-SIZE: 8pt">Case No.</font></div>
                                                          </td>
                                                          <td width="34%">
                                                            <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font size="3">-10-</font></font></div>
                                                          </td>
                                                          <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                        </tr>
                                                    </table>
                                                  </div>
                                                  <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                    <div id="PN" style="PAGE-BREAK-AFTER: always">
                                                      <div style="WIDTH: 100%; TEXT-ALIGN: center">
                                                      </div>
                                                      <div style="WIDTH: 100%; TEXT-ALIGN: center">
                                                        <hr style="COLOR: black" noshade size="2">
                                                      </div>
                                                    </div>
                                                    <div id="HDR">
                                                      <div id="GLHDR" style="WIDTH: 100%" align="right">
                                                      </div>
                                                    </div>
                                                  </div>
                                                  <div style="TEXT-INDENT: 36pt; TEXT-ALIGN: justify" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">38.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">The
extent and nature of the due diligence performed by &#8220;Party A&#8221; is necessary
information to allow Longs shareholders to assess the value of the Acquisition
Proposal. In particular, Longs shareholders need to know if &#8220;Party A&#8221; conducted
due diligence on the value of Longs&#8217; real estate assets.&#160;&#160;As such,
Longs shareholders cannot evaluate the Proposed Transaction adequately until the
Company makes clear to its shareholders whether only one of the interested
bidders was actually fully engaged in the bidding process for Longs.
</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">39.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Further,
the Proxy should make other disclosures, including whether the negotiating
process did indeed accelerate after August 5, when Longs learned about Pershing
Square&#8217;s investment.</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">40.&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">The Proxy
should also explain the basis for the Board&#8217;s conclusion that it may not be able
to monetize the Company&#8217;s real estate holdings for full value, which is listed
as a reason supporting the Directors&#8217; recommendation in favor of the Proposed
Transaction.</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify">&#160;</div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Provisions in the Agreement
and Plan of Merger Pose Significant Barriers to Longs Directors Fulfilling Their
Fiduciary Duties</font></font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">41.&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">The terms
of the Agreement and Plan of Merger are meant to deter competing bids and
prevent the Longs Directors from exercising their fiduciary duties to obtain the
best available price for Longs shareholders.&#160;&#160;The defensive provisions
erect barriers to competing offers and function to substantially increase the
likelihood that the Proposed Transaction will be consummated, and cannot be
justified as an appropriate and proportionate response to any reasonable threat
posed to Longs shareholders.</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">42.&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">$115 Million Termination
Fee</font>: The Agreement and Plan of Merger requires Longs to pay to CVS
Caremark the sum of $115 million in cash if Longs terminates the Agreement and
Plan of Merger (the &#8220;Termination Fee&#8221;).&#160;&#160;This represents an astounding
4.5% of the equity value of the deal, which is excessive and unreasonable under
the circumstances and acts to punish Longs shareholders and the Longs Directors
for simply pursuing more attractive alternatives, while also deterring such
alternatives from emerging.</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">43.&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">The
Termination Fee is enforceable even if the agreement is terminated as a result
of the Longs Directors&#8217; recommendation in favor of a superior offer for Longs
shares.&#160;&#160;Thus, this </font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify">
                                                    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                      <div id="FTR">
                                                        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                          <div id="FTR">
                                                            <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                              <div id="FTR">&#160;</div>
                                                              <div id="PN" style="PAGE-BREAK-AFTER: always">
                                                                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">
                                                                  <div align="center">
                                                                    <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
                                                                        <tr>
                                                                          <td colspan="3" width="33%" style="BORDER-TOP: medium none; BORDER-BOTTOM: #000000 1px solid">&#160;</td>
                                                                        </tr>
                                                                        <tr>
                                                                          <td width="33%"><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">CLASS ACTION
      COMPLAINT </font>

                                                                            <div><font style="FONT-SIZE: 8pt">Case No.</font></div>
                                                                          </td>
                                                                          <td width="34%">
                                                                            <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="FONT-SIZE: 8pt">&#160;</font><font size="3">-11-</font></font></div>
                                                                          </td>
                                                                          <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                        </tr>
                                                                    </table>
                                                                    <div style="WIDTH: 100%; TEXT-ALIGN: center">
                                                                      <hr style="COLOR: black" noshade size="2">
                                                                    </div>
                                                                    <div id="HDR">
                                                                      <div id="GLHDR" style="WIDTH: 100%" align="right">
                                                                      </div>
                                                                    </div>
                                                                  </div>
                                                                </div>
                                                              </div>
                                                            </div>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </div>
                                                  </div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">$115
million termination fee deters the Longs Directors from freely and effectively
exercising their fiduciary judgment in the interests of Longs
shareholders.&#160;&#160;Specifically, the Agreement and Plan of Merger
provides:</font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify">&#160;</div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">(e) <font style="DISPLAY: inline; TEXT-DECORATION: underline">Termination
Right</font>.&#160;&#160;If, prior to the Acceptance Time, the Board of
Directors shall have made an Adverse Recommendation Change in compliance with
the terms of this Agreement (including Section 7.04(d)), the Company shall have
the right to terminate this Agreement so long as (i) at least 20 Business Days
have elapsed from the date the Company publicly announced such Adverse
Recommendation Change, (ii) at least 20 Business Days have elapsed from the date
the Third Party making such Superior Proposal publicly announced any material
amendment to any of the terms or conditions of such Superior Proposal (it being
understood that any change to the financial terms shall be deemed a material
amendment), (iii) at least 10 Business Days have elapsed from the date of any
<font style="DISPLAY: inline; FONT-STYLE: italic">bona fide</font> increase by
Parent of the Offer Price with a view to satisfying the Minimum Condition and
(iv) the Minimum Condition is not satisfied; <font style="DISPLAY: inline; FONT-STYLE: italic">provided</font> that, simultaneously
with any termination pursuant to this Section 7.04(e), the Company shall pay the
amount due pursuant to Section 12.04(b) in connection with such
termination.</font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="justify">&#160;</div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">44.&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">In turn,
Section 12.04(b) of the Agreement and Plan of Merger (referred to in the
immediately preceding quotation) states, in relevant part:</font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">(b) <font style="DISPLAY: inline; TEXT-DECORATION: underline">Termination
Fee</font>.</font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify">&#160;</div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">(i) If
this Agreement is terminated by Parent pursuant to Section 11.01(c)(i) or
Section 11.01(c)(ii) or by the Company pursuant to Section 11.01(d)(ii), then
the Company shall pay to Parent in immediately available funds $115,000,000
<font style="DISPLAY: inline; FONT-STYLE: italic">minus</font> all amounts
reimbursed by the Company pursuant to Section 12.04(c) (the &#8220;Termination Fee&#8221;),
in the case of termination by the Company, simultaneously with such termination
and, in the case of termination by Parent, within one Business Day after such
termination.</font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">(ii) If
(A) this Agreement is terminated by Parent or the Company pursuant to Section
11.01(b)(i), (B) prior to such termination, a <font style="DISPLAY: inline; FONT-STYLE: italic">bona fide</font> Acquisition
Proposal shall have been publicly announced or otherwise been communicated to
the Board of Directors or the Company&#8217;s stockholders and (C) within 12 months
following the date of such termination, the Company shall have entered into a
definitive agreement with respect to or recommended to its stockholders an
Acquisition Proposal or an Acquisition Proposal shall have been consummated
(<font style="DISPLAY: inline; FONT-STYLE: italic">provided</font> that, in each
case, for purposes of this clause (C), each reference to &#8220;15%&#8221; in the definition
of Acquisition Proposal shall be deemed to be a reference to &#8220;50%&#8221;), then the
Company shall pay to Parent in immediately available funds, concurrently with
the occurrence of the applicable event described in clause (C), the Termination
Fee.</font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">45.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">&#8220;Last
Look&#8221; Provision: The Agreement and Plan of Merger requires Longs to offer CVS
Caremark a &#8220;last look&#8221; &#8211; <font style="DISPLAY: inline; FONT-STYLE: italic">i.e.</font>, should another offer
emerge and the Longs Directors conclude that the other offer is superior to the
Acquisition Proposal, Longs is nonetheless </font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">
                                                    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify">
                                                      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                        <div id="FTR">
                                                          <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                            <div id="FTR">
                                                              <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                                <div id="FTR">&#160;</div>
                                                                <div id="PN" style="PAGE-BREAK-AFTER: always">
                                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">
                                                                    <div align="center">
                                                                      <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
                                                                          <tr>
                                                                            <td colspan="3" width="33%" style="BORDER-TOP: medium none; BORDER-BOTTOM: #000000 1px solid">&#160;</td>
                                                                          </tr>
                                                                          <tr>
                                                                            <td width="33%"><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">CLASS ACTION
      COMPLAINT </font>

                                                                              <div><font style="FONT-SIZE: 8pt">Case No.</font></div>
                                                                            </td>
                                                                            <td width="34%">
                                                                              <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="FONT-SIZE: 8pt">&#160;</font><font size="3">-12-</font></font></div>
                                                                            </td>
                                                                            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                          </tr>
                                                                      </table>
                                                                      <div style="WIDTH: 100%; TEXT-ALIGN: center">
                                                                        <hr style="COLOR: black" noshade size="2">
                                                                      </div>
                                                                      <div id="HDR">
                                                                        <div id="GLHDR" style="WIDTH: 100%" align="right">
                                                                        </div>
                                                                      </div>
                                                                    </div>
                                                                  </div>
                                                                </div>
                                                              </div>
                                                            </div>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </div>
                                                    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">required to offer CVS
Caremark the opportunity to make &#8220;within five Business Days after its receipt of
that written notification, an offer that is at least as favorable to the
stockholders of the Company as such Superior Proposal....&#8221; This provision of the
Agreement and Plan of Merger prevents the Longs Directors from the unhindered
exercise of their fiduciary judgment in the best interests of Longs
shareholders.&#160;&#160;Any potential third-party bidders will be loath to
invest the time and resources necessary to pursue a superior bid while knowing
that CVS Caremark retains control of the bidding.&#160;&#160;For the same
reason, the &#8220;last look&#8221; provision prevents the Longs Directors from freely
negotiating the highest possible price that CVS Caremark is willing to
pay.&#160;&#160;Specifically, the Agreement and Plan of Merger
provides:</font></div>
                                                  </div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="justify">&#160;</div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">&#8220;Last
Look&#8221;</font>.&#160;&#160;Further, the Board of Directors of the Company shall
not make an Adverse Recommendation Change, unless (i) it has received an
Acquisition Proposal that constitutes a Superior Proposal, (ii) the Company
promptly notifies Parent in writing at least five Business Days before taking
that action of its intention to do so, attaching the most current version of the
proposed agreement under which such Superior Proposal is proposed to be
consummated and the identity of the third party making the Acquisition Proposal,
and (iii) Parent does not make, within five Business Days after its receipt of
that written notification, an offer that is at least as favorable to the
stockholders of the Company as such Superior Proposal (it being understood and
agreed that any amendment to the financial terms or other material terms of such
Superior Proposal shall require a new written notification from the Company and
a new five Business Day period under this Section 7.04(d)).</font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">46.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">The
merger agreement also gives strict notice rights to CVS Caremark in the event of
any third-party offer and requires that CVS Caremark receive any materials that
Longs delivers to a third-party bidder.&#160;&#160;Longs cannot terminate the
merger agreement for at least 20 days after providing CVS Caremark this
notice.</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">47.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">In
effect, this means that even if any third-party bid comes along in the short
time between the announcement of the deal and closing of the tender offer, CVS
Caremark will have the ability to complete its tender offer before Longs can
accept that bid.&#160;&#160;CVS Caremark will also know everything happening in
connection with the third-party competitive bid.</font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Defendants Structured the
Tender Offer with an Unlawful &#8220;Top-Up Option&#8221;</font></font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">48.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">CVS
Caremark&#8217;s offer is structured as a tender offer in the first instance, with a
merger to follow.&#160;&#160;A tender offer can close in as little as 20
days.&#160;&#160;As such, CVS Caremark has avoided the usual time period
necessary for a shareholder vote to be scheduled and completed.</font></div>
                                                  <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                    <div id="FTR">
                                                      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                        <div id="FTR">
                                                          <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                            <div id="FTR">
                                                              <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                                <div id="FTR">
                                                                  <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                                    <div id="FTR">&#160;</div>
                                                                    <div id="PN" style="PAGE-BREAK-AFTER: always">
                                                                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">
                                                                        <div align="center">
                                                                          <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
                                                                              <tr>
                                                                                <td colspan="3" width="33%" style="BORDER-TOP: medium none; BORDER-BOTTOM: #000000 1px solid">&#160;</td>
                                                                              </tr>
                                                                              <tr>
                                                                                <td width="33%"><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">CLASS ACTION
      COMPLAINT </font>

                                                                                  <div><font style="FONT-SIZE: 8pt">Case No.</font></div>
                                                                                </td>
                                                                                <td width="34%">
                                                                                  <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font size="3">-13-</font></font></div>
                                                                                </td>
                                                                                <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                              </tr>
                                                                          </table>
                                                                          <div style="WIDTH: 100%; TEXT-ALIGN: center">
                                                                            <hr style="COLOR: black" noshade size="2">
                                                                          </div>
                                                                          <div id="HDR">
                                                                            <div id="GLHDR" style="WIDTH: 100%" align="right">
                                                                            </div>
                                                                          </div>
                                                                        </div>
                                                                      </div>
                                                                    </div>
                                                                  </div>
                                                                </div>
                                                              </div>
                                                            </div>
                                                          </div>
                                                        </div>
                                                        <div style="TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">49.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">This
typical time period not only allows for competing bidders to emerge&#160;<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#8211;</font> itself an
important assurance to investors that the price offered is the highest price
available&#160;<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#8211;</font> but it also gives
shareholders a chance to assess the performance of the board, including the
negotiation of the merger agreement, and to resist the deal if the shareholders
are dissatisfied with the board&#8217;s performance.&#160;&#160;But the Longs
Directors structured the deal so that CVS Caremark need not comply with the
usual corporate formalities that go along with the usual third-party
merger.&#160;&#160;In fact, the Longs Directors neglected to play even a passive
role, where they would step aside so that CVS could make an offer directly to
shareholders and let the market decide the Company&#8217;s
fate.</font></div>
                                                      </div>
                                                    </div>
                                                  </div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">50.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Instead,
in addition to granting significant &#8220;deal protections&#8221; in the merger agreement,
the Longs Directors have granted a &#8220;top-up option&#8221; to CVS Caremark that allows
CVS Caremark to complete a &#8220;short form&#8221; merger even if it never pays a price
sufficient to obtain 90% of the Company&#8217;s outstanding shares.</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">51.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">The law
treats corporate acquirers very differently when they acquire less than 90% of
the outstanding shares and when they pay a sufficient price to acquire over 90%
of the Company&#8217;s outstanding shares.&#160;&#160;If a controlling shareholder or
a third party pays a sufficiently high price to acquire a 90% stake in a target
corporation, the acquirer is rewarded with the ability to effectuate a &#8220;short
form merger,&#8221; meaning that it need only file a certificate of merger without the
action of any shareholders or the board of the target.</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">52.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Here, the
Longs Directors have granted to CVS Caremark a &#8220;top-up option&#8221; that allows CVS
to pay the lowest possible price necessary to get 66-2/3% of the Company&#8217;s
shares, but then enjoy the benefits of a short form merger.&#160;&#160;According
to Section 2.04 of the Merger Agreement, provided CVS Caremark obtains just
66-2/3% of the Company&#8217;s outstanding shares, CVS Caremark is able to exercise an
option that results in Longs issuing brand new shares &#8211; diluting the existing
shareholders&#160;<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#8211;</font> at a level
sufficient to let CVS Caremark end up with over 90% of the Company&#8217;s outstanding
shares.&#160;&#160;Section 2.04 states, in pertinent part:</font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify">&#160;</div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Section
2.04</font>.&#160;&#160;<font style="DISPLAY: inline; FONT-STYLE: italic">Top-Up
Option</font>. (a) Subject to Section 2.04(b) and Section 2.04(c), the Company
grants to Merger Subsidiary an irrevocable option, for so long as this Agreement
has not been terminated pursuant to the provisions hereof (the</font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
                                                    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                      <div id="FTR">
                                                        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                          <div id="FTR">
                                                            <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                              <div id="FTR">
                                                                <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                                  <div id="FTR">&#160;</div>
                                                                  <div id="PN" style="PAGE-BREAK-AFTER: always">
                                                                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">
                                                                      <div align="center">
                                                                        <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
                                                                            <tr>
                                                                              <td colspan="3" width="33%" style="BORDER-TOP: medium none; BORDER-BOTTOM: #000000 1px solid">&#160;</td>
                                                                            </tr>
                                                                            <tr>
                                                                              <td width="33%"><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">CLASS ACTION
      COMPLAINT </font>

                                                                                <div><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Case
      No.</font></div>
                                                                              </td>
                                                                              <td width="34%">
                                                                                <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font size="3">-14-</font></font></div>
                                                                              </td>
                                                                              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                            </tr>
                                                                        </table>
                                                                        <div style="WIDTH: 100%; TEXT-ALIGN: center">
                                                                          <hr style="COLOR: black" noshade size="2">
                                                                        </div>
                                                                        <div id="HDR">
                                                                          <div id="GLHDR" style="WIDTH: 100%" align="right">
                                                                          </div>
                                                                        </div>
                                                                      </div>
                                                                    </div>
                                                                  </div>
                                                                </div>
                                                              </div>
                                                            </div>
                                                          </div>
                                                        </div>
                                                      </div>
                                                      <div style="LINE-HEIGHT: 1.7"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal">&#8220;</font>Top-Up Option<font style="FONT-WEIGHT: normal">&#8221;</font></font>), to purchase from the Company up to
the number of authorized and unissued Shares equal to the number of Shares that,
when added to the number of Shares owned by Merger Subsidiary at the time of
exercise of the Top-Up Option, constitutes one Share more than the number of
Shares (the <font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal">&#8220;</font>Requisite Short-Form Merger Shares<font style="FONT-WEIGHT: normal">&#8221;</font></font>) entitled to cast 90% of all the
votes entitled to be cast by each group or class of shares entitled to vote as a
group or class on the Merger after the issuance of all Shares to be issued upon
exercise of the Top-Up Option, calculated on a fully-diluted basis or, as may be
elected by Parent, on a primary basis at the Effective Time (such Shares to be
issued upon exercise of the Top-Up Option, the <font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal">&#8220;</font>Top-Up Shares<font style="FONT-WEIGHT: normal">&#8221;</font></font>).</font></div>
                                                    </div>
                                                  </div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">53.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">The
parties also made clear, in Section 2.04(c), their intent for the exercise of
the Top-Up Option to be on the very same day that CVS Caremark gives notice of
its intent to exercise its rights.&#160;&#160;In other words, as soon as it
holds 66-2/3% of the Company&#8217;s shares, CVS Caremark can close the transaction
pursuant to a short form merger, as if it held 90% of the shares.</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">54.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Section
9.06 makes clear the parties&#8217; intent to avoid a subsequent shareholder vote if
possible:</font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.2; MARGIN-RIGHT: 36pt" align="justify">&#160;</div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.2; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Section
9.06</font>.&#160;&#160;<font style="DISPLAY: inline; FONT-STYLE: italic">Merger
Without Meeting of Stockholders</font>.&#160;&#160;If, at any time after the
Acceptance Time, Parent, Merger Subsidiary and any other Subsidiary of Parent
shall collectively own at least the Requisite Short-Form Merger Shares, the
parties shall take all necessary and appropriate action to cause the Merger to
be effected as soon as practicable without a meeting of stockholders of the
Company in accordance with Section 3-106 of Maryland Law.</font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">55.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">The
merger agreement also includes in Section 2.04(e) a provision requiring Longs to
take all actions necessary to circumvent any otherwise applicable shareholder
voting protections, including those set forth by the New York Stock
Exchange:</font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify">&#160;</div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">[CVS
Caremark] and [Longs] shall use their respective reasonable best efforts to
take, or cause to be taken, all actions and to do, or cause to be done, and
assist and cooperate with each other in doing, all things necessary or desirable
to procure from the NYSE or any other Governmental Authority any necessary
waiver or other exemption from the requirements of NYSE Rule 312 or other
Applicable Law in order to enable the issuance of the Top-Up Shares to occur
without the need to obtain the approval of holders of a majority of the Shares
present and voting at the Company Stockholder Meeting.</font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="justify">&#160;</div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">56.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Rule 312
is the New York Stock Exchange rule requiring a shareholder vote for a 20
percent or greater share issuance. In their rush to let this deal close as soon
as possible, Longs and CVS agreed to seek a waiver around this
rule.&#160;&#160;In other words, even if CVS Caremark gets 66-2/3% but does not
get more than 70%, it will still have Longs working at its side to make sure
</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify">
                                                    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                      <div id="FTR">
                                                        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                          <div id="FTR">
                                                            <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                              <div id="FTR">
                                                                <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                                  <div id="FTR">&#160;</div>
                                                                  <div id="PN" style="PAGE-BREAK-AFTER: always">
                                                                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">
                                                                      <div align="center">
                                                                        <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
                                                                            <tr>
                                                                              <td colspan="3" width="33%" style="BORDER-TOP: medium none; BORDER-BOTTOM: #000000 1px solid">&#160;</td>
                                                                            </tr>
                                                                            <tr>
                                                                              <td width="33%"><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">CLASS ACTION
      COMPLAINT </font>

                                                                                <div><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Case
      No.</font></div>
                                                                              </td>
                                                                              <td width="34%">
                                                                                <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font size="3">-15-</font></font></div>
                                                                              </td>
                                                                              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                            </tr>
                                                                        </table>
                                                                        <div style="WIDTH: 100%; TEXT-ALIGN: center">
                                                                          <hr style="COLOR: black" noshade size="2">
                                                                        </div>
                                                                        <div id="HDR">
                                                                          <div id="GLHDR" style="WIDTH: 100%" align="right">
                                                                          </div>
                                                                        </div>
                                                                      </div>
                                                                    </div>
                                                                  </div>
                                                                </div>
                                                              </div>
                                                            </div>
                                                          </div>
                                                        </div>
                                                      </div>
                                                      <div><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">the
top-up-option is effectuated and allow CVS Caremark to close the deal before CVS
Caremark is exposed to any risk of competition.</font></div>
                                                    </div>
                                                  </div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify">&#160;</div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">CLASS ACTION
ALLEGATIONS</font></font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">57.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Plaintiff
brings this action pursuant to California Code of Civil Procedure &#167; 382,
individually and on behalf of all other stockholders of the Company (except the
defendants herein and any persons, firm, trust, corporation, or other entity
related to or affiliated with them and their successors in interest), who are or
will be threatened with injury arising from defendants&#8217; actions, as more fully
described herein (the &#8220;Class&#8221;).</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">58.&#160;&#160;&#160;</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">This
action is properly maintainable as a class action for the following
reasons:</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify">
                                                    <div style="LINE-HEIGHT: 1.7">
                                                      <div style="LINE-HEIGHT: 1.7; TEXT-ALIGN: left">
                                                        <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                                                            <tr valign="top" style="LINE-HEIGHT: 1.7;">
                                                              <td align="right" style="WIDTH: 63pt">
                                                                <div style="TEXT-INDENT: 18pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font size="3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a)</font></font></div>
                                                              </td>
                                                              <td align="left">
                                                                <div style="LINE-HEIGHT: 1.7; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Class is so
      numerous that joinder of all members is impracticable.&#160;&#160;As of
      August 20, 2008, there were over 34.8 million publicly traded shares of
      Longs.</font></div>
                                                              </td>
                                                            </tr>
                                                            <tr valign="top" style="LINE-HEIGHT: 1.7;">
                                                              <td align="right" style="WIDTH: 63pt">
                                                                <div style="TEXT-INDENT: 18pt; TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman"><font size="3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b)</font></font></font></div>
                                                              </td>
                                                              <td align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;<font size="3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Plaintiff is
      committed to prosecuting this action and has retained competent counsel
      experienced in litigation of this nature.&#160;&#160;Plaintiff&#8217;s claims
      are typical of the claims of the other members of the Class and Plaintiff
      has the same interests as the other members of the
      Class.&#160;&#160;Accordingly, Plaintiff is adequately representative of
      the Class and will fairly and adequately protect the interests of the
      Class.</font></font></font></font></font></td>
                                                            </tr>
                                                            <tr valign="top" style="LINE-HEIGHT: 1.7;">
                                                              <td align="right" style="WIDTH: 63pt">
                                                                <div style="TEXT-INDENT: 18pt; TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font size="3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c)</font></font></div>
                                                              </td>
                                                              <td align="left">
                                                                <div>
                                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">The
      prosecution of separate actions by individual members of the <font size="+0">Class </font>would create the risk of inconsistent or varying
      adjudications with respect to individual members of the Class, which would
      establish incompatible standards of conduct for defendants, or
      adjudications with respect to individual members of the Class which would,
      as a practical matter, be dispositive of the interests of the other
      members not parties to the adjudications or substantially impair or impede
      their ability to protect their interests.</font></div>
                                                                </div>
                                                              </td>
                                                            </tr>
                                                            <tr valign="top" style="LINE-HEIGHT: 1.7;">
                                                              <td align="right" style="WIDTH: 63pt">
                                                                <div style="TEXT-INDENT: 18pt; TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font size="3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d)</font></font></div>
                                                              </td>
                                                              <td align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;<font size="3" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To the extent
      defendants take further steps to effectuate the Proposed Acquisition,
      preliminary and final injunctive relief on behalf of the Class as a whole
      will be entirely appropriate because defendants have acted, or refused to
      act, on grounds generally applicable and causing injury to the
      Class.</font></font></font></font></td>
                                                            </tr>
                                                        </table>
                                                      </div>
                                                      <div style="LINE-HEIGHT: 1.7; TEXT-ALIGN: left">&#160;</div>
                                                    </div>
                                                  </div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify">
                                                    <div>
                                                      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                        <div id="PN" style="PAGE-BREAK-AFTER: always">
                                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">
                                                            <div align="center">
                                                              <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
                                                                  <tr>
                                                                    <td colspan="3" width="33%" style="BORDER-TOP: medium none; BORDER-BOTTOM: #000000 1px solid">&#160;</td>
                                                                  </tr>
                                                                  <tr>
                                                                    <td width="33%"><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">CLASS ACTION
      COMPLAINT </font>

                                                                      <div><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Case
      No.</font></div>
                                                                    </td>
                                                                    <td width="34%">
                                                                      <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font size="3">-16-</font></font></div>
                                                                    </td>
                                                                    <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                  </tr>
                                                              </table>
                                                            </div>
                                                            <div style="TEXT-ALIGN: left" align="center">
                                                              <div style="WIDTH: 100%; TEXT-ALIGN: center">
                                                                <hr style="COLOR: black" noshade size="2">
                                                              </div>
                                                              <div id="HDR">
                                                                <div id="GLHDR" style="WIDTH: 100%" align="right">
                                                                </div>
                                                              </div>
                                                            </div>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </div>
                                                    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                      <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt"><font style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">59.&#160;&#160; <font id="TAB2" style="FONT-SIZE: 12pt; COLOR: black; FONT-FAMILY: Times New Roman; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">There are
questions of law and fact which are common to the Class and which predominate
over questions affecting any individual class member.&#160;&#160;The common
questions include, <font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">inter
alia</font>, the following:</font></font></div>
                                                      <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                        <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify">
                                                          <div style="LINE-HEIGHT: 1.7">
                                                            <div style="LINE-HEIGHT: 1.7; TEXT-ALIGN: left">
                                                              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                                                                  <tr valign="top" style="LINE-HEIGHT: 1.7;">
                                                                    <td align="right" style="WIDTH: 63pt">
                                                                      <div style="LINE-HEIGHT: 1.7; TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font size="3">&#160;&#160;&#160;&#160;&#160;&#160;&#160;
a)</font></font></div>
                                                                    </td>
                                                                    <td align="left">
                                                                      <div style="LINE-HEIGHT: 1.7; TEXT-ALIGN: left">
                                                                        <div style="LINE-HEIGHT: 1.7" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Whether
      the Longs Directors breached their fiduciary duties and other common law
      duties by entering into the Proposed Transaction;</font></div>
                                                                      </div>
                                                                    </td>
                                                                  </tr>
                                                                  <tr valign="top" style="LINE-HEIGHT: 1.7;">
                                                                    <td align="right" style="WIDTH: 63pt">
                                                                      <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font size="3">&#160;&#160;&#160;&#160;&#160; &#160;&#160;
      b)</font>&#160;</font></div>
                                                                    </td>
                                                                    <td align="left">
                                                                      <div style="LINE-HEIGHT: 1.7" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Whether
      the Longs Directors have breached their fiduciary duties of disclosure by
      failing to inform shareholders of certain material information in
      connection with the Proposed Transaction, including, but not limited to,
      the method used by the Company and CVS to value Longs&#8217; real estate assets
      and the true value of Longs&#8217; real estate assets;</font></div>
                                                                    </td>
                                                                  </tr>
                                                                  <tr valign="top" style="LINE-HEIGHT: 1.7;">
                                                                    <td align="right" style="WIDTH: 63pt">
                                                                      <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font size="3">&#160;&#160;&#160;&#160;&#160;&#160;
&#160;c)</font></font></div>
                                                                    </td>
                                                                    <td align="left">
                                                                      <div>
                                                                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
                                                                          <div style="LINE-HEIGHT: 1.7" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Whether
      defendants breached their fiduciary duties by agreeing to an excessive
      break up fee and other improper deal protection provisions with CVS
      Caremark;</font></div>
                                                                        </div>
                                                                      </div>
                                                                    </td>
                                                                  </tr>
                                                                  <tr valign="top" style="LINE-HEIGHT: 1.7;">
                                                                    <td align="right" style="WIDTH: 63pt">
                                                                      <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font size="3">&#160;&#160;&#160;&#160;&#160;&#160;&#160;
d)</font></font></div>
                                                                    </td>
                                                                    <td align="left">
                                                                      <div style="LINE-HEIGHT: 1.7" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Whether
      the Proposed Transaction is entirely fair to the members of the Class;
      and</font></div>
                                                                    </td>
                                                                  </tr>
                                                                  <tr valign="top" style="LINE-HEIGHT: 1.7;">
                                                                    <td align="right" valign="top" style="WIDTH: 63pt; TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font size="3">&#160;&#160;&#160;&#160;&#160;&#160;&#160; e)</font></font></td>
                                                                    <td align="left">
                                                                      <div style="LINE-HEIGHT: 1.7" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Whether
      Plaintiffs and the other members of the Class would be irreparably damaged
      if Longs, Longs Directors, CVS Caremark and Blue MergerSub are not
      enjoined from effectuating the conduct described
  herein.</font></div>
                                                                    </td>
                                                                  </tr>
                                                              </table>
                                                            </div>
                                                            <div style="LINE-HEIGHT: 1.7; TEXT-ALIGN: left">&#160;</div>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </div>
                                                  </div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">FIRST CAUSE OF
ACTION</font></font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">For Class Claim For Breach
Of Fiduciary Duty</font></font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">(Against
The Company and The Individual Defendants)</font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font size="+0"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">60.&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Plaintiff
repeats and realleges each and every allegation above as if set forth in full
herein.</font></font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">61.&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">The
Company and the Individual Defendants owe the Class the utmost fiduciary duties
of due care, good faith and loyalty.&#160;&#160;As such, the Individual
Defendants are bound by their fiduciary duties to the Class to employ all
measures necessary to provide the Class with all information material to the
Class members&#8217; decision on whether to accept the Acquisition Proposal or
not.</font></div>
                                                  <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                    <div id="FTR">
                                                      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                        <div id="FTR">&#160;</div>
                                                        <div id="PN" style="PAGE-BREAK-AFTER: always">
                                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">
                                                            <div align="center">
                                                              <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
                                                                  <tr>
                                                                    <td colspan="3" width="33%" style="BORDER-TOP: medium none; BORDER-BOTTOM: #000000 1px solid">&#160;</td>
                                                                  </tr>
                                                                  <tr>
                                                                    <td width="33%"><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">CLASS ACTION
      COMPLAINT </font>

                                                                      <div><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Case
      No.</font></div>
                                                                    </td>
                                                                    <td width="34%">
                                                                      <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font size="3">-17-</font></font></div>
                                                                    </td>
                                                                    <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                  </tr>
                                                              </table>
                                                            </div>
                                                            <div style="TEXT-ALIGN: left" align="center">
                                                              <div style="WIDTH: 100%; TEXT-ALIGN: center">
                                                                <hr style="COLOR: black" noshade size="2">
                                                              </div>
                                                              <div id="HDR">
                                                                <div id="GLHDR" style="WIDTH: 100%" align="right">
                                                                </div>
                                                              </div>
                                                            </div>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </div>
                                                  </div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">62.&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">The
Company and the Individual Defendants have breached their fiduciary duties in
the sale of Longs by failing to fully disclose the circumstances and procedures
of the Acquisition Proposal by, <font style="DISPLAY: inline; FONT-STYLE: italic">inter alia</font>, failing to
disclose the method used by the Company and CVS Caremark to value Long&#8217;s real
estate assets as well as the true value of Longs&#8217; real estate
assets.</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">63.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">The
Company and the Individual Defendants have breached their fiduciary duties by
failing to fully disclose the circumstances and effect of the Agreement and Plan
of Merger.</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">64.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">The
Company and the Individual Defendants also breached their fiduciary duty by
favoring their own interests over those of Longs
shareholders.&#160;&#160;Furthermore, the Individual Defendants caused the
Company to enter into the Agreement and Plan of Merger in order to perpetuate
their own interests and the interests of CVS Caremark and Blue MergerSub over
the interests of Longs shareholders.</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">65.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Plaintiff
and the Class have been harmed by these breaches of fiduciary duty.</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">66.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160; </font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Plaintiff
and the Class have no adequate remedy at law.&#160;&#160;Only through the
exercise of this Court&#8217;s equitable powers can Plaintiff and the Class be fully
protected from the immediate and irreparable injury the actions of the Company
and the Individual Defendants threaten to inflict.</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify">&#160;</div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">SECOND CAUSE OF
ACTION</font></font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">For Class Claim For Breach
Of Fiduciary Duty</font></font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">(Against
All Defendants)</font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">67.&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Plaintiff
repeats and realleges each and every allegation above as if set forth in full
herein.</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">68.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Defendants
owe the Class the fiduciary duties of care, good faith and
loyalty.&#160;&#160;The defendants breached those fiduciary duties by favoring
their own interests over those of Longs shareholders by erecting defensive
measures to protect the inferior Acquisition Proposal.</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">69.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Defendants
agreed to the inclusion of, <font style="DISPLAY: inline; FONT-STYLE: italic">inter alia</font>, an unreasonably
high termination fee, and a &#8220;Last Look&#8221; provision that are each unfavorable to
Longs shareholders.&#160;&#160;These provisions were included in the Agreement
and Plan of Merger to deter and erect barriers </font></div>
                                                  <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                    <div id="FTR">
                                                      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                        <div id="FTR">&#160;</div>
                                                        <div id="PN" style="PAGE-BREAK-AFTER: always">
                                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">
                                                            <div align="center">
                                                              <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
                                                                  <tr>
                                                                    <td colspan="3" width="33%" style="BORDER-TOP: medium none; BORDER-BOTTOM: #000000 1px solid">&#160;</td>
                                                                  </tr>
                                                                  <tr>
                                                                    <td width="33%"><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">CLASS ACTION
      COMPLAINT </font>

                                                                      <div><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Case
      No.</font></div>
                                                                    </td>
                                                                    <td width="34%">
                                                                      <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font size="3">-18-</font></font></div>
                                                                    </td>
                                                                    <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                  </tr>
                                                              </table>
                                                            </div>
                                                            <div style="TEXT-ALIGN: left" align="center">
                                                              <div style="WIDTH: 100%; TEXT-ALIGN: center">
                                                                <hr style="COLOR: black" noshade size="2">
                                                              </div>
                                                              <div id="HDR">
                                                                <div id="GLHDR" style="WIDTH: 100%" align="right">
                                                                </div>
                                                              </div>
                                                            </div>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </div>
                                                  </div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">to the
success of unsolicited competing offers for the Company.&#160;&#160;Defendants
did so in order to secure the benefits that the Acquisition Proposal provides to
them.&#160;&#160;There was no threat to defendants at the time defendants agreed
to these defensive measures in the Agreement and Plan of Merger, making their
adoption disproportionate and unreasonable to any purported threat
posed.</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">70.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">As a
result of defendants&#8217; breaches of fiduciary duty &#8211; in, among other breaches,
erecting these defensive measures in the Agreement and Plan of Merger and in
their treatment of the Acquisition Proposal&#160;<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#8211;</font> the Class will be
harmed by not receiving the maximum price any bidder is willing to pay for
Longs.&#160;&#160;The defensive measures erected by defendants, and their
interpretations thereof, impose excessive and disproportionate impediments to
any other potential superior alternative.</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">71.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Plaintiff
and the Class have been harmed by these breaches of fiduciary duty.</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">72.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Plaintiff
and the Class have no adequate remedy at law.&#160;&#160;Only through the
exercise of this Court&#8217;s equitable powers can Plaintiff and the Class be fully
protected from the immediate and irreparable injury the actions of defendants
threaten to inflict.</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify">&#160;</div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">THIRD CAUSE OF
ACTION</font></font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">For Class Claim For Aiding
And Abetting Breaches of Fiduciary Duty</font></font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">(Against
CVS Caremark and Blue MergerSub)</font></div>
                                                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">73.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Plaintiff
repeats and realleges each and every allegation above as if set forth in full
herein.</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">74.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">The Longs
Directors owe the Class the fiduciary duties of care, good faith, and
loyalty.&#160;&#160;That the Longs Directors owe the Class these fiduciary
duties is well known to CVS Caremark and Blue MergerSub.</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">75.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">As is
detailed in the previous paragraphs, the Longs Directors have breached their
fiduciary duties to the Class.</font></div>
                                                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">76.&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">CVS
Caremark and Blue MergerSub aided and abetted the Longs Directors&#8217; breaches of
fiduciary duty. CVS Caremark and Blue MergerSub actively and knowingly induced
the Longs Directors to breach their fiduciary duties to Longs
shareholders.&#160;&#160;CVS Caremark and </font></div>
                                                  <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                    <div id="FTR">
                                                      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                        <div id="FTR">
                                                          <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                            <div id="FTR">
                                                              <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                                <div id="FTR">
                                                                  <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                                    <div id="FTR">&#160;</div>
                                                                    <div id="PN" style="PAGE-BREAK-AFTER: always">
                                                                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">
                                                                        <div align="center">
                                                                          <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
                                                                              <tr>
                                                                                <td colspan="3" width="33%" style="BORDER-TOP: medium none; BORDER-BOTTOM: #000000 1px solid">&#160;</td>
                                                                              </tr>
                                                                              <tr>
                                                                                <td width="33%"><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">CLASS ACTION
      COMPLAINT </font>

                                                                                  <div><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Case
      No.</font></div>
                                                                                </td>
                                                                                <td width="34%">
                                                                                  <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font size="3">-19-</font></font></div>
                                                                                </td>
                                                                                <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                              </tr>
                                                                          </table>
                                                                          <div style="WIDTH: 100%; TEXT-ALIGN: center">
                                                                            <hr style="COLOR: black" noshade size="2">
                                                                          </div>
                                                                          <div id="HDR">
                                                                            <div id="GLHDR" style="WIDTH: 100%" align="right">
                                                                            </div>
                                                                          </div>
                                                                        </div>
                                                                      </div>
                                                                    </div>
                                                                  </div>
                                                                </div>
                                                              </div>
                                                            </div>
                                                          </div>
                                                        </div>
                                                        <div id="PN" style="PAGE-BREAK-AFTER: always">
                                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">
                                                            <div style="TEXT-ALIGN: justify" align="center">
                                                              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">
                                                                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Bluer
MergerSub also colluded with the Longs Directors to breach their fiduciary
duties owed to Longs shareholders by, <font style="DISPLAY: inline; FONT-STYLE: italic">inter alia</font>, entering into an
agreement with Longs and the Longs Directors that prevented them from disclosing
material information necessary for Longs shareholders to make an informed
decision regarding the Acquisition Proposal, including, among other things, the
method used by Longs and CVS Caremark to value Longs&#8217; real estate assets as well
as the true value of Longs&#8217; real estate assets.</font></div>
                                                                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">77.&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">CVS
Caremark and Blue MergerSub colluded in or aided and abetted the Individual
Defendants&#8217; breaches of fiduciary duties, and were active and knowing
participants in the Individual Defendants&#8217; breaches of fiduciary duties owed to
Plaintiff and the members of the Class, including the duty of fair and
reasonable disclosure of all material information needed to evaluate the terms
of the Acquisition Proposal.</font></div>
                                                                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">78.&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">CVS
Caremark and Blue MergerSub participated in the breach of fiduciary duties by
Longs Directors for the purpose of advancing their own interests.&#160;&#160;CVS
Caremark and Blue MergerSub will obtain both direct and indirect benefits from
colluding in or aiding and abetting the Individual Defendants&#8217; breaches of
fiduciary duties.&#160;&#160;CVS Caremark and Blue MergerSub will benefit, <font style="DISPLAY: inline; FONT-STYLE: italic">inter alia</font>, from the
acquisition of the Company at an inadequate price if the Proposed Transaction is
consummated.</font></div>
                                                                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">79.&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Plaintiff
and the Class have been harmed by CVS Caremark&#8217;s and Blue MergerSub&#8217;s aiding and
abetting of the Longs Directors&#8217; breaches of fiduciary duty.</font></div>
                                                                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">80.&#160;&#160;&#160;
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Plaintiff
and the Class have no adequate remedy at law.&#160;&#160;Only through the
exercise of this Court&#8217;s equitable powers can Plaintiff and the Class be fully
protected from the immediate and irreparable injury the actions of CVS Caremark
and Blue MergerSub threaten to inflict.</font></div>
                                                                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt">&#160;</div>
                                                                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">RELIEF
REQUESTED</font></font></div>
                                                                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                                                                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">WHEREFORE,</font> Plaintiff demands
judgment as follows:</font></div>
                                                                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;&#160;
&#160;&#160;Declaring this Action properly maintainable as a class
action;</font></div>
                                                                <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;
&#160;&#160;&#160;Preliminarily and permanently enjoining Longs and any of the
Individual Defendants and any and all other employees, agents, or
representatives of the Company and</font></div>
                                                                <div id="PGBRK" style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">
                                                                  <div id="FTR">
                                                                    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                                                                      <div id="FTR">&#160;</div>
                                                                      <div id="PN" style="PAGE-BREAK-AFTER: always">
                                                                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.7; MARGIN-RIGHT: 0pt" align="justify">
                                                                          <div align="center">
                                                                            <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
                                                                                <tr>
                                                                                  <td colspan="3" width="33%" style="BORDER-TOP: medium none; BORDER-BOTTOM: #000000 1px solid">&#160;</td>
                                                                                </tr>
                                                                                <tr>
                                                                                  <td width="33%"><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">CLASS ACTION
      COMPLAINT </font>

                                                                                    <div><font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Case
      No.</font></div>
                                                                                  </td>
                                                                                  <td width="34%">
                                                                                    <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font size="3">-20-</font></font></div>
                                                                                  </td>
                                                                                  <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                                </tr>
                                                                            </table>
                                                                          </div>
                                                                          <div style="TEXT-ALIGN: left" align="center">
                                                                            <div style="WIDTH: 100%; TEXT-ALIGN: center">
                                                                              <hr style="COLOR: black" noshade size="2">
                                                                            </div>
                                                                            <div id="HDR">
                                                                              <div id="GLHDR" style="WIDTH: 100%" align="right">
                                                                              </div>
                                                                            </div>
                                                                          </div>
                                                                        </div>
                                                                      </div>
                                                                    </div>
                                                                  </div>
                                                                </div>
                                                                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">persons
acting in concert with any one or more of any of the foregoing, during the
pendency of this action, from taking any action to consummate the Agreement and
Plan of Merger until the Individual Defendants have fully complied with their
duties to fully and fairly disclose all material facts and act solely for the
benefit of Longs&#8217; shareholders;</font></font></div>
                                                                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A
declaration that the Individual Defendants have breached their fiduciary duties
to the Class;</font></div>
                                                                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Awarding
Plaintiff the costs and disbursements of this action, including attorneys&#8217;,
accountants&#8217;, and experts&#8217; fees; and</font></div>
                                                                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Awarding
such other and further relief as is just and equitable.</font></div>
                                                                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">JURY
DEMAND</font></font></div>
                                                                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="center">&#160;</div>
                                                                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Plaintiff
demands a trial by jury on all claims so triable.</font></div>
                                                                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="justify">&#160;</div>
                                                                <div align="left">
                                                                  <table cellpadding="0" cellspacing="0" width="100%">
                                                                      <tr>
                                                                        <td align="left" valign="bottom" width="55%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;Dated:
      August 22, 2008&#160;&#160;</font></td>
                                                                        <td align="left" valign="top" width="36%" style="PADDING-LEFT: 0pt">
                                                                          <div><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">BERNST<font>EIN</font> LITOWITZ BERGER</font></div>
                                                                          <div style="MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&amp;
      GROSSMANN LLP</font></div>
                                                                        </td>
                                                                        <td align="left" valign="top" width="9%" style="PADDING-LEFT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                      </tr>
                                                                      <tr>
                                                                        <td align="left" valign="top" width="55%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                        <td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                        <td align="left" valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                      </tr>
                                                                      <tr>
                                                                        <td align="left" valign="top" width="55%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                        <td align="left" valign="top" width="36%" style="BORDER-BOTTOM: #000000 2px solid">
                                                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">/s/
      BLAIR A. NICHOLAS</font></div>
                                                                        </td>
                                                                        <td align="left" valign="top" width="9%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                      </tr>
                                                                      <tr>
                                                                        <td align="left" valign="top" width="55%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                        <td align="left" valign="top" width="36%">
                                                                          <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>BLAIR A. NICHOLAS</font></div>
                                                                        </td>
                                                                        <td align="left" valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                      </tr>
                                                                  </table>
                                                                </div>
                                                                <div>&#160;</div>
                                                                <div align="left">
                                                                  <table cellpadding="0" cellspacing="0" width="100%">
                                                                      <tr>
                                                                        <td align="left" valign="top" width="55%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                        <td align="left" colspan="2" valign="top" width="11%">
                                                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">BLAIR
      A. NICHOLAS (Bar No. 178428)</font></div>
                                                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">12481
      High Bluff Drive, Suite 300</font></div>
                                                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">San
      Diego, CA 92130</font>&#160;</div>
                                                                        </td>
                                                                      </tr>
                                                                      <tr>
                                                                        <td align="left" valign="top" width="55%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                        <td align="left" valign="top" width="5%">
                                                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Tel:</font></div>
                                                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Fax:</font></div>
                                                                        </td>
                                                                        <td align="left" valign="top" width="40%">
                                                                          <div><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">(858)
      793-0070&#160;</font></div>
                                                                          <div><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">(858)
      793-0323</font></div>
                                                                        </td>
                                                                      </tr>
                                                                      <tr>
                                                                        <td align="left" valign="top" width="55%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                        <td align="left" colspan="2" valign="top" width="11%">
                                                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">blairn@blbglaw.com</font></div>
                                                                        </td>
                                                                      </tr>
                                                                      <tr>
                                                                        <td align="left" valign="top" width="55%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                        <td align="left" colspan="2" valign="top" width="10%">
                                                                          <div><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">-and-&#160;</font></div>
                                                                        </td>
                                                                      </tr>
                                                                      <tr>
                                                                        <td align="left" valign="top" width="55%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                        <td align="left" colspan="2" valign="top" width="11%">
                                                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
                                                                            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">MARK
      LEBOVITCH</font></div>
                                                                            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">KATHERINE
      M. SINDERSON</font></div>
                                                                            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">1285
      Avenue of the Americas</font></div>
                                                                            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">New
      York, New York 10019</font></div>
                                                                          </div>
                                                                        </td>
                                                                      </tr>
                                                                      <tr>
                                                                        <td align="left" valign="top" width="55%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                        <td align="left" valign="top" width="5%">
                                                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Tel:&#160;</font></div>
                                                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">Fax:</font></div>
                                                                        </td>
                                                                        <td align="left" valign="top" width="40%">
                                                                          <div><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">(212)
      554-1400&#160;</font></div>
                                                                          <div><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">(212)
      554-1444</font></div>
                                                                        </td>
                                                                      </tr>
                                                                  </table>
                                                                </div>
                                                                <div>&#160;</div>
                                                                <div align="left">
                                                                  <table cellpadding="0" cellspacing="0" width="100%">
                                                                      <tr>
                                                                        <td align="left" valign="top" width="55%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                        <td align="left" valign="top" width="45%"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">      </font>
                                                                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Counsel
      for Plaintiff&#160; Louisiana Municipal Police Employees&#8217; Retirement
      System and Proposed Lead Counsel for the
  Class</font></div>
                                                                        </td>
                                                                      </tr>
                                                                  </table>
                                                                </div>
                                                                <div>&#160;</div>
                                                                <div align="left">
                                                                  <table cellpadding="0" cellspacing="0" width="100%">
                                                                      <tr>
                                                                        <td align="left" valign="top" width="33%" style="BORDER-TOP: black 1px solid; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">      </font>
                                                                          <div><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">CLASS
      ACTION COMPLAINT</font></div>
                                                                          <div><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"><font size="2" style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">Case
      No.</font>&#160;</font></div>
                                                                        </td>
                                                                        <td align="left" valign="top" width="34%" style="BORDER-TOP: black 1px solid; BORDER-BOTTOM: black 2px solid">
                                                                          <div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">-21-</font></div>
                                                                        </td>
                                                                        <td align="left" valign="top" width="33%" style="BORDER-TOP: black 1px solid; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: times new roman">&#160;</font></td>
                                                                      </tr>
                                                                  </table>
                                                                </div>
                                                              </div>
                                                            </div>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </div>
                                                  </div>
                                                </div>
                                              </div>
                                            </div>
                                          </div>
                                        </div>
                                      </div>
                                    </div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>sum_p1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sum_p1.jpg
M_]C_X``02D9)1@`!``$`8`!@``#__@`?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$``("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("
M`@("`@,#`@(#`@("`P0#`P,#!`0$`@,$!`0$!`,$!`,!`@("`@("`@("`@,"
M`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`__$`:(```$%`0$!`0$!```````````!`@,$!08'"`D*"P$``P$!
M`0$!`0$!`0````````$"`P0%!@<("0H+$``"`0,#`@0#!04$!````7T!`@,`
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1``(!`@0$`P0'!00$``$"=P`!`@,1
M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_``!$(`)H`E@,!$0`"$0$#$0'_V@`,
M`P$``A$#$0`_`/W\H`*`"@`H`^;OB3^T-;_#?Q%XYLKKPK>:GX7^&GPXC^(W
MC/Q+8IXMNY+*V%AXTUB^T2UM]$\":GI,.JVVB^$K:](UKQ!H:RIXBLA&6`9B
M`>:^+_VM=?\`!4NHZ+J7PY\,W?B[0I[U?$.D:!\0/%_B?2]$M]+\)>&-=UG[
M=JWAGX,:A>6MUIFL^/\`X<:;?R76CVVFV-OXXL-3N]3A@#1$#;R/=-8^*.LV
MGB?3?!FD^$].F\1KX4\->,/$]IXB\6Q^'+/1+'Q3XAD\,:9I6E:I:Z'JMMXB
M\12:M8ZQ"EH'L8)'M+91=`ZA#@`\6MOVK?$5Q<^`((OA'',GQ:&AZM\.I+'X
M@VE[CPAK'Q+\&>"UUOQ^T/A@0>#M5E\+>+KGQ79:-83^(I;J'PIK=A+/:75A
M,8P"AX0_;$N_'?Q!@\%>%_AHESI]_J\6F:)X@O/$7BBWAUZ*?Q?\4M+CO+![
M'X87FCV+IX`^'NE>/GL]8U[2[E]&\7P+9Q7EU:K%>@'H>D?';Q>?A]8>-/$/
M@#PK'?Z]\5M`^%GAC1?`_P`1-=\:V6KW&I?%;_A66L>(WUN\^%F@O;:'IMM;
MZIXE$T6GW:7&EZ7+*TEN6!`&WD<W9?M57<^LW#WWPTO]`\`VU]X[LH/&VLZO
MJT!UEO`_B'X@:1.FC:9:>#+BSM[^XT7P/;>)4L-?UG0+F?1_%6GW>EQZJL%X
M+4`[BP^-7B0^`HO%>M^`(=!UW6_%GA7P9X/\):CJGC?1+G4=;\6W>D65E'XA
MN/&?PK\/W>A6]G)JDLU[<:=I>OPK!I5[]DDO;N(6C`;>1XO<?MU^&-'OM$T?
MQ#X'U*QU74?%,WP]O'T[7].O=!@\?R?';5_@7HND:5K.IVFE/JNBZQ>>#?B9
MXBLM5FLM/=]*^&VMF2SCNK=X(@#TW4/VD=0LOA)\*?BE:_"+QGJ<OQ=L[!/#
MW@JSN+#_`(2.R\0^)]#N=9\!Z)K#2!;33+;67@CM;C5;F:&UTI[N)[P^7O*`
M;>5CZ>A,QAB-Q''%.8T,\4,K3PQS%09(XIWAA::-7W!7:*(L`"44G:`"6@`H
M`*`"@`H`*`/GOXP_&'5_`FLV'ACPW9^%#JEWX;O-=EU/QKXDT_PWI$5[>ZWI
M7A+P9X<T_P#M/4=-AU37M<\2ZNP@MVU*S##1GM`ZSZI;2P@'C/A#]JGQ+XF&
MDS2P_#VQM%U/X3V,S>?KT>H>-X/B?\1-:\.W%SX7T?59K"Z\/?\`".>`=.M/
M$VHR.GB6T%P-:TV.[-MH$^L7``ZW_:"\+>)O!/PZUQ;;X1^!4_:#\`>+/B+X
MS\0?$0:7=>$M.\+^'O"_A*:T\/\`CXVVLV%OJ7B>[\(>-O"D4UIJ.L(MKIUC
MJK^7<06*P,!MY&?J/BC0=)L?AM\,_A)^SQ\,[@>*?@OJ'C/Q;X`@\*Z-8>&_
M"_@KXGWV@PZCX4O(K/3K'2]'T/Q3J%AXA;4)]6BMK2^_X09RUI?SPF&W`/+/
M$7[6?PC\>ZS:>+[OX1^%O'OB7P5XY\-7'P/UJ3PSJ?BGQ58^`O$.B?$+Q7JW
MQ2M=/F\-QZE9"'P[\%O'6L6VGZ`^H33_`-F^'YM\,U];M"`=CX*UGX*>(O'&
MA?!C4O@)\%/#</Q=T+3?%WQ5T6RL/#U[=7/Q9N-&U7XF^$]$N?[#TE]-UG6[
M+P7I6I>*KB2?4&N]/C\3:-/9&XBO9[L`'4K\7_#*Z=H=KX`^#/@*[@T+Q7\5
M&^'VFO9Z;X>2QD^!GB;PW^SKINI^%;-]&CMK3Q7=+K&HZ#HNG6US87MUI>C2
M:7IN]#+#:@&2_P`8=!\5>$_!7AR[^&?PWU?P&_B[X"^']8\.75OXBTG41XE^
M+7C5%T#4_!W@[Q!X5LKO3KSP[;SZ=XJO+F^\J>WGT[Q%;Q3-<Z!)=W0`SQ]K
MWPC\*:AXKMU^"WPJU'PAX3A\=_!W3].M-':SUG5+?PA^SCK'C;6-&M-.LM";
M3[;PLNCWM_X#,I.(I-<;3HR3J4=K=`'I6F?V-I_PL\%^%_''PG\'Z+'\4OBQ
MX;T*U\`3/>V5J=4%U%XKNM;FM_$EM!?7GB/2O^$-UG6K3RH5F?\`X1^QO(3&
MB&6(`YGPY\1/@/XC_:5N?V:?#?P\^']Y;_#WP1<7O]O:=-I22^'O&'PWNM'\
MOP59^'+/3FVVUCH/QSU:>+5!>P""^F\5::;>2YCO&@`V\CD/!WQ*DNO"7PKN
M/`GP/^&-I:?$_P`5Z=XA_9QT.X^)FKVSVNH7?@OXE:EI_B[XB6*>"9)_"&GR
M_"GP+J^HV_\`9D&N%)[V31_(%U8B\N`#L=-_:^\0:Q\3_!_PLTOX8:-=:UKL
M2:?K%Q'XQ\>SZ79^*K>3Q3<:W8^&O$MA\#[GPOKWAZP\-Z#IGB4:CJWB+PQJ
M%[H_B.TGL=%N+AX+6\`,'1OVO/B]KFM>"O#>G_`KP+<ZUXWL=0U>U72?BM\7
M_%NE:%H@\9R^!O"^K^+M6\"?LG:Y'X.TSQ)JFF^);NPU'7(].TZ.Q\,W\M]?
M6D\$UK``?8/PG\?V_P`5?A?\//B;::7=Z):_$#P5X9\90:1?,7NM,B\2:/9Z
MLEE).881="(7>Q;E(D2=56:,!)%H`]!H`*`"@`H`^./C3J/CS5?CAX<^&GPV
M\/\`P;GUOQ'\%?&NNZWK7Q?AUCQ!IEQH.C>,_!NEP>'(/!GA_P`365S?0'4=
M?&HS7-W9>0PL1:PW<<DTIA`-:P\"_M23:[I^I:UXB_93M;73;B71[.72O@A\
M0;OQ'8>"+B[V7.G:5K=_\8HH;"]ETN.$&W%A)9>=C?%+%&%D`,B3P[X_\">.
M/AYI?B>P_9WUGX<>./BYJVFZ7X9\-_!;6?#GB#PO=GPEXU\8>'M?7Q1+X\U;
M3KS7+8>$K:">['A6T>XGO"RSV,>'@`-GQKK'QH\1?'SQ!\,_A]XB^'G@70]-
M^#?@CQA)KOC#X/:]\1[GQ!>>(/&/Q(T#5]%&J:?\3_"-KI]MI]MH.BSK8/%J
M+R'6II6:)&".`=-\%-9UCQ3KGQ8MO'FE>#+KQ=\*/B;'\.])\4>'_"_]@2:I
MX:M_AQX-\6:3?Q6M[J^L76G;)OB)XFLO+BU.6$,U\(UA\^>!`#S;P?IWQ<U;
M2?&^L^'O%GP7\`Z!X0^*/QOM=,\.^$?@P;^_\KPUKOB#PUX:O]0\1CXAR6G_
M``E$FCP+)J\]MX<MYI)+M[!8HOLTSWX![-\*_#NA^+/A7X2\1^+O"'@"[\2_
M$OP'X'\0_$J72?"MG!HOBGQ%?:)I^LZA<W%KJ5@MU?V"ZU=W=Q:IJB//$)%+
MA9=U`'5ZSX3\$:%;CQC:^%O!.EZ[X(\(ZQIGAKQ+=:/H&FS^%-`6R:>XTRQU
MV>V0^'O#?^C1/<0QS06H2#=*NV/(`V\K'B_@+X'Z;XCT;PIX]\7>*KSQ'XC\
M4>!;*3Q<]KH?P3;1/%-UXH\/Z<VIS:AJO@[X<V__``E6EI=8N+/=J5[8,T5M
M<H)S#;RH`0W/[)W@"X\*VG@_6?&WCK6/`>EWUQ?Q>$M>E^'M_P"$XKJ<7EO=
MB72KGP#]F\B4W^H++;D")VOKH2(QN9A(`>+PZK<^#_V4_P!I#7?"RRZ?K?P9
M\0_M':'X"\1Q:#I-IXDT;2M%\0W5[+>6][I6B:)'$MR]G'=2ZO-"89H+:UU#
M5+C5(H);R\`/5/$_[&'P.U#PQ;Z'J-WXFT#P]::IK.MZ_P#V9K^G:!;^+;S5
M]:GUBTG\=20Z3'%XADT>YOKVVTNXO`9[6VU">V\Z2.8J0/P,*P_9+TKPSIIU
MGX"?%/5K#Q!I_B+2O%NA3?$4:3\;_"3^(_#OA2/P)81WK>*8;C6]%5?!%IIG
MAP:EX9UW1=5M]/LDA^UW$)>WE`.L^%VA_##XZ>!KS4-7^$WAGX?>//"4>N_`
M;Q3;:1H>B6?BCP$G@JXO-(?POX0\4QZ-!J&C^%)=(U%=3T1K-;%H=.\3VMU:
M);33+(H!]3Z;IUCH^G6&DZ7:PV.FZ796NG:=96R".WL[&R@CMK2U@C'"0Q6\
M4<:J.BH!VH`NT`%`!0`4`?)VOO-'^V]\,8UAL/(NOV9_B\SS/!9MJ.^P^)/P
MB"1PW-Q`9X+<#4F)ALY4\XN7N%=;6,H`2:IIGBWQS^T;\1O"`^*OQ*\&>&/"
M7P@^#/B/1]%\'/X2T^Q?5_&_BGXY:3KNH7-UJWA+5+FZ;R/`N@B$-<1!7CN@
M8Y$`V`'H%A\$+*/5_#>L^(/B+\5/&DWA/7HO$NC6GB7Q+IT6GPZO!I&I:-;S
MW%IX:T'2%O(TM]7U&3R9B\<CW`$RR111QQ@%>R:\3]ICQ&CSS+I]Q\"O!36M
MJTTHMVO+/Q_X_%_/%;F;RC,D%_IJ22)$KA985=V!C5`#,^"NEZOIGQ&_:HFU
M#2;W3=.USXX:'KF@76H1WME)K>GGX"?!?0KO5-.L9[2."XT)=;T'5+&'5;2X
MN%NKG3-1MY!%+I;!P-O(9\![2>71_C5I-]!:QJWQY^,4*6IGU+5-.^Q:QK`U
M2%C_`&@EL[K=0ZH+FZM+=A;P7-W=VMO*T<*R$`B_8ZDLI/V3_P!FYK":WG@7
MX(?#*-WML^6M[#X0TF'4H6W2/_I$6HI=13<@>;%)A4&$4#;RL>]Z["USH>LV
MZ26<+SZ5J,*2ZBUPFGQ-+:3(LE\UI<V\ZV:E@93#/!($#%)$;#*`?,'B?3K&
MU_8;U32=>U""73K?]E]M.U?5X;F6]TX6D7PP6VO=7GN/L]JVH:(D:R75R9+6
M-;BT282VS)(T#`'DDMY_P2N@F*QV7[#MW,UO<3-%I>@_!76=EMIT5W=W=PT&
ME:?<B"*&V@NIY9BJ`0PB1V\I$8`'NOQ6T/P7X3_9+^,%G\*-#\%>%?"#?!+X
MEZOX>L?#5EX?\)^#H+76/!NMZJ^K6\-MI$FDVEO.+J2^>::PE@E:1GN%9)':
M@";]I?3=(O?A#X>T'7O#MEXAT'5OC#^S'X<UCP_KMCI%[I%SI>M?M"?"O1;R
MTUS2&5M.U"S:WO'B>T2WG@:1X]L8C3S(@"GX"\$^"?AC^T%XE\,_#[PYI7@/
M0-?^#OA;7KCPGX/\)Z?X>\'WFK:+XM\0Z(^O2C29;>SMO$$6E76DZ?Y<.FK+
M<6D4/GW+IIUM%$`:7PQCGM?V@/VG(%D?[!>7'P<UL1/;:M&(]6N?`,FBW\D5
MU<DV%S&^F^'="&RQQ)&\3_:ES+"S@'T=0`4`%`!0`4`?,7BBSE7]L+X,Z@D,
MQAD_9^^/]C-.UHPMHGC\=_L_7$*1WL+@O=/YDI,-P#&D:%H@9)6:,#;R/5/$
MOPA^'7BW6KGQ#KWAN.YUJ]T[3-)O]1MM1UC2;C4-.T5M<?2+74/[(U"U6^2R
M_P"$F\0K`9UD:)-:O$0A+AU8`\N\*_#_`,+?#WX_VUGX.M;G0[#5?@]KUSJF
ME1ZOJ5W8ZC>6?C;PTECJ%Q;:EJD[-=V<5YJ$44L<1"+JUT&=#.!,`=U'`5^/
MUW<@B,2?!_3X"/*0&Y-OXTU.12)RN]A:BY;]VI*K_:(+`%ER`5/`*R/\7/CU
M=7&H6US/%J7PYTJSL(%S-IFB6G@6SU.V2\E>]D<33ZWKGB*985MK:!(VCD1I
MIKBX\H#;R-+X8VDMEKGQGADBCAW_`!9FNXU2:SE+17_P[^'5\DLBVMM$T$C_
M`&@MY=RT\P#!O,\IHHX@-O*Q@_LS64FF?`_P-ITH"O81Z_9[!'<0^6MMXJUR
M&.)DN[FXF$B1HJ,99G=F5F8Y.``>ZNB2(\<B*\;JR.CJ&1T8%61U8$,I4D$$
M8(-`'B/P9U?1M!_9L^%.NZU<V>C^'M%^!_@75]6N[TP6]AI6C:=X"TN\O[F[
M*6UO#!9VUC#*\FVW@14B;$:*-J@!JOQZ^&JZ9>_9M9UI;B2WU""U/_"!_$MP
MMU#:W;JTJZ9X9%W'`6MVVR0%'D+1K;N99X=X!S'B6#5+;]CKQ!;7D^L6NM0?
MLT:K!=W,^F6T6OV^J1?"V>.>>;1I;<V\>L1W:L[63P&,3*8C&5&V@#N/B[IH
MO/`6C6UW?:9HLEC\1?@9JAE>]N]-TO[9H'QD^'VLP:5'=VT#RQ6]]>:?'I\2
MM"4?[:D<R^4\@H`RH[$_\-+W6I,EI@?`NPL;>03V*W\9/C_4KB\1[7;]L>TD
M_P!!*RAO(1X)%QYD@(`(O`XN$^/OQY5M,AM;9O#OP8F@U--,@MI=3E:P\<0W
M$4VJ?8X[C4C:"W@58VN+BWMUN0(5BFGNQ(`>\T`%`!0`4`%`'S]XKM'_`.&G
M/@AJ*W5M''!\'?VBM,>R^WQ0:A<'4/%/[.EZEQ'IQC:2^TR#^QF6XE4QI!/>
M:=O?=/''*`4/$GP"\`^.?CCK7COQ[X$\)>/-.O/A%X;\$VUGXOT[0/$VGZ5+
M8>+O%NKZ@T'AK6-+G^RS:O;ZKI\<U_YDJW$?AFVMRD7V/-P`>C>`O@S\(?A7
M+=S_``S^%OP\^'US?VMO9:C>>"_!GAWPS>ZE:6K%[:#4[W1M.MY]1CCD9G`N
M9)?G=G^\Q)`+,NDZNWQ5L-<2*]708/A]JVDS3B2P&G2:O=>(]%O+6(Q"<WOV
MV*SM+M@S0I;B.X(61Y"RQ@&3X:L&L?B]\4Y6OVD_M;PU\+]633%ND,-E'GQS
MHHO#8I!'Y%W=RZ)-&]PYG>:+3K:/SMEI'!;`%[P);W=KXA^+Z3FW^S/\2;2X
MTQ8%1'2TN?A=\-)K@721VT*BX;5GU-\@REHY(G>1I'<*!M\CS3P'\5?A1\._
M")\/^-?B_P##O1-5T75_B/>:@/$WBSPSX4O%T[3_`(F^(=*N]6N-(U358IM,
MTV+49[>U8S;A#+/#!-,\[9D`/6_!WQ-^'GQ`\S_A!?&WACQ:(M.T_5V;P[K5
MAJR#2M6>ZCTW4D>RFD62QN9+*[2.="R,UM(H;*D4`>;>'X3?_LO6-EIMC]K\
MSX)R:7IND^'(MTLJQ>#9=/LM)TJ+3YD62]"QQ6J"RE2-YE_T9EC:,@`[N3XI
M^&(O+W:7\1SYD:RJ(_@Y\79<*Y8`2"+P.WDR94YC?:X&"5`89`.<\:^+?#?C
M3X0_&)M*N[R"#2/"'C70M=37O#OB?P[>:/>OX'&L/'J&BZSI5CJBI_8VM:9>
M`Q6Q,D-XAA9F/`!L_$*SN#\/+;9IVJ:G/HVJ_#O79+'PU8XU%AX6\9^&-?N9
M-.TIK*621((]+DG-C#:27$D4#P6\#3M'&0#%\-3R>)_BWJ7C#3=$U73_``]8
M?#K3O#4FK>(_!^M^$M6U36;KQ-J6J#3M/A\3Z38ZG<Z=IMC;":=_(AM/,\06
MP@DNIDN5TT#\!?!&B6X^,OQR\6VTL0-Y#\+_``5>VR+J\;IJ'A3PYJ?B=KJ8
M72+I\K3:;\1]+B$UAYDA6S6.ZD)@ACA`V/:J`"@`H`*`"@#POXF:O9>%_B'\
M+O%.L0:XFA:7IGQ&M;W4]+\/^)?$%I97-_8>'I+.UO[?PWIM\UI-<QV-Z]O/
M=0QQ,;&:!)A/<10W0!B_#GQWX?\`B3\6O$?BCP=!XN;0+;X<^'M"O-6UOP#\
M0O!.EZEJ=KXI\37MK;6=SXQ\,Z3;Z_):6=_/<QO:M=>3;ZZLT9$&IAYP-O(^
MCJ`.%UU-4L_%_A[7+32=3U;3K'PMXSTZ^ATR[MXY8[O4M4\#WE@[6%]=VMO>
M$P:-J:K()C<1D[(8G2YF:(`B\+3W>LZ]JWBLZ-J&BZ7JWAOPSIEE#KEA<:5K
MYO-$UKQP^H)?:;/=L;6T6/5=/DMRUM`[BYF<O+&T0A`V\C+TB*Z\,^+?B+<M
MX?UJ]_X2OQ'IOB"UN]-L=.-LUA8>!?!OAP^;>FZMP\XO-$U(+;SF2[Q;G&8)
MK&,@;'2GQ3='39M0M/!WBV[DAE:`:6+;1M/U*206UK<)Y*:SKEE`\4DMU]G$
MWV@1++;SF1TBC,I`(--BU&[\63:S=:!J&D6S^%-.LXYK^[T%Y%O&U/4+JYTY
MX-*O+V4S0QFV=I?M(M_WH6+SF+M$`8GAB?7O#/AWPOX;M_A[JRKI>E)IMQ+!
MK'A46%L-,TR403>;)KWVJZGOKV&V0_Z.2KWLLLTI$1:8`NZKXA^(-NFFRZ+\
M.+?45NM/BN+^#4/&FFZ1>:3J)>19M/DC@TZ_M[N-4$3+<P73!][`HFP%P#F/
M"'A?QE9?\+PU+7]*\/B?XA>+O[>\-^&[K5FU[2Q8V_PF^'_@9++79QH=BMO:
M7NJ^$[UY[%(M1V174DOVR470M;$#;R-V7Q%\3HA9Q0?#?3;V3[+9)J-W-XVL
MM)MAJ3QD:@]A;1Z9J,KZ3',N8I)GCN'21=UNK!A0!DZI?_'7519V&@>&OAYX
M,6YFOHM3\3:]XFUCQC-HMK%:W`L[K2?!NE:!HT?B*[GO_L@\JZ\1:/'#`TLS
MM-+&MI,`>DZ'H-CX?MKF"R^TO)?:A=ZMJ5Y>WU]J-Y?ZG?N'N;F>[U&ZN)A$
MJ)%;VULL@@LK2UM;&SC@L[.W@A`-J@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H
M`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`P/$
M?BOPMX.L8M2\6^)=`\*Z;/<BR@U#Q'K.G:'8S7C6]Q=K:176IW,$4ER;6SNY
MA$K%S':S/C;&Q4`U[6ZM;VWCNK&YM[NUE!:&YM9HY[>10Q0F.:%F1QN5@2I/
M((ZB@"Q0`4`>&>-?B'X[\&>,)H9?#WA6^\$-X<US5]/:TUS5#XMF;PUX6UO7
M]8O]5MFT=;/1=._M6UT/1[>./^T5D_M9[R6\@E2'3;D#;R.6T_XI?$2ZENM/
MD3PB;SPSJ>NW'B"\T_0=7O;;Q%X>T;PU\-O%MO!X8TS_`(3".[TW5+_0/B"U
MP+MVUJVMY](^Q/#+->0.X!T'P_\`'GC_`%GXC>(O#_B?_A%8_#K6GC.]\,Z?
MIF@ZYI/B;2X/"'Q1\0>!(9M?O]2\1WMOK=IJ^DV.F:C;7%MI>CHKM=+%]KA*
M2Q@'3?%GQ=JW@W3O#5_H[@-)XHB?6(!;F^DN/"VD:)KGB#Q+%#IEI97>I7]P
MVF:3*D"Z5!)<QW,MK,ZR6L5S%*`9GBK6]=CL_&45AXBO[*YTGXI_"BTL'L['
M1`UEHNH:I\+I=4\-2F_""?2=66\UR&]U"7=<P6OB.[%A*;BP@C@`V\CS?0[*
M.V^.7AG5[O\`:,U'3?%>N1_$B#5OV?\`Q#XCT"\MO&GA:PUSQ#9^'-1\'>!Y
M-76?PP_AZ?29YI=;TFUOI[^WM+FUU&X=8M]N`>I_%_P'X@^(6E:/H=E\3/$O
MPN\)V^IR:KX\U/P/?Q>'O&6MZ)864\EIX?TSQD\4LW@W2IM2:WNM1U#31;:B
M]OI_V:UO;1+FX=P#YO\`A;H?B'XL_`#39/'?Q=^(6G_#>Q^)/CK5H?%NKSR?
M#_QO\2/@7H6K^([#P?:^)_%-A=:?JGAG1+RW%AJ)\06ES::GJ^EZ5IU\]S:)
MK-Q"H!ZW^RR^KS?#G4;LW^O7_@"]\:>)+KX+2>+K[5]7\6K\)9);?_A''UO7
M/$&H7>IZQ;3WPUBZTB?4I6O%T&ZT2&Z>6:)Y'`V\CM;'Q%+XI^&'CC4HI[^T
M>&;XJZ-;WBIJ>F:C`V@Z[XFT5;FWBU*VAN;)HI;$_9I5$L$D45O<V<]Q9S6\
M\H!\R?#6+]CK3_`GP?NO&?B/X16OBB]\`^"$ATCQ_P#$")[ZXU.;P9I4,MK<
M>%_B'KHO)]52"<;H=3T\7T<A62>-+I25`V\K'M_[+T_B&;X8.-6D\57/A^'Q
M?XN@^&6I^.99W\7ZS\+$U>4^"]3UQ+W2]/O8?,L6D2S74+87C:;!ITMQ)/+,
MTTH![%XH\.^'=<M8+C7?!VE^,IM$>>]TBPOM*T+4KNWO)[66RG?27\0/%;6-
MW-97%Q`TIN+<-%-)&S['((!R?@(3:1>GPO:ZQHTF@V>D7VJZ;H%Y]LMO'6D+
MJ/C3Q-]F@NM/N)(U@\(6&FI9:/8-]ER7T:=1<31JC4!M\BW\6(Q)X,;/GJ8?
M%7P\NDEMY[*V-I):?$+PM=17\]Q?P2Q0V%I)"ES<N!'*+>WG,$UO/Y<\(`?$
M'1O$^H7WP]U3PG!X3N;[PSXU?5=1M/%<TEB+W0KKP?XMT6\M-$U2VT'5KC3=
M96^U72[U9(8(_,ATRXBDE$4KI(`=OI^HI>F]@,<D-YI5S!8:G&;>_CM([^72
M].U5DTZ^O;&U36;);?4[91>6J/%YHF@<I<VMQ!``:5`!0!XGXNMEU;QOJFDW
M-KXESJ_PZO?!7AW4-.\-Z_#IFFWOBL:WJ'B>XNO'NE:?*_AY#!X:\'H)8;FQ
M5+@VQ)N[K[.--`/-HO"U_-=-K$>A:XUKJFGZOX1MHY_#&NVLL\FK_#;P)H(M
M;W3KNY2>P\/SZOX1FMI=4U?3$2UV_N;RWM[^>YG`.R\%>&/$5A\8_$^L77A_
M4=-TF+2/$UI-X@N;VRDTWQ1)X@\7VGB'PTNE6D6IW-VDVDZ8NL6MW)=Q6Z@W
M5I%;QQQ18<`[;QWX.UKQCJN@6*:DNG^#AI'C.S\4BVO!%K4MUK6FV6D:0=+M
M+C1;RTF46%WXCCFGGG@>`74?DQ3/,9+,`Y'5O`WCZ^OQ8_9O!TWAKQ%9>!;K
MQ5=_\)!KFE>(M%\1^#KF"\F;18+'PM)8^(M'O&TW2X$7/A>:W'VJ=2Q>&"`#
M8R[WX5>,]5^*/PPUJ\G\-V/@;X4^-OB9\1=.N+/5M6NO$OB?7_B%H'CCP[!I
M>H>'YM!@L-"TW2[+XAZZYO(M9U.:ZDLK4K!9I--&H&WE8Z#X^^!/%?Q*\$VO
M@SP];^'M1T35]>ME^(GA_P`0^(-5\)Q>*_`UMIFKW4_A6U\1:1X7\0RZ9'JG
MB:'PQ:ZENTFX%QH<NNVD;07%W!/"`<S\3/A]\4OBG\,]"\):C8_##PX[^+[:
MY\>>"/[1UWQ?X)\5>`=&N]1NM)\)-KDWA70KQ+:]N;;PM-JMM_8D<5S;6VI:
M4)/LUX9F`/9_!EOXSM=,N(/&LWA*2^CU"9=*C\&:=JNF:9::"EO:QV-K<1:M
MJ%W)+J"RI=L\D)@A\MX(TA!B:24`UK?0=-LM*N]%M(IK>PO)-8FG5;N[>X,^
MO7EYJ.J3K=S3/.DTU]J%W,&$GR-+B/:JJ%`V\K'/?#'PEJ'@#X<^!/`VJ^('
M\5:AX-\)>'_"]UXEDM+JQFUU]!TNUTL:K/:WNK:I<17-REJLLGGZC>R,[NSS
MR,Q8@;?([F@#G/$NG^)=1M(H?#'B.U\,W:R[I[RZT&/7P\&/]5%;2ZC:+#)O
M`_>,T@VEALW$.@!9T'1DT+3TL_M,U]<-->W5YJ%RL:W%W=ZEJ5[J]XY6)56&
MW^W:C=M#;H-D,<@C3A<D#\"76M(MM<TZ33;IGCB:XL+I9(XK.9XKC3;^UU*T
ME6+4+6YMW*7=I"V)()!\N0`P!`!F>*_!^B>,K/3[/68KH/H^LV'B+1+_`$^]
MN=-U/1M=TPR?8]3TZ^M)$DAF$4]U;RQMOAN;:\NK2YBFMKJ:&0`W+"QBTZW-
MM#+>3*UU?7C27]_>:C<&?4;ZXU"Y`N+Z>5XK9;BZE6"UC9+>T@6*UM(H+6WA
MAB`V\K%R@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H
M`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@#C?$.NWNFZUH&DV5WI-L
M=6@U%Y(M1LM1FDQ;ZCX>L([J*YM;B*"W@CEUI8##*6EN;K4-.AB\J,W-Q;@"
M>+;W6--DTBZTV]>"U$FIK?6,6C)J4E\UKI=SK=N&O'OH%TN`Q:->VA8JWF2:
MI``\3(I<`+C4-5LM2TNPN==TW[1.FHB6TM?!^MSI<M+;ZS>Z6XN+;6YTTMH;
M;2R")Y'%XUE=1PB*6\MUM`-OD;]I/<M/%!-,LA%@EQ+LT;4;*-I)IF6)TNKB
MXDAA98T97LF+W"DK(Q1&"L!MY6++B]6:'R3`8&NR;H3LPDCLOL$H46:Q0J//
M.HK;DK,SCRGG8/GRXU`(K**58[=VU#4+I4CN5;[;;VEK).9YTDCDN(8M.MFB
MDMT1H8A&D*F.5C,LLFR1`-OD2&&>6WC47=Y:2&X@NF<+I[7"QI>)=R:<X-M-
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M'_:SW=U-;:H]P9%N_LUHMM<QW\FR=8+18WG9C=O>`;?(?XUU>:PTG4(88]2M
M)'TOQ)]EU.WGMK6".]L_#5YJ%O$"+D7;RR)]IFA:"':DFD3-)+$5A6Z`.PM+
M<6EK;6HFN+@6UO#;B>[E:>ZG$,:QB:YG;F:X?;N>0\LS$GK0!8H`*`"@#F]<
M\)Z)X@G@N]1MYOMUEIVJ:9IU_;7EW:76F1:O/I5U=75@T$RI;ZFEUHFF2P7P
M0W%LUN?(DC6>990"YJ.@Z7JL-C;ZA#-<PZ;)/);QM?7Z!FNM'U+0;@7ABNE.
MHQOIFK7T92[,Z^9*EQC[1!#+$`<QX:N]:FM=`-U;Z/IMWK&F3:H\0N]2U^[M
M]'LKK2VM-,EU2_FMKG5;LP:Q=2/>NB16TUPL:V\ZYEG`V\CHY([V'4[34GB`
MM5T:^AU.."_U:Z:"\2:QN;(6&E1JMK>1E!JJ27(M5O6864<:&.258@"=K.[V
MQ`26WG3W$)U2:$7MDLD$"2LKVD$-ZS1W;,MK"SO.<Q*=Y=8TA(&WD0/+J4-]
M9VWVFQBCN;B[F\K^S]2O)S:0/O9/M27B16KLDT9\^95CB<K!'%-YBE`-O(?/
M#K<D]^JW&F+ITMNEO96X@U"*_CED\I;F_N-2@OT&U%>X\NT@MX7)AC;[;&93
MY`!+*-9?^T8X'TRTQ);_`-DW4L5W?_NC'";L:CIZ366)!,+A8S#>$%9(V8`Q
MLLH&WD9?F726\UGK^JVS&2_MK+S=,TK6_#WF+J'[NRM+&Z76[B1[OSY("]S:
MW!5%CE5TBY:(`MQPB\E\0PR6FGKONX-/=YK".5;^P.DZ?.\5^@NLWJ;KZ^A7
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MLLVMKG3=5:"8+>+I["\NH1"9(VV`;>5CJI/"/A.33TTF7PQX>DTN,W!CTV31
M=-;3XS=Z1<^'[LI9M;&%#-H-[>:;)A!OM+N:V;,,K(P&WE8Z*@`H`*`"@`H`
M*`.-LO!L>G6=KIUIX@\0P:?8WLLEE:0RZ3;K9Z+(L`B\*6T]OI$=Q%H5N;:'
MR76;^T(U7ROMYA_=T`;7]BVHB^RH[QZ>+&^T]=*CAL$TM;6^%JOE_8!9^5((
M$MG2(2*ZA;RX619%D`0`O16B0NLGFW4CH;W;YMU.R;;ZZ6ZD1H=XB<1LB1PL
MZ,T,0,<;*LCAP-OD58=+$5X;QK_5)VW2F.WFO76SA$LEQ)M%K`L:2A!<R(GG
M"4A4B&<PQE`-OD.ETT,UXT5Y?6AO0CM]FEB7R;R)8(XKZ$RP2$2K';6Z&!R]
MK(L9$MO()9?-`+#V<3I<QL]TJW;K)+Y=]>Q.C+%#$!;217"O9(4@0E+=HE+-
M(Y!>:1G`*^H:1I^IQW$5[;^:+FRGTYW6:>"XBM+EE>=+2ZMY8YK"5Y(X)#-;
M/%+OM;=PX>WB:,`ANM#LKI[QVEU*#[?`T%VMAJ^J:9YA86J+<Q/I]W#)9WJ1
M6D4:W%L\,NPLI8@C`'X#8O#^EP?:-L=XPN;/^SV2;5-5N(X;,VMI9O!917%Z
MZ:>KPV5L7-JL)>1&F<M-(\C@"OH5A)_:<,D0^P:II5MI%SI\6^WM_LT"7T#[
M!!(GE/):WJP%HPCA+6$!L1H$`V,^W\&Z!:Z%9>'%AU&;2]/N'NX!?:_K^HZB
M]U+<7%W+<WNMZAJ<VI:E/)<W5Q(\EW=SLYD^8G`P`:=EH>EZ<T36MLT;0><8
M6EN;JX,9N(K6"9D^TSR;7:&S@3=U`#@$>=)Y@&WE8UJ`"@`H`*`"@#R#XJ^/
M_$_@BY\$V?AKPY8:R_BO6=:TR[O]6G\16^EZ(ND^$]<\30RW\OASPUK$]O!=
M'198/M#0$1$@B*8,[0`&;X.^*^M>*$\$D^%[%?\`A)M*@\6:C<>']<N?$FFZ
M5X+\0L8?`>J07::+9S3W.MR223XNK2RMX;;PUK\CS^;#90:@`>XT`%`!0`4`
M%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`'FOQ`^%N@_$.Z\*:EJ.I^*=!UKP3J>
MHZIX=UOPCX@O-`U*TEU?1[S0M4MIF@WP7UE<Z?>N&AN8)0KPPR1E'CR0";3?
MA=X5T6STW3M&;Q#I5GI&B>!?#MBEEXL\2QW2Z1\/;W5+[0;2]U5M4;4-7\YM
M8OXM1DU&[NY-3CF(OFG<EV`V\BG;?"](+DW,OC_XH7G,$B07'C&XBMHYX/-=
MIEAL+6W#B6:>222WD+VQ^2)85@ABAC`-:+X>:'''&C:IXZF9$1&FE^)?Q$$D
MK*H!DD$/B>.,.Q&XA$1<D[548``%O=!L+:XT;3#<:RMC?R7=GYTWQ!\6VFI?
M:X=(N6MH;,G6Q<:I*]A#J4TB+-YB&U%[AI+<RQ`%^\\-6")<S1R>(Y9YXI+5
M84\8^,((MUW%:V091;ZNPL0H@A<W4$/F6Y-Q<1XEFF:4`Z)XV21IX06ED%K"
MZ2W5PENL$4\C/)'"!)''<+'<3MN2)&F*0QRR!(T:$#;R.?TJRUG3;;68$M[0
M,^H7=QHWVOQ-XAUUI(9FPCZA<ZO;/-8Y"K-]CM&D@A\XP1'$7GS@;>1#I%E]
MEEUJP@^V2V\=V?(-^/$L%W##JLIEU5[7Q'JFHWKWR%U=XHK'[&D+VT:XC26&
M8`&M;:-812I>M;NUY]D:UDDN;BZN28YG:65'2XNYU9]SL@<M(RQXA60Q*%H#
M;RL8%M;Z3)IFBQW'@^WDM?$"VD]S;VFCZ;+8:6PM$DTZ/5X'DWM]GM=EJMS'
M!(BM;G(MTDC2@"M_9/AI3;MJ'P^TRTEO+R>$[M,\+W31(=0MK*TN[D03M(Z7
M+7MN[>2D_DEG$Q4!'E`V\K'.>%D\&^)8M%L[CX>^%;8:YX$TSQ9*;/3M+UG0
M&BUJ]6YN=.T_5TT:"WUBT-\L5ZL^R!YUEM[F2UA>0!0"L_ACPN+%E7PC\-FL
M8/$&BZ%8V5MX.T\?V;I\/C6_\-3QW45P,%)-+3[';-;VT:17+73*)+;F,`YZ
M\U[PAIZ/I</PPTK2[E?"_P`4O$[7*^&[!+#3['X?R^'4%Q;6E_I-A-JMSJ<O
MC'1YX8XX8;=Q%J!6[D2&&6]`/7O`&K:9KO@?PEKNB6.F:9I&M^'M)UG3+#1I
MK>XTNTLM4LH;^V@LI[2VMX985BN%&Z*&-"<[1CD@;>5CKZ`"@`H`*`"@`H`*
M`,;5-#M]6N-,GN;K4XH]+NDO%L[/4+BRL[V>">VN[7^T8K=E-U'!>6=O,B%U
M4E7CD#PS2Q2@%V^L+;4;=K2[$K6[AUDCBNKJT$B2120R1RM:S1M)$T<K@QL2
MI.&QN52`!9[&WN&+3K(_[L1;/M%PL*[)DN(YD@241I=QS1QO'<J@FC*#8ZT`
M1W6F65[::E87L)NK+5H9[?4+2XEFE@GM[JT6QN+=8I)"MO;R6RX:*$1H6DDD
M(\R5V<`EBLX8;NZO$>Z\Z[CMHY4DOKV:T1;03"(VMA-<-;6,C>>_FO;0Q--M
MC\XR>5'L`V\B.QTVRTU3'8PFVB\JU@$*RS&".*RMUM;98H'D,<)6WCCC+1JK
M.(DWEMBX`V\BA:>&M'L;+1M/M[><6F@7)N]+CGU'4KMX;@P7ML)+B>[NY)=0
MVQW]R56[>=5<Q2J!)!"\0!%IOA3P_I$&DP6>DZ?&VBRS7-A<)865O<17]W:2
MV5_J.;.VAC2^O()YQ<21QIYIF8D=,`;>5B2TT"TL=5BU"U\FUM;/0;70--TJ
MUL-/M;73K2"Y>>3[/+!;+<"%XTL(4M?-%O"MB#%$K3.2`10>$/#%K>:G?Q:'
MIWVK5]6L==U"26W6<3:SIL<4=AJ<<4^^.UO(#"DJ2P)&PF9Y\^=*\C@;>1GV
M_P`.?A_:6$NE0>"/"4>F36WB2QFT_P#X1[26LY+#QE+%/XLT][=[0HVGZQ)!
M;?;K4KY-RMK`DR.L,:H!MY6.HL-/L-*M(-/TRRM--L+52EM8V%M#9VENA9G*
M06UNB1PJ79FPB@98GJ:`V\K%N@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"
,@`H`*`"@`H`*`/_9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
